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Abstract 
The high mobility group of nucleosome binding proteins (HMGNs) are chromatin 
architectural proteins that bind specifically to nucleosomes and influence 
chromatin structure and DNA-dependent functions. However, the mechanisms 
underlying these events remain largely unknown. HMGN1 and HMGN2 are highly 
expressed by embryonic stem cells and are downregulated as differentiation 
proceeds. Nevertheless, embryonic and adult neural stem cells retain elevated 
levels of these proteins. Chromatin plasticity is essential for the pluri- and 
multipotency of stem cells and it is achieved by maintaining an open and 
dynamic chromatin conformation. Conversely, developmental potential seems to 
be restricted by chromatin condensation. The present work shows that loss of 
HMGN1 or HMGN2 in pluripotent embryonal carcinoma cells leads to increased 
spontaneous neuronal differentiation, which is accompanied by a reduction in 
pluripotency markers and higher gene expression of lineage-specific 
transcription factors. Inhibition of signalling pathways relevant for neurogenesis 
does not re-establish the phenotype observed in Hmgn2-knockout cells. 
Withdrawal of the factors sustaining pluripotency in embryonal carcinoma cells 
results in higher induction of pro-neural factors in cells lacking HMGN1 or 
HMGN2. Neural stem cells derived from Hmgn-knockout cells also display higher 
gene expression of pro-neural transcription factors and increased spontaneous 
neuronal differentiation. Loss of HMGN2 disrupts the active histone modification 
landscape, and therefore affects the chromatin structure at local and global 
levels. The proposition is that the local changes directly influence the 
transcription rates of pluripotency and lineage-specific transcription factors, 
while the global changes may restrict chromatin plasticity. The present data 
support a hypothesis whereby HMGNs contribute to the chromatin plasticity of 
stem cells by promoting an active histone modification landscape and open 
chromatin conformation, which are essential for preserving the self-renewal and 
developmental potential of stem cells.  
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Chapter 1 Introduction 
1.1 Chromatin biology 
DNA is the molecule that carries heritable information encoding cellular 
structure and function (McCarty, 2003). In eukaryotic cells, it is packaged within 
the nucleus in a nucleoprotein complex called chromatin. The nucleosome is the 
building block of chromatin and consists of an octamer of histone proteins, two 
of each H2A, H2B, H3, and H4, wrapped by 147 base pairs (bp) of DNA 
(Felsenfeld & Groudine, 2003; Kornberg, 1974). Nucleosomes are connected by 
linker DNA, forming an array that folds into a compact fibre of 30 nm in the 
presence of linker histones (Ball, 2003; Felsenfeld & Groudine, 2003). The fibre 
is then looped and folded into higher order structures, such as the mitotic 
chromosomes. In interphase cells, however, chromatin is present in different 
states of condensation that are broadly divided in two types: highly compacted, 
repressive heterochromatin and unfolded, transcriptionally active euchromatin 
(Ball, 2003; Felsenfeld & Groudine, 2003). 
All cellular activities that use the DNA as a template, such as transcription, 
replication, and repair, rely on mechanisms that modulate chromatin and DNA 
accessibility (Bell et al, 2011). In the context of a nucleosome, the linker DNA is 
accessible to catalytic enzymes, such as polymerases, and to transcription 
factors, whereas DNA wrapped tightly around the histone octamer is much less 
accessible. Therefore, nucleosome positioning and stability, and chromatin 
compaction are determining factors for the regulation of DNA-dependent 
functions (Bell et al, 2011). 
Nucleosome positioning is largely reliant on ATP-dependent remodelling 
complexes, which use the energy produced by the hydrolysis of ATP to slide 
nucleosomes, exposing different DNA sequences (Becker & Hörz, 2002). This 
mechanism does not operate randomly throughout the genome, however.  
Nucleosome remodelling complexes are enriched in gene regulatory regions 
where they play roles in marking transcriptional direction and preventing 
inappropriate transcription (Whitehouse et al, 2007). Furthermore, they can be 
recruited by transcription factors to specific genomic regions (Hartley & 
Madhani, 2009). 
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Nucleosome stability is influenced by the nucleosome composition. The 
canonical histones can be replaced by different histone variants, which provide 
specific properties to nucleosomes (Talbert & Henikoff, 2010). Two variants of 
H3 have been widely studied; cenH3 is incorporated at the highly compact 
centromeres whereas H3.3 is associated with active transcription and 
nucleosome remodelling (Talbert & Henikoff, 2010). Interestingly, nucleosomes 
containing H3.3 and H2A.Z have been identified close to transcription start sites 
(TSS), where nucleosome eviction creates a nucleosome-free region, facilitating 
transcription initiation (Jin et al, 2009a). 
Chromatin compaction is largely reliant on reversible and stable covalent 
modifications of the nucleosome. These includes DNA methylation, which can 
result in stable gene silencing, and post-translational histone modifications 
(PTMs), most of which are deposited on the histone tails that protrude from the 
nucleosome (Bannister & Kouzarides, 2011; Bird, 2002). These modifications 
constitute a code that can be read by effectors, influencing DNA-dependent 
activities in a variety of ways (Jenuwein & Allis, 2001).  
For instance, acetylation of the histone tails is recognised by bromodomains, 
which are found in a variety of transcriptional co-activator and adaptor proteins. 
Interestingly, several protein complexes that contain bromodomains also possess 
histone acetyl transferase activity, thus magnifying the message of this 
particular modification (Dhalluin et al, 1999). Chromodomains are readers of 
histone lysine methylation; for example, the chromodomain of the 
heterochromatin protein 1 (HP1) specifically targets the trimethylation on lysine 
9 of H3 (H3K9me3), an PTM that promotes chromatin compaction (Nakayama et 
al, 2001).  
Histone methylation promotes both chromatin activation and repression, 
depending on the residue that is modified. H3K4me3 is enriched at actively 
transcribed genes, while H3K27me3 marks transcriptional silencing (Sims et al, 
2003). These two modifications have been linked with developmental regulation 
by the polycomb group (PcG) of transcriptional repressors, and the trithorax 
group (TrxG) of transcriptional activators (Ringrose & Paro, 2004). Importantly, 
PcG and TrxG, in addition to DNA methylation, form the basis of epigenetic 
inheritance or cellular memory, enabling information concerning gene activation 
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or repression to be transmitted to a daughter cell, which in turn, ensures the 
maintenance of tissue-specific expression profiles and the unidirectionallity of 
developmental processes (Bird, 2002; Margueron & Reinberg, 2011; Ringrose & 
Paro, 2004; Weintraub et al, 1978). 
Chromatin architectural proteins have been also shown to impact chromatin 
compaction. They are devoid of enzymatic activity and bind to chromatin 
without any specificity to the underlying DNA sequence (Postnikov & Bustin, 
2016). There are two super families of chromatin architectural proteins, the high 
mobility group (HMG) and the linker histones (Bustin et al, 2005). The 
classification of the HMG proteins relates to their functional chromatin binding 
motifs, and includes HMGA, HMGB, and HMGN families (Bustin, 2001). HMGAs 
contain the AT hook motif, HMGBs bind and bend the minor groove of DNA, and 
HMGNs specifically target the nucleosome, with higher affinity than to free 
histones or purified DNA (Shirakawa et al, 2000a). In general, HMGs are 
associated with a relaxed chromatin conformation permissive for DNA-dependent 
functions such as transcription, replication, and repair, while linker histones 
promote chromatin compaction and higher order conformations (Postnikov & 
Bustin, 2016). The association of the architectural proteins with chromatin is 
transient and dynamic; they continuously exchange from one nucleosome to 
another (Phair & Misteli, 2000). FRAP studies have demonstrated that all HMGs 
compete with H1 for binding sites (Catez et al, 2002; Catez et al, 2004). The 
emerging picture is that the architectural proteins work in a dynamic network of 
interactions that ultimately modulates chromatin dynamics, structure, and 
function (Postnikov & Bustin, 2016). 
1.2 HMGN family of chromatin architectural proteins 
Pioneering studies identified the two founder members of the HMGN family of 
chromatin architectural proteins among the most abundant and ubiquitous non-
histone proteins found in the nuclei of higher eukaryotes. Weintraub and 
Groudine first showed in 1976 that the chromatin conformation of active genes 
was particularly sensitive to DNase I digestion (Weintraub & Groudine, 1976). 
The DNase I hypersensitivity sites (DHSs) constitute nuclease-accessible regions 
located at transcriptional regulatory sequences, such as promoters and 
enhancers, and are considered to be a hallmark of genes poised or activated for 
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transcription (Martínez de Paz & Ausió, 2016). In a subsequent work, the authors 
eluted the chromatin of active genes with 0.35 M NaCl and noticed that it lost 
the DNase I hypersensitivity (Weisbrod & Weintraub, 1979). This property could 
be reconstituted with a fraction of the 0.35 M NaCl elution, which was highly 
enriched in two proteins that had high mobility on SDS polyacrylamide gels 
(Weisbrod & Weintraub, 1979). HMGN1 and HMGN2 were first described as 
proteins that bind the nucleosomes of actively transcribed genes (Weisbrod et 
al, 1980). 
Expanding the repertory, three other members of the HMGN family were 
described in the subsequent years (Birger et al, 2001; Shirakawa et al, 2000b; 
West et al, 2001). HMGN1 to 5 share a general structure consisting of a bipartite 
nuclear localisation signal (Hock et al, 1998a), a variable negatively charged C-
terminal or regulatory domain (Trieschmann et al, 1995), and a highly conserved 
nucleosome binding domain (NBD) that is the hallmark of the family (Ueda et al, 
2008). 
The genes encoding HMGN1 and HMGN2 have been identified in all vertebrates 
and consist of six exons and five introns. The first exon codes the 5´UTR and the 
first four amino acids of the proteins, the third and fourth exons code the NBD, 
and the last and largest exon codes for the complete 3´UTR, constituting 70% of 
the transcript (Bustin et al, 1990). Genes encoding HMGN3 and HMGN5 also 
exhibit the described structure, although the occurrence of Hmgn3 has only been 
reported in mammals, birds, and amphibians, and that of Hmgn5 exclusively in 
mammals (González-Romero et al, 2015). Hmgn4, however, represents an 
intronless gene that seems to be originated from an insertion of an Hmgn2 
retropseudogene next to an active promoter around 25 million years ago and is 
restricted to primates (Birger et al, 2001; González-Romero et al, 2015). The 
retropseudogene origin of Hmgn4 is in line with the previous finding that the 
HMGN family is among the largest retropseudogene families (González-Romero 
et al, 2015). The structural similarities of the genes suggest that all five 
members evolved from a common ancestor that emerged after the divergence of 
vertebrates (González-Romero et al, 2015). Importantly, previous attempts to 
extract proteins from invertebrates homologous to HMGNs, carrying the NBD, 
have been unsuccessful (González-Romero et al, 2015).  
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Hmgn1 and Hmgn2 transcripts are similar in size, from 1100 to 1250 bp long. The 
open reading frame represents approximately 25% of the sequence, the 5´UTRs 
are short and rich in C and G residues, while the 3´UTRs contain several A and U 
residues and constitute around 70% of the sequence (Bustin et al, 1990). The 
previous structural features are conserved in Hmgn3, Hmgn4, and Hmgn5 
mRNAs. In contrast, the sequences are distinctive of each variant. For instance, 
the open reading frame of Hmgn3 shares 56 and 65% identity with those of 
Hmgn1 and Hmgn2, respectively (West et al, 2001). HMGN4 human transcript, 
however, is 86% identical to HMGN2 but only 62% to HMGN1, which is consistent 
with its potential evolutionary origin (Birger et al, 2001). 
Interestingly, the mRNA sequence of each variant is evolutionarily conserved 
between species, particularly that of the open reading frame. In this sense, the 
open reading frame of the Hmgn2 has 87% sequence identity between chicken 
and human and 93% between mouse and human, which represent evolutionary 
distances of 350 and 96 million years, respectively (Bustin et al, 1990). In the 
case of Hmgn3, the open reading frame of the mouse mRNA is 91% identical to 
that of the human, while Hmgn1 transcript is less conserved among species with 
sequence identities of 60-65% between chicken, mouse, and humans.  
Analyses of the protein sequences agree with the conservation levels of the open 
reading frame of the mRNAs. The mouse, cow, and frog HMGN3 proteins share 
91, 86, and 71% identity with human HMGN3, respectively (West et al, 2001). 
The amino acid sequence identity among HMGN2 proteins is higher than 90%, 
while among the HMGN1 varies between 50-95% (Bustin et al, 1990). Therefore, 
HMGN2 evolved slower than HMGN1. 
Certain degree of amino acid sequence identity is observed between HMGN1 and 
HMGN2, but this is less than 50%; HMGN3 is 41 and 54% identical to HMGN1 and 
HMGN2 (Bustin et al, 1990; West et al, 2001). Importantly, the regions that are 
evolutionary conserved between all five variants encompass the functional 
domains characteristic of the HMGN family; the bipartite nuclear localisation 
signal encoded by exon I and exon V, and the nucleosome binding domain 
encoded by exons III and IV  (Bustin et al, 1990; Malicet et al, 2011; West et al, 
2001). 
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HMGN proteins are expressed in nearly all vertebrate cells and tissues. However, 
the expression patterns of the HMGN variants are different, raising the 
possibility that these proteins function in a tissue-specific manner. Their 
widespread occurrence and evolutionary conservation strongly suggest that they 
play a relevant role for the proper cellular function. 
1.2.1 HMGN binding to chromatin 
HMGNs bind to chromatin through their highly conserved NBD. Point mutations in 
the NBD abolish the structural and functional effects of HMGNs in chromatin 
(Birger et al, 2003; Catez et al, 2002; Deng et al, 2017; Lim et al, 2005; 
Prymakowska-Bosak et al, 2001; Rattner et al, 2009). Two molecules of the same 
variant bind simultaneously to one nucleosome (Postnikov et al, 1995). The core 
of the NBD contacts the acidic patch formed by H2A and H2B, while the NBD C-
terminal region interacts with the DNA (Alfonso et al, 1994; Kato et al, 2011; 
Murphy et al, 2017; Ueda et al, 2008). The regulatory domain contacts and 
repositions the H3 and H4 tails disrupting their interaction with the linker DNA 
(Murphy et al, 2017; Trieschmann et al, 1998). These events result in chromatin 
decompaction via physical interactions. 
Although recent studies have shown that HMGNs and H1 can simultaneously bind 
a nucleosome, the conformational changes induced after HMGN binding might 
affect H1 affinity, displacing it from chromatin and interfering with its 
architectural role in compaction (Murphy et al, 2017). Indeed, it has been 
reported that HMGNs counteract H1-mediated heterochromatin formation (Ding 
et al, 1997; Rochman et al, 2009). Furthermore, the interplay between the two 
major HMGN variants and H1 regulates gene expression relevant for 
oligodendrocyte development (Deng et al, 2017). 
Since their discovery, the HMGNs have been related with active and unfolded 
chromatin (Bustin, 2001; Weisbrod et al, 1980). A major question is how these 
HMGNs are targeted to particular regions in the chromatin. The fact that the 
members of the HMGN family share a disordered structure that facilitates 
multiple protein to protein interactions raises the possibility that other proteins 
recruit HMGNs to specific genomic regions. Indeed, a high proportion of them 
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are found forming macromolecular complexes in the nuclei of cells (Hansen et 
al, 2006; Lim et al, 2002). 
Considering that HMGNs induce conformational changes in the nucleosome and 
are capable of multiple protein to protein interactions, they are also proposed 
to mediate chromatin accessibility to transcription factors or chromatin 
modulators, or act as molecular bridges for epigenetic players and 
transcriptional activators/repressors. In this sense, an antagonistic role of 
HMGNs in ATP-dependent nucleosome remodelling has been described (Rattner 
et al, 2009). In addition, three members of the family have been shown to 
enhance the action of histone acetyl transferases (HATs), and consequently, 
Hmgn1-knockout cells display reduced levels of H3 acetylation (Barkess et al, 
2012; Lim et al, 2005; Ueda et al, 2006). HMGN1 also modulates H3 
phosphorylation (Lim et al, 2004). The influence of HMGNs on post-translational 
histone modifications may be a key mechanism underlying their roles in 
chromatin structure and function. 
1.2.2 Biological functions of HMGN proteins 
The generation of HMGN variant-specific knockout mice in recent years has 
offered considerable opportunities to gain insights into the biological function of 
HMGNs. Single knockout mice are available lacking HMGN1, HMGN2, HMGN3, or 
HMGN5 proteins, and additionally, Hmgn1 and Hmgn2 double-knockout mice 
have been generated. Surprisingly, all mice are viable and do not display severe 
or obvious phenotypes, considering the high degree of evolutionary conservation 
and widespread occurrence of HMGNs. Although in different levels, all variants 
are expressed in many tissues and cell types, which raises the possibility of 
functional compensation among them. In fact, HMGN2 binding to chromatin is 
increased in cells derived from the Hmgn1-knckout mice, and vice versa, without 
affecting the transcriptional or translational rates of the residual HMGN variants 
(Deng et al, 2015). Alternatively, other chromatin architectural proteins 
members of the HMG and H1 super families can compensate the loss of HMGNs, 
since they all work in a dynamic network of interactions (Postnikov & Bustin, 
2016) that may be adjusted in order to maintain chromatin dynamics, structure, 
and function. 
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Nevertheless, HMGNs are not fully redundant. Variant-specific phenotypic 
alterations have been observed; Hmgn1-knockout mice exhibit increased 
tumorigenicity and impaired DNA damage response (Birger et al, 2005; Birger et 
al, 2003), the energy metabolism seem to be perturbed in Hmgn2-knockout mice 
(Deng et al, 2015), and Hmgn3-knockout mice are mildly diabetic (Ueda et al, 
2009). Noteworthy, the phenotypes mentioned above suggest an inefficient 
response to stress or to metabolic conditions. In this regard, alterations in 
epigenetic regulators or chromatin architecture are not always evident in the 
steady state, but in the cellular response to extrinsic stimuli. 
1.2.2.1 Establishment and maintenance of DNA regulatory regions 
A major question is whether the HMGNs are randomly distributed throughout the 
genome in physiological conditions or whether they are positioned at specific 
sites. The development of genome-wide techniques facilitates the analysis of the 
genomic distribution of these proteins. For instance, HMGN1 and HMGN2 have 
shown to colocalise with DHSs of mammalian cells (Cuddapah et al, 2011; Deng 
et al, 2013; Deng et al, 2015; Zhang et al, 2016). Accordingly, the loss of the two 
major HMGN variants reduces the number and intensity of DHSs in living cells, 
suggesting that the chromatin is less accessible in regulatory regions (Deng et al, 
2015; Zhang et al, 2016). Furthermore, cells derived from double-knockout mice 
show a remodelling of the DHS landscape, particularly at enhancer regions (Deng 
et al, 2015; Zhang et al, 2016). Importantly, the loss of the two major HMGN 
variants is required for the chromatin accessibility effects mentioned above, as 
in single-knockout mice the loss of HMGN1 is compensated by increased HMGN2 
binding to chromatin, and vice versa, which ultimate maintains the most of the 
original DHSs.  
Although there is evidence about a relationship between enhancers and HMGNs 
dating from when HMGNs were discovered (Martínez de Paz & Ausió, 2016), it 
remains to be resolved how HMGNs are targeted to enhancers and what 
mechanisms HMGNs utilise for the establishment and maintenance of the DHSs. 
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1.2.2.2 Regulation of gene expression 
The role of the HMGNs in chromatin structure, and particularly, in the 
establishment and maintenance of DHSs, is expected to impact gene expression 
in vertebrate cells.  
Microarray hybridisation and RNA-seq experiments performed in different tissues 
from single Hmgn-knockout mice suggest that the loss of an HMGN leads to both 
upregulation and downregulation of limited genes in a cell type- and variant-
specific manner (Deng et al, 2015; Kugler et al, 2013). In other words, there is 
little overlap of the affected genes between the tissues after the loss of a 
particular HMGN variant, and additionally, the genes affected in a certain tissue 
are different after the loss of each variant. Several conclusions can be derived 
from the previous data. First, HMGNs do not act as general promoters or 
inhibitors of transcription, which contrasts with previous studies in vivo where 
displacing a major HMGN variant from chromatin arrests polymerase II 
dependent transcription (Hock et al, 1998b). Second, there is not a specific 
subset of genes regulated by each HMGN variant, which suggests that the HMGNs 
do not work as transcription factors and is in agreement with the lack of a 
consensus DNA sequence targeting HMGNs to certain genomic loci (Shirakawa et 
al, 2000a). Third, the HMGNs are not fully redundant, since the lack of a single 
variant affects gene expression in every tissue (Deng et al, 2015; Kugler et al, 
2013). And fourth, the HMGNs do not modify the pre-existing expression profile 
of tissues, which is illustrated by principal component analysis where the 
different tissues cluster together regardless the presence or absence of an HMGN 
variant (Kugler et al, 2013). 
The last conclusion is supported by transcriptional analysis during neuronal 
differentiation of embryonic stem cells derived from Hmgn1-knockout mice 
(Deng et al, 2013). In this study, the loss of HMGN1 did not interfere with the 
temporal regulation of gene expression, enabling the establishment of 
expression profiles dictated by the developmental stages. However, subtle 
differences in a subset of genes were observed in the three different stages 
evaluated (Deng et al, 2013). Furthermore, the transition from one stage to 
another is not identical; the directional changes of the genes are retained, i.e. 
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up and downregulation, yet the magnitude of change differs (Deng et al, 2013), 
suggesting that HMGNs optimise the regulation of gene expression. 
Similar observations have been reported when studying the kinetics of 
immediate early genes (IEGs) activation following a stress stimulus. In mouse 
embryonic fibroblasts (MEFs) derived from the double-knockout mice lacking 
HMGN1 and HMGN2, the transcriptional response to treatment with a protein 
synthesis inhibitor and to heat shock displays different kinetics than that 
observed in MEFs derived from control littermates (Deng et al, 2015). Some of 
the evaluated IEGs are induced faster and others slower in the double-knockout 
mice (Deng et al, 2015), reinforcing the concept that HMGNs optimise gene 
expression processes rather than work as activators or repressors of 
transcription. Likewise, the loss of the two major members of the HMGN family 
dampens the magnitude of the defence transcriptional response of B 
lymphocytes when exposed to lipopolysaccharide (Zhang et al, 2016). 
Importantly, the proportion of genes showing alterations in the absence of 
HMGNs is greater when the cells are exposed to stimuli than in the rest state 
(Deng et al, 2015; Zhang et al, 2016). This may explain the impaired glucose 
tolerance of Hmgn3-knockout mice, since the levels of glucose and insulin in the 
serum of fasting animals are normal, while after feeding, sugar-stimulated 
insulin secretion is lower leading to higher blood sugar levels (Ueda et al, 2009). 
Similarly, the Hmgn1-knockout mice exhibit an impaired response to DNA 
damage (Birger et al, 2003).   
Considering these recent experiments and the phenotypes of the knockout mice, 
the emergent picture is that HMGNs fine-tune an already established expression 
profile and ensure the appropriate cellular response to external cues such as 
stress, feeding, infections, and developmental programs. This in turn guarantees 
normal cellular and organism phenotypes. 
1.2.2.3 HMGNs during embryonic development 
The two major HMGN variants are developmentally regulated. They are 
expressed in oocytes and throughout all preimplantation stages (Deng et al, 
2017; Deng et al, 2013; Mohamed et al, 2001). Interestingly, targeting both 
HMGN1 and HMGN2 with small interference RNAs or antibodies complementary 
Chapter 1  28 
 
to the NBD delays initial cell divisions, suggesting that these proteins are 
essential for the proper timing of early developmental stages (Mohamed et al, 
2001).  
After implantation, HMGN1 and HMGN2 are progressively downregulated as 
differentiation proceeds (Furusawa et al, 2006; Lehtonen & Lehtonen, 2001; 
Lehtonen et al, 1998). Their decreasing levels have been observed during 
myogenesis, erythropoiesis, and chondrongenesis, and seems to be required 
since overexpression of HMGN1 impairs normal cellular differentiation (Crippa et 
al, 1991; Furusawa et al, 2006; Pash et al, 1990). Thus, downregulation of the 
two major members of HMGN family seems to be characteristic of and necessary 
for tissue differentiation. 
It is worth mentioning that tissue-specific stem cells and transient amplifying 
precursors appear to retain high levels of HMGN1 and HMGN2 (Furusawa et al, 
2006; Lehtonen & Lehtonen, 2001), suggesting that HMGNs are important for 
stem cell biology. Indeed, the Allen Developing Mouse Brain Atlas (Allen Institute 
for Brain Science, 2008) and the Allen Mouse Brain Atlas (Allen Institute for Brain 
Science, 2004) from the Allen Institute from Brain Sciences database reveal that 
Hmgn1 and Hmgn2 transcripts are highly abundant in the ventricular and 
subventricular zone (VZ and SVZ) of the developing and adult brain, in addition 
to the adult hippocampus. These regions are well-characterised neurogenic 
niches providing the adequate microenvironment sustaining neural stem cell 
(NSC) survival, self-renewal, and differentiation (Bjornsson et al, 2015; Gage, 
2000; Temple, 2001). Immunofluorescence of coronal sections of the developing 
mouse brain demonstrates that HMGN1 and HMGN2 are strongly expressed in the 
VZ and SVZ, and largely colocalise with NSC markers (Nagao et al, 2014). 
1.3 Modelling embryonic development in vitro 
Embryonic development is the process through which the zygotic cell creates a 
complete organism, following cell division and differentiation programs. It is by 
definition epigenetic, since all cells in an organism contain the same genome, 
while expressing different genes. Therefore, it relies on the establishment of 
self-renewal or lineage-specific expression profiles according to a spatio-
temporal patterning (see below). 
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In the 1970s, Stevens reported that pre- and post-implantation mouse embryos 
grafted into the testes of adult mice developed tumours of multilineage 
differentiated cells, and remarkably, that some of the embryonal cells remained 
undifferentiated retaining the capacity to form other teratocarcinomas when 
transplanted serially (Stevens, 1970). The observation that the undifferentiated 
cells were pluripotent and capable of proliferating indefinitely encouraged 
efforts to capture pluripotency in vitro, resulting in defined culture conditions 
suitable for derivation and propagation of embryonal carcinoma cell (ECC) lines 
(Martin, 1980). 
1.3.1 Embryonal carcinoma cells 
ECCs surprised researchers with their similarities to the cells that originate the 
developing mouse embryo; they share several markers corresponding to an 
embryonal identity and can contribute to all tissues in mouse chimaeras (Martin, 
1980). Furthermore, when allowed to aggregate, ECCs form differentiating 
embryoid bodies that resemble early embryos (Martin & Evans, 1975). 
P19 is an ECC line derived from a 7.5-day embryo that was transplanted into the 
testis of an adult mouse, and exhibits a normal male diploid karyotype 
(McBurney & Rogers, 1982). P19 cells does not spontaneously differentiate and 
can be indefinitely propagated in serum-supplemented media (McBurney, 1993). 
However, when stimulated with retinoic acid (RA) they differentiate into 
neurons and glia, while generating endodermal and mesodermal lineages, 
including cardiac and skeletal muscle, after exposure to dimethyl sulfoxide 
(DMSO) (McBurney, 1993). P19 cells can be genetically manipulated, providing a 
suitable system for studying mammalian embryonic development (McBurney, 
1993). 
1.3.2 Embryonic stem cells 
Taking advantage of the derivation method for ECCs, embryonic stem cell (ESC) 
lines were established from mouse pre-implantation blastocysts (Evans & 
Kaufman, 1981). One of the main properties of ESCs is their pluripotency, 
defined as the ability to differentiate into all cell types present in an organism 
and tested as the colonisation of all embryonic tissues after injection into pre-
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implantation mouse embryos (Smith, 2001). Importantly, unlike most of ECCs, 
ESCs present a stable diploid karyotype suitable for contribution into the germ 
line in chimeras, and therefore raise the possibility of transgenic mice derivation 
(Smith, 2001). Finally, ESCs are clonogenic, which means that a clonal 
population can be propagated from a single cell, demonstrating their indefinite 
self-renewal capacity (Smith, 2001). 
Human embryonic stem cells (hESCs) originating from pre-implantation 
blastocysts have been also captured in vitro (Guo et al, 2016; Thomson et al, 
1998). These cells are capable of multilineage differentiation tested in vitro or 
by teratocarcinoma formation, and are indefinitely propagated as 
undifferentiated cells (Guo et al, 2016; Thomson et al, 1998). Conventional hESC 
lines differ in several ways to their mouse counterparts, and interestingly, to 
human blastocysts, including signalling responses, epigenetic landscape, and 
expression profiles (Davidson et al, 2015). It is thought that these hESCs develop 
to post-implantation stages in vitro, which is consistent with the observation 
that human pluripotent cells are transient and rapidly proceed to differentiation 
(Rossant, 2015). Nevertheless, a recent study reported the derivation of hESC 
lines closely related to mouse ESCs and blastocysts in terms of transcriptome, 
epigenome, and metabolism, using a different formulation of the media (Guo et 
al, 2016). Although the coming years will provide further information about 
these hESCs, it seems likely that capturing human pre-implantation stages in 
vitro has been achieved (Guo et al, 2016).  
1.3.3 Epiblast stem cells 
Recently, pluripotent cell lines were derived from the mouse post-implantation 
epiblast, and therefore, are referred as epiblast stem cells (EpiSCs) (Brons et al, 
2007; Tesar et al, 2007). Similar to ESCs, EpiSCs express pluripotency 
transcription factors, maintain their karyotype, and differentiate into all somatic 
cell types; however, they respond differently to signalling pathways involved in 
self-renewal and differentiation (Brons et al, 2007; Tesar et al, 2007). 
Furthermore, EpiSCs display distinct transcriptional profiles resembling late-
gastrulation ectoderm, the layer that develops into neuroectoderm, suggesting 
that these cells are already primed for lineage specification (Kojima et al, 
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2014). Interestingly, mouse EpiSCs and hESCs share important features, such as 
signalling pathway responses and gene expression patterns (Tesar et al, 2007).  
1.3.4 Signalling pathways regulating stemness 
The culture conditions that supported the first successful derivation of mouse 
ESCs consisted of a co-culture with mitotically inactivated feeder cells in serum-
supplemented media (Smith, 2001). Subsequent studies arrived at the conclusion 
that the contribution of feeder cells to ESC propagation relied on the secretion 
of leukaemia inhibitor factor (LIF), and therefore, the layer of feeders could be 
replaced by LIF (Smith et al, 1988). LIF activates the Janus associated kinases 
(JAKs), promoting signal transducer and activator of transcription 3 (STAT3)-
mediated effects in ESC self-renewal (Niwa et al, 1998). However, LIF alone does 
not indefinitely sustain pluripotency and, after few cell passages, the cells 
differentiate towards the neural pathway (Ying et al, 2003b). Therefore, serum 
was suggested to contain inhibitors of neural fates. In this sense, bone 
morphogenetic proteins (BMPs) antagonise neural induction and can replace the 
serum in the culture media, allowing the development of chemically defined 
formulations (Ying et al, 2003a). 
As previously mentioned, in the presence of LIF alone, ESCs proceed towards 
neural lineages (Ying et al, 2003b), and intriguingly, in the absence of LIF, BMPs 
promote non-neural specification (Ying et al, 2003a). Therefore, serum/LIF or 
BMP/LIF combinations sustain self-renewal by preventing differentiation, which, 
in chemically defined media, indicates that ESC differentiation is triggered by 
either intrinsic programs, or autocrine/paracrine cues (Martello & Smith, 2014). 
Further studies demonstrated that the autocrine stimulation of the fibroblast 
growth factor (FGF) receptor by FGF4 is required for ESC differentiation (Kunath 
et al, 2007; Stavridis et al, 2007). Ablation of FGF signalling in ESCs impedes 
neural and non-neural induction, indicating that FGF signalling acts upstream of 
the commitment to a certain lineage, and LIF/BMP block differentiation of 
committed cells (Kunath et al, 2007; Ying et al, 2003b). FGF signalling activates 
the mitogen-activated protein kinase (MAPK) cascade (Stavridis et al, 2007); 
accordingly, inhibition of the MAPK cascade sustains ESC self-renewal in the 
absence of LIF and BMPs (Ying et al, 2008).  
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It is worth mentioning that the FGF/MAPK cascade promotes proliferation in 
many cell types, including EpiSCs and hESCs (Brons et al, 2007; Tesar et al, 2007; 
Thomson et al, 1998). Therefore, independence from this signalling pathway is a 
particular characteristic of ESCs that changes during development (Martello & 
Smith, 2014; Smith, 2017). 
The observation that the factors sustaining ESC self-renewal shield the cells from 
differentiation means that pluripotency can be regarded a stable cell state. 
Hence, ESCs will remain undifferentiated unless instructed otherwise (Ying et al, 
2008). However, culturing ESC under MAPK cascade inhibition in chemically 
defined media leads to increased apoptosis (Ying et al, 2008). The inclusion of 
an antagonist of glycogen synthase kinase 3 (GSK3) in the culture media 
increases the survival of ESCs and, in conjunction with LIF, these two inhibitors 
(2i) support the propagation of a more homogeneous population in terms of 
morphology and pluripotency gene expression than that cultured in serum/LIF or 
BMP/LIF (Wray et al, 2010; Ying et al, 2008).   
1.3.5 Transcription factors of stemness 
The POU class V homeobox 1 (POU5F1) was the first described pluripotency 
transcription factor; it is highly expressed in P19 cells and its transcription rates 
drop upon RA induced neuronal differentiation (Okamoto et al, 1990). In mouse 
development, POU5F1 is detected in the oocyte, blastocyst, and epiblast; during 
gastrulation, however, POU5F1 is present exclusively in cells generating the 
germ line (Schöler et al, 1990). Furthermore, embryos lacking POU5F1 can 
proceed towards the blastocyst stage, but the pre-implantation epiblast loses 
pluripotency and differentiates into trophoectoderm (Nichols et al, 1998). 
Surprisingly, trophoectoderm differentiation is also observed after the loss of 
POU5F1 in ESCs, even when blastocysts does not differentiate into 
trophoectoderm (Niwa et al, 2000). 
The sex-determining region-Y box 2 (SOX2) binds co-operatively with POU5F1 at 
enhancers of relevant pluripotent genes, including NANOG homeobox, Pou5f1, 
and Sox2, among others (Masui et al, 2007). SOX2 is essential in this positive 
feedback loop that stabilises Pou5f1 gene expression (Masui et al, 2007). POU5F1 
and SOX2 are included in the transcription factor cocktail that induces active 
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cellular reprogramming from fibroblasts into induced pluripotent stem cells 
(iPSCs), demonstrating their determinant role in pluripotency (Takahashi & 
Yamanaka, 2006). 
The transcription factor NANOG can promote ESC self-renewal in serum-
supplemented media in the absence of LIF (Chambers et al, 2003). Conversely, 
loss of NANOG reduced the clonogenic capacity of ESCs; however, it did not 
completely abolish self-renewal (Chambers et al, 2007). Nanog expression during 
development is more restricted than that of Pou5f1 and Sox2; it starts in the 
morula stage and is downregulated upon implantation (Chambers et al, 2003). 
POU5F1, SOX2, and NANOG co-occupy several target genes (Boyer et al, 2005). In 
addition, they collaborate to form a pluripotency transcriptional network that is 
auto-regulated by positive feedback loops (Boyer et al, 2005; Chen et al, 2008). 
Other elements of the pluripotency transcriptional network are KLF2, KLF4, 
ESRRB, TBX3, among others (Nichols & Smith, 2012). It has been shown that the 
expression of target genes regulated by this network is higher when four or more 
of the pluripotency transcription factors bind to the regulatory regions (Kim et 
al, 2008). NANOG, KLF2, KLF4, ESRRB, TBX3 are individually dispensable for ESC 
self-renewal, but collaborate in the maintenance of the pluripotency 
transcriptional network (Nichols & Smith, 2012). Interestingly, these are all 
uniformly expressed by ESCs cultured in 2i/LIF media, while displaying a mosaic 
gene expression in serum/LIF or BMP/LIF (Chambers et al, 2007; Kalmar et al, 
2009; Marks et al, 2012; Wray et al, 2010). Furthermore, they are downregulated 
in the post-implantation epiblast and in EpiSCs, and their downregulation is 
accompanied by higher expression of lineage-specific genes (Chambers et al, 
2007; Kalmar et al, 2009; Kinoshita & Smith, 2018; Nichols & Smith, 2009; Smith, 
2017). 
The previous observations led to the proposition of the existence of a naïve 
pluripotency state that is largely homogeneous in morphology and transcription 
factor gene expression, and a primed pluripotency state that represents a 
further developmental stage, displaying lineage-specific gene expression 
(Kinoshita & Smith, 2018; Nichols & Smith, 2009; Smith, 2017). In the mouse 
embryo, these pluripotency states correspond to pre- and post-implantation 
embryos, whereas in pluripotent cells they correspond to naïve ESCs and EpiSCs, 
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respectively (Kinoshita & Smith, 2018; Nichols & Smith, 2009; Smith, 2017). 
Naïve ESCs are uniformly propagated in 2i/LIF media and homogeneously express 
NANOG, KLF2, KLF4, ESRRB, TBX3, among other naïve pluripotency transcription 
factors (Marks et al, 2012; Wray et al, 2010; Ying et al, 2008). ESCs cultured in 
serum/LIF or BMP/LIF constitute a heterogeneous population of naïve, primed, 
and intermediate pluripotency states (Chambers et al, 2007; Kalmar et al, 2009; 
Kinoshita & Smith, 2018; Nichols & Smith, 2009; Smith, 2017). 
It is worth mentioning that the expression profiles and morphological features of 
cells cultured in serum/LIF or BMP/LIF and 2i/LIF are interconvertible (Marks et 
al, 2012). Furthermore, cells expressing lower levels of naïve pluripotency 
factors and higher levels of lineage-specific genes are capable of self-renewal, 
and can originate cells with naïve expression profiles (Abranches et al, 2014; 
Chambers et al, 2007; Herberg et al, 2016; Kalmar et al, 2009). 
In contrast to the loss of naïve pluripotency factors, POU5F1 and SOX2 remain 
expressed at high levels during early ESC differentiation (Kalkan et al, 2017; 
Trott & Martinez Arias, 2013). It is likely that these two factors contribute to 
cell fate decisions by interacting with lineage-specific transcription factors in 
the establishment of transitory expression profiles. For example, POU5F1 and 
OTX2 co-occupy a set of enhancers during early ESC differentiation that is 
different to the enhancers bound by POU5F1/SOX2 in pluripotent cells (Buecker 
et al, 2014). In addition, this developmental transition is accompanied by 
changes in the epigenetic landscape, highlighting the importance of chromatin in 
the establishment and maintenance of lineage-specific expression profiles 
(Buecker et al, 2014). 
1.3.6 Epigenetic modulators of stemness 
POU5F1, SOX2, NANOG, and other naïve pluripotency transcription factors 
collaborate to regulate the expression of target genes (Chen et al, 2008; Kim et 
al, 2008). Notable, their binding sites in ESCs strongly colocalise with those of 
the HATs CREBBP and EP300 (Chen et al, 2008; Fang et al, 2014; Göke et al, 
2011). Additionally, POU5F1 physically interacts with WDR5, which is a member 
of TrxG, and their binding sites in ESCs extensively overlap (Ang et al, 2011). 
These observations suggest that pluripotency transcription factors recruit 
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chromatin modifiers to activate the expression of target genes. Furthermore, 
the overlapping sites include regulatory regions of the master regulators of 
pluripotency, POU5F1, SOX2, and NANOG, suggesting that chromatin modifiers 
participate in the positive feedback loops stabilising self-renewal of ESCs (Ang et 
al, 2011; Göke et al, 2011; Zhong & Jin, 2009). 
Accordingly, the lower pluripotency transcription factor gene expression upon 
ESC differentiation is accompanied by a global reduction of histone acetylation, 
H3K4me3, and Wdr5 expression (Ang et al, 2011; Krejčí et al, 2009; Lee et al, 
2003). Furthermore, knockdown of WDR5 and double-knockdown of CREBBP and 
EP300 in mouse ESCs compromise self-renewal and facilitate differentiation, 
since the cells display lower alkaline phosphatase reactivity and pluripotency 
gene expression, in addition to higher lineage-specific transcription rates (Ang et 
al, 2011; Fang et al, 2014). Conversely, treatment with histone deacetylase 
(HDAC) inhibitors supports ESC self-renewal and delays induced differentiation 
(Qiao et al, 2015; Ware et al, 2009). 
These observations suggest that an open chromatin conformation is essential for 
the maintenance of self-renewal and pluripotency of ESCs, and enhances the 
function of the pluripotency transcriptional network. In agreement, chromatin of 
ESCs present unique global features that distinguish it from that of 
differentiated cells, provide a homogeneously decondensed and dynamic 
structure, and confer great plasticity to the fibre (Mattout & Meshorer, 2010). 
Such features include numerous DHSs (Deng et al, 2013), enriched active marks 
(Efroni et al, 2008; Guenther et al, 2007; Krejčí et al, 2009), reduced DNA 
methylation and H3K9me3 (Bibikova et al, 2006; Efroni et al, 2008), fewer and 
less condensed heterochromatin foci (Efroni et al, 2008; Meshorer et al, 2006), 
and hyperdynamic binding of chromatin architectural proteins, such as H1 and 
HP1 (Meshorer et al, 2006), in addition to HMGNs (Deng et al, 2013). 
The open chromatin conformation of ESCs favours global activation of the 
genome. Indeed, the total RNA content normalised to DNA is two fold higher in 
ESCs than in lineage-specific precursors (Efroni et al, 2008). ESCs transcribe 
genomic regions that are usually repressed in somatic cells, such as repetitive 
sequences and lineage-specific genes for other tissues, although at very low 
levels, denoting a noisy transcriptional hyperactivity, which is suggested to 
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constitute a hallmark of ESCs (Efroni et al, 2008). This transcriptional 
hyperactivity requires further control to avoid misinterpreted signals that may 
result in precocious differentiation (Chi & Bernstein, 2009). Chromatin modifiers 
have been shown to buffer gene expression; accordingly, HATs and HDACs are 
both targeted to active and silenced genes (Wang et al, 2009). Dynamic cycles of 
acetylation and deacetylation inhibit promiscuous initiation at active genes 
while also priming the repressed genes for future activation (Wang et al, 2009). 
In ESCs, developmental transcription factors driving differentiation towards a 
specific lineage are repressed by PcG, displaying increased levels of H3K27me3 
compared to differentiating cells of that lineage (Boyer et al, 2006). However, 
these genes also accumulate H3K4me3 at the promoter region (Azuara et al, 
2006; Bernstein et al, 2006). These bivalent domains at developmental gene 
promoters constitute another hallmark of ESCs, which restrict gene expression 
while poising the genes for transcriptional activation (Azuara et al, 2006; 
Bernstein et al, 2006; Marks et al, 2012). Bivalent genes resolve into 
monovalency during differentiation, retaining either H3K4me3 or H3K27me3 
marks, depending on whether the gene becomes active or silenced (Mikkelsen et 
al, 2007). In this sense, epigenetic pre-patterning has been shown to play an 
important role in cell fate decisions during development (Szutorisz et al, 2005; 
Xu et al, 2011). 
Once a cell’s fate has been specified, its expression profiles and cellular identity 
are highly stable, and modifiers of chromatin structure play an important role in 
cellular memory (Ringrose & Paro, 2004). Consequently, epigenetic cellular 
memory represents an enormous challenge for the reprogramming of somatic 
cells into iPSCs (Chen & Dent, 2013). 
Considering all of the above, it is clear that chromatin structure and modifiers 
perform important roles in pluripotency maintenance and ESC fate decisions, 
and these roles are beyond that of stabilising the expression profile driven by 
transcription factors (Chen & Dent, 2013).  
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1.4 Neural fates 
Neural induction of ESCs occurs in the gastrulation embryo under BMP/SMAD 
signalling inhibition (Wilson & Houart, 2004). This observation led to the 
proposition of a default model of neural induction, suggesting that ESCs 
naturally acquire a neural identity unless instructed otherwise (Hemmati-
Brivanlou, 1997; Munoz-Sanjuan & Brivanlou, 2002; Wilson & Edlund, 2001). In 
agreement, ESCs differentiate into neural progenitors in vitro upon withdrawal 
of the factors that sustain pluripotency (Ying et al, 2003b). The neuroectoderm 
is the first neural structure and is comprised of neuroepithelial cells that amplify 
by symmetric divisions, constructing first the neural plate, and subsequently, 
the neural tube (Martynoga et al, 2012). At the onset of neurogenesis, these 
neuroepithelial cells specify into radial glia cells, expressing fatty acid binding 
protein 7 (FABP7) and attaching to the VZ, which function as NSCs during 
development and in the adult brain (Kriegstein & Alvarez-Buylla, 2009). 
1.4.1 Neural stem cells: neurogenesis and gliogenesis  
NSCs are multipotent tissue-specific stem cells capable of self-renewal, and they 
can differentiate into neurons and into the main macroglial lineages: astrocytes 
and oligodendrocytes (Gage, 2000; Kriegstein & Alvarez-Buylla, 2009; Temple, 
2001).  
Once the NSCs have specified into radial glia, they divide asymmetrically to 
generate another radial glial cell and a more differentiated cell, which leaves 
the VZ and initiates neuronal differentiation (Martynoga et al, 2012). In the 
particular case of the cerebral cortex, there are intermediate states mediated 
by intermediate progenitors that, after limited rounds of self-renewal at the 
SVZ, differentiate into early-born and late-born cortical neurons migrating 
towards deeper and upper cortical layers, respectively (Molyneaux et al, 2007). 
In agreement, NSCs isolated from early stages produce a majority of early-born 
neurons, while NSCs from later stages differentiate into late-born neurons (Shen 
et al, 2006). Interestingly, early-stage NSCs can differentiate into late-born 
neurons after exposure to the proper environmental cues, however, late-stage 
NSCs cannot produce early-born neurons even if they are embedded into an early 
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environment, which suggest that there is a temporal restriction in the 
developmental potential of NSCs (Shen et al, 2006). 
In fact, the developmental potential of NSCs changes over time and a neurogenic 
to gliogenic switch is observed in vitro from isolated NSCs (Qian et al, 2000). 
After the neurogenic phase, most of the radial glia transform into astrocytes and 
the astrogenesis continues postnatally (Kriegstein & Alvarez-Buylla, 2009). 
Similarly, oligodendrocyte differentiation occurs in waves starting from the 
onset of astrogenesis to postnatal stages (Kessaris et al, 2005). The precise 
spatio-temporal regulating of the molecular switches defining the neurogenic to 
gliogenic transition is crucial for the proper size and morphology of neural 
tissues (Hirabayashi & Gotoh, 2005; Miller & Gauthier, 2007).  
Finally, some NSCs persist in the adult brain at the SVZ and the dentate gyrus of 
the hippocampus, where they continuously generate neurons and glia (Gage, 
2000; Kriegstein & Alvarez-Buylla, 2009; Temple, 2001).    
1.4.2 Molecular mechanisms regulating neurogenesis 
The basic helix-loop-helix (bHLH) pro-neural transcription factors perform 
pivotal roles in neuronal differentiation. Three of them, Neurogenin 1 and 2 
(NEUROG1 and NEUROG2), and mammalian achaete-scute family bHLH 
transcription factor 1 (ASCL1), are expressed in cortical NSCs and their loss is 
associated with impaired neurogenesis and premature glial differentiation (Nieto 
et al, 2001). Furthermore, forced gene expression of a single one or a 
combination of these pro-neural transcription factors is sufficient to induce 
neurogenesis in P19, mouse ESCs, and human iPSCs (Farah et al, 2000; Reyes et 
al, 2008; Thoma et al, 2012; Velkey & O'Shea, 2013). These observations suggest 
that the pro-neural transcription factors orchestrate neuronal differentiation 
programs. In addition to its neurogenic role, NEUROG1 inhibits astrocyte 
differentiation of NSCs, contributing to a proper timing of the developmental 
switches (Sun et al, 2001).   
Considering the above information, it is essential to maintain silencing of pro-
neural genes in order to avoid precocious or extended neuronal differentiation. 
In this sense, NOTCH signalling has been proven to promote survival and self-
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renewal of NSCs, and to promote gliogenesis following the neurogenic phase 
(Ohtsuka et al, 2001; Oishi et al, 2004). NOTCH signalling is mediated by the 
proteolytic cleavage of the cell membrane receptor upon ligand binding; 
subsequently, the NOTCH intracellular domain (NICD) translocates to the nucleus 
where it activates the transcription of the pathway effectors (Lai, 2004). The 
hairy and enhancer of split (HES) family of bHLH transcriptional repressors are 
among the main NOTCH effectors, regulating lineage-specific stem cell 
maintenance and fate decisions (Kageyama et al, 2007; Ohtsuka et al, 1999). In 
particular, NOTCH signalling promotes self-renewal of NSCs and gliogenesis, 
through a mechanism in which HES1 and HES5 antagonise the expression of pro-
neural genes, and therefore, the commitment to neurogenesis (Kageyama et al, 
2007; Shimojo et al, 2008).  
In addition, FGF signalling potentiates self-renewal of NSCs in a cell-autonomous 
manner that impedes precocious differentiation into intermediate progenitors or 
neurons (Kang et al, 2009). Interestingly, WNT signalling performs dual roles in 
NSC fate decisions; at early stages, WNT stimulates self-renewal (Kuwahara et 
al, 2010), while instructing neurogenesis by the induction of Neurog1 expression 
at later stages (Hirabayashi et al, 2004). 
At the onset of the gliogenic phase, stable silencing is required to guarantee the 
neurogenic to gliogenic switch. The PcG repressor complex PRC2 is recruited to 
the Neurog1 gene promoter where it deposits the repressive PTM H3K27me3, 
reducing the chromatin accessibility of this pro-neural gene (Hirabayashi et al, 
2009). Furthermore, chromatin of NSCs experiences a progressive condensation, 
where the self-renewal and neurogenic potential of early-stage NSCs correlate 
with a higher DNase I hypersensitivity, while late-stage NSCs show a more 
compacted chromatin conformation (Kishi et al, 2012). 
These observations provide evidence that NSC fate decisions are regulated by 
the interaction of extrinsic cues, intrinsic transcriptional programs, and 
epigenetic modulators. 
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1.4.3 HMGN proteins in neural lineages 
As previously mentioned, NSCs express high levels of HMGN1 and HMGN2 (Nagao 
et al, 2014), and interestingly, Deng et al (2013) reported an increase in the 
expression of Hmgn1 in the transition from ESC to NSC following a neuronal 
differentiation protocol. Although this result was out of the scope of the 
authors’ work, it strongly suggests that HMGNs are relevant for NSC biology. In 
agreement, the SVZ of the adult Hmgn1-knockout mice harbor fewer cells for 
the NSC marker Nestin (NES) and displays lower Nes transcript levels (Deng et al, 
2013). 
The HMGNs are not only important for the maintenance of NSCs, but in addition, 
for NSC fate decisions. Nagao et al (2014) reported that HMGNs promote 
astrocyte differentiation at the expense of neurogenesis. Overexpression of 
either HMGN1 or HMGN2 in NSCs isolated from both early and late stage 
embryogenesis resulted in higher numbers of astrocytes compared to control, 
and conversely, siRNAs targeting Hmgn1, Hmgn2, or Hmgn3 increased 
neurogenesis from these cells (Nagao et al, 2014). Similar outputs were observed 
when evaluating the brains of seven day old mice after introducing plasmids 
encoding HMGN1, HMGN2, HMGN3, or siRNAs targeting either of these variants 
into cortical neural precursor cells by in utero electroporation at the stage 
corresponding to gliogenesis onset (Nagao et al, 2014). Notably, Hmgn-
expressing plasmids failed to increase gliogenesis when introduced to the neural 
precursor cells at earlier stages (Nagao et al, 2014), suggesting that a pre-
requisite for these phenomena is that the neural precursor cells have acquired 
gliogenic potential. 
Recent studies have shown that ESC differentiation towards neural lineages is 
altered when one or both of the major HMGN variants are lacking (Deng et al, 
2017; Deng et al, 2013). Gene ontology analysis revealed that expression of 
genes in pathways related to neuronal development were altered in the 
knockout cells (Deng et al, 2017). Moreover, in vitro oligodendrocyte 
differentiation of double-knockout ESCs is significantly less efficient than control 
ESCs, which is consistent with the lower number of OLIG2-positive cells observed 
in the spinal cord of the double-knockout mice and the behavioural alterations 
of these animals (Deng et al, 2017).  
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Taken together, these studies support a role for HMGNs in the regulation of 
developmental processes along the neural lineage. 
1.5 Hypothesis and specific aims 
The general hypothesis of this project is that the two major members of the 
HMGN family of chromatin architectural proteins, HMGN1 and HMGN2, play an 
important role in the establishment and/or maintenance of the particular active 
chromatin conformation and histone modification landscape of pluripotent cells, 
which in turn are essential for the self-renewal and the preservation of the 
differentiation potential of these cells. Therefore, loss of HMGN1 or HMGN2 may 
interfere with the pluripotency of P19 embryonal carcinoma cells. 
1.5.1 Specific aims: 
1. To investigate whether the loss of HMGN1 and HMGN2 affects the protein 
and transcript levels of pluripotency and lineage-specific markers. 
2. To investigate whether P19 cells retain their differentiation potential 
after the loss of a major HMGN variant. 
3. To investigate whether NSCs can be derived from P19 cells lacking HMGN1 
or HMGN2, as they can be derived from P19 WT cells and ESCs, and 
whether these cells present a normal phenotype. 
4. To investigate whether the loss of a major HMGN variant modifies the 
histone modification landscape of P19 cells. 
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Chapter 2 Materials and Methods 
2.1 Cell culture 
Table 2.1 Cell culture product information 
Product Provider Catalogue number 
DMEM/F12 Thermo Fisher Scientific 12634-010 
Neurobasal media Thermo Fisher Scientific  21103-049 
Recovery cell culture 
freezing media 
Thermo Fisher Scientific 12648-010 
New born calf serum Thermo Fisher Scientific 26010-074 
Fetal bovine serum Sigma-Aldrich F7624 
GlutaMAX Thermo Fisher Scientific 35050-038 
N2 supplement  Thermo Fisher Scientific  17502-048 
B27 supplement  Thermo Fisher Scientific  17504-044 
BSA fraction V  Thermo Fisher Scientific  15260-037 
TrypLE Thermo Fisher Scientific 12604-013 
LIF ESGRO, Millipore  ESG1107 
PD03259010 Stratech S1036-SEL 
CHIR99021 Stratech G09-901B-SGC 
FGF2 Peprotech 450-33 
EGF Peprotech 315-09 
FGF8 Thermo Fisher Scientific  PHG0184 
SU-5402 Sigma-Aldrich SML0443 
XAV-939 Stratech S1180-SEL 
DAPT Sigma-Aldrich D5942 
RA Sigma-Aldrich R3255 
Laminin Sigma-Aldrich L2020 
Gelatine Sigma-Aldrich G1890 
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2.1.1 Embryonal carcinoma cells 
P19 mouse ECCs (ATCC CRL-1825) were routinely propagated onto uncoated 
tissue culture flasks in DMEM/F12 basal media supplemented with 2 mM 
glutaMAX and 10% new born calf serum (P19 media) at 37°C in a 5% CO2 
incubator. Cells were passaged every two days using TrypLE at a constant 1:12 
split ratio. For freezing, 2 x 106 cells were re-suspended in 1 ml of recovery cell 
culture freezing media, immediately transferred into a cryovial, and deposited 
into a cell freezing container (Biocision BCS-405) at -80°C. Then, cells were 
stored in liquid nitrogen. For thawing, a cryovial was partially thawed and cells 
were transferred drop by drop to 9 ml of pre-warmed P19 media. Cells were 
then centrifuged at 200 RFC, re-suspended in new P19 media and seeded onto an 
uncoated tissue culture flask. 
2.1.2 Retroviral production of HMGN2 
Retroviral production using the pBABE-hygro vector, and P19 cell infection were 
performed by Mariarca Bailo and Faika Laz Banti. Briefly, Phoenix-Eco retrovirus 
producer cells were obtained from ATCC and cultured in DMEM with 10% FBS. 
Protocols were based on those defined by the Nolan laboratory, Stanford 
University. Phoenix-Eco cells were transfected with plasmid pBABE-hygro 
(Addgene) or pBABE-hygro-HMGN2 using lipofectamine 2000 (Thermo Fisher 
Scientific 31985-062). pBABE-hygro-HMGN2 contains the human HMGN2 cDNA 
inserted in the EcoRI/Sal1 sites of the pBABE-hygro vector and was created by 
Brenna Flately. Retroviral suspension was passed through a 0.2 µm filter, 
concentrate with a centrifugal filter, then added to P19 cells in the presence of 
hexadimethrine bromide (Sigma-Aldrich H9268). Infected cells were selected 
with 400 µg/ml hygromycin, then maintained in 200 µg/ml hygromycin routinely. 
2.1.3 Pathway inhibitor treatment 
P19 WT and Hmgn-knockout cells were seeded at 2 x 105 cells/well in 6-well 
plates with 2 ml of P19 media. Cells were allowed to attach overnight at 37°C in 
a 5% CO2 incubator. The next day, XAV-939 was used for inhibiting WNT, DAPT 
for NOTCH, and SU-5402 for FGF; all inhibitors were added to the culture media 
at a final concentration of 10 µM. After 24 h, cells were harvested according to 
the qRT-PCR protocol and samples were stored at -80°C until required. For the 
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present work, the experiment was performed in triplicated at consecutive cell 
passages. 
2.1.4 Neural induction 
Neuronal induction of P19 WT and Hmgn-knockout cells was performed according 
to the rapid and efficient method of neuronal differentiation previously reported 
(Nakayama et al, 2014). Cells were seeded at 1 x 105 cells/ml onto laminin-
coated wells of 6-well plates in neural induction media. For the laminin-coating, 
laminin was added to sterile PBS at a final concentration of 0.5 µg/ml and the 
solution was filter-sterilised; then, enough volume to cover the surface was 
added to the dish and removed following 4 h of incubation at 37°C. Neural 
induction media consisted of DMEM/F12, 1X N2 supplement, 200 mM glutaMAX, 
500 nM RA, 10 ng/ml FGF8, and 10 µM DAPT. The day of seeding was considered 
day 0. For the present work, the protocol was performed two independent 
times, including different cell lines each time, and therefore, the results were 
presented separately (see chapter 5). 
2.1.5 Differentiation in N2 media 
P19 WT and Hmgn-knockout cells were seeded at 1 x 105 cells/ml onto laminin- 
coated wells of 6-well plates (see above) in N2 media. N2 media consists of 
DMEM/F12, 1X N2 supplement, and 200 mM glutaMAX. The day of seeding was 
considered day 0. 
2.1.6 Embryonic stem cells 
E14 mouse ESCs (Genome Research Limited) were routinely propagated onto 
0.1% gelatine-coated dishes in 2i media (Ying et al, 2008) at 37°C in a 5% CO2 
incubator. Cells were passaged every two days using TrypLE at a constant 1:10 
split ratio (approximate seeding density of 1.5 x 104 cells/cm2). For gelatine-
coating, 0.1% w/v gelatine solution was prepared and filter-sterilised; then, 
enough volume to cover the surface of the dish was added and, after 1 h at 
37°C, the solution was removed. For preparing 2i media 1 x 103 U/ml LIF, 1 µM 
PD03259010 (MAP2K inhibitor), and 3 µM CHIR99021 (GSK3 inhibitor) were added 
to N2B27 media (Table 2.2). For freezing, 2 x 106 cells were re-suspended in 1 ml 
of freshly prepared freezing media (60% N2B27 media, 30% fetal bovine serum, 
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and 10% DMSO), immediately transferred into a cryovial, and deposited into a 
cell freezing container (Biocision BCS-405) at -80°C. Then, the cells were stored 
in liquid nitrogen. For thawing, a cryovial was partially thawed and the cells 
were transferred drop by drop to 9 ml of pre-warmed 2i media. Cells were then 
centrifuged at 200 RFC, re-suspended in new 2i media, and seeded onto a 
gelatine-coated 10 cm dish. 
Table 2.2 N2B27 media  
Product Final conc. 
DMEM/F12 
Mixture 1:1 ratio 
Neurobasal 
N2 supplement 0.5X 
B27 supplement 0.25X 
GlutaMAX 2 mM 
BSA fraction V 50 µg/ml 
2-mercaptoethanol 0.1 mM 
 
2.1.6.1 Differentiation 
Neural induction and differentiation of E14 cells were performed according to a 
previous report (Ying et al, 2003b). Before starting, E14 cells were cultured at 
high density (1.5 x 105 cells/cm2) onto gelatine-coated dishes in 2i media and 
usual conditions for 24 h. Then, cells were dissociated using TrypLE and seeded 
onto gelatine-coated wells of 6-well plates at low density (1.0 x 104 cells/cm2) in 
N2B27 media (Table 2.2). Neural induction was therefore achieved by 
withdrawing the factors that sustain pluripotency of ESCs. The day of seeding in 
N2B27 media was considered day 0. The medium was renewed every day. 
2.1.7 Neural stem cells 
Neural induction of P19 cells and ESCs was achieved as previously described. At 
indicated time points, NSC derivation and differentiation were performed by 
following and adapting a previously reported method (Conti et al, 2005). 
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2.1.7.1 NSC derivation 
E14 cells: at day 6, the cells were dissociated and 3 x 106 cells were seeded as 
suspension into an uncoated tissue culture flask in NSC media (10 ng/ml each, 
FGF and epidermal growth factor (EGF), were added to N2B27 media), allowing 
the formation of floating neurospheres. Three days after, the floating aggregates 
were collected and seeded onto gelatine-coated dishes in NSC media, this was 
considered passage 1. From this point, the cells were routinely propagated in 
gelatine-coated dishes and NSC media by passaging them every two days at 1:3-
1:5 split ratio. Under these conditions, after few passages, the cells acquired a 
homogeneous characteristic bipolar morphology. Cells from passage 8 and 
onwards were used for analysis. 
P19: at 3 days after induction, NSC media replaced the neural induction media. 
The day after, the cells were transferred to a gelatine-coated dish in NSC media, 
this was considered passage 1. From this point, the cells were routinely 
propagated in gelatine-coated dishes and NSC media by passaging them every 
two days at 1:3-1:5 split ratio. Under these conditions, after few passages, the 
cells acquired a homogeneous characteristic bipolar morphology. Cells from 
passage 8 and onwards were used for analysis.  
2.1.7.2 NSC differentiation 
Neuronal differentiation of E14- and P19-derived NSCs was triggered by 
withdrawing EGF and dropping the concentration of FGF2 to 5ng/ml in N2B27 
media. The cells were seeded onto laminin-coated wells of 6-well plates or 
coverslips at a density of 1 x 105 cells/ml. The medium was replaced every two 
days and the cells were harvested for analysis one week after growth factor 
restriction. 
For glial differentiation 2 x 105 cells/ml were seeded onto laminin-coated wells 
of 6-well plates and coverslips in N2B27 media supplemented with 1% of new 
born calf serum. The medium was replaced every two days and the cells were 
harvested for analysis one week after growth factor deprivation. 
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2.2 qRT-PCR 
For RNA analysis of the undifferentiated cells, cells were seeded at 2 x 105 
cells/well in 6-well plates with 2 ml of P19 media and cells were harvested after 
48 h. For the present work, samples were collected from 3 to 10 independent 
cultures (different cell passages and/or frozen batches). In the cases of the 
treatment with inhibitors or the differentiation protocols, the time points in 
which the cells were harvested are either previously indicated in this chapter or 
mentioned in chapter 5. Table 2.3 contains relevant product information. 
Table 2.3 qRT-PCR product information 
Product Provider Catalogue number 
RNeasy mini kit Qiagen 74104 
DNase set Qiagen 79254 
Superscript III Thermo Fisher Scientific 18080044 
RNase OUT Thermo Fisher Scientific 10777019 
FastStart universal 
SYBR green master 
(rox) 
Sigma-Aldrich 04913914001 
 
2.2.1 RNA isolation 
Cells were harvested from one well of 6-well plates in 350 µl of RLT buffer 
(RNeasy mini kit) using a cell scraper and samples were stored at -80°C until 
required. RNA was isolated with RNeasy mini kit, following the manufacturer 
instructions. Briefly, cell lysates were mixed 1:1 with 70 % ethanol and applied 
to a column (to induce RNA binding to the silica membrane of the column). On-
column DNase digestion was performed according to the manufacturer to remove 
genomic DNA traces. Then, the RNA was washed using two different buffer 
solutions, and eluted in 50 μl of RNase-free water. RNA concentration (A260) and 
purity (A260/A280 > 2) were determined using the Nanodrop and RNA integrity was 
tested on a 1% agarose gel. 
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2.2.2 cDNA synthesis 
For the cDNA synthesis, a first mixture per reaction was prepared as follows: 300 
ng of RNA, 0.5 µl of 100 µM oligo dT20, 0.5 µl of 10 mM dNTPs, and RNase-free 
water up to 10 µl. Once prepared, the mixture was incubated for 5 min at 65°C 
and placed on ice for at least 1 min. During the incubation time, a second 
mixture per reaction consisted on: 3 µl of 5X first strand buffer, 1 µl of 0.1 M 
DTT, 0.5 µl of RNase OUT, and 0.5 µl of Superscript III. The RT negative control 
utilised RNase-free water instead of Superscript III. The second mixture was 
incubated for 50 min at 50°C, 5 min at 85°C, and ice for 1 min. Finally, 1 µl of 
1:5 dilution of RNase H was added to each sample and the reaction was 
incubated for 20 min at 37°C to digest the RNA. Samples were stored shortly at -
20°C. 
2.2.3 Real time PCR 
Real time or quantitative PCR (qPCR) reactions were performed in 96-well 
plates. Before starting, cDNA samples were diluted 1:5 with nuclease-free 
water. One qPCR reaction contained 5 µl of diluted cDNA, 12.5 µl of FastStart 
universal SYBR green master (with rox), 3 µl of forward primer, 3 µl of reverse 
primer, and 1.5 µl of nuclease-free water. The 96-well plate was centrifuged for 
3 min at 1000 RFC. qPCRs were run in the Stratagen Mx 3000P thermocycler and 
the conditions were indicated in Table 2.4. Primer sequences and concentrations 
were provided in Table 2.5. 
Table 2.4 qRT-PCR thermal cycling conditions 
Segment Cycles Time Temperature Collection of data 
Polymerase activation 1 10 min 95°C  
Denaturation 
40 
30 s 95°C  
Alignment-extension 60 s 60°C In the extension 
Dissociation curve 
analysis 
1 
60 s 95°C  
30 s 55°C In the ramp from 
55 to 95°C   
30 s 95°C 
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Table 2.5 qRT-PCR primer information 
Primer Sequence (5’-3’) Final conc. (nM) 
Pou5f1 F CGTTCTCTTTGGAAAGGTGTTCA 600 
Pou5f1 R GGTTCTCATTGTTGTCGGCTTC 600 
Sox2 F CGTTCATGTGCGCGTAGCTG 600 
Sox2 R GGAACAGCATGGCGAGCGG 600 
Nanog F ACCTGAGCTATAAGCAGGTTAAG 600 
Nanog R TCAGACCATTGCTAGTCTTC 600 
Nes F AAAGTTCCAGCTGGCTGT 300 
Nes R CACTTCCAGACTAAGGGACAT 300 
Tubb3 F AAGGTAGCCGTGTGTGACATC 300 
Tubb3 R ACCAGGTCATTCATGTTGCTC 300 
Map2 F TCTGCCTCTAGCAGCCGAAG 300 
Map2 R CACTGTGGCTGTTTGTTCTG 300 
Gfap F CAACCTGGCTGCGTATACCAG 600 
Gfap R TTAAGAACTGGATCTCCTCC 600 
Neurog1 F GGCTTCATGCATTATGGATCC 900 
Neurog1 R CTCCAGTCCAGTGCCTGAATAG 900 
Ascl1 F CCAACTGGTTCTGAGGACCTG 600 
Ascl1 R CTGCCATCCTGCTTCCAAA 600 
Gata4 F TAGTCTGGCAGTTGGCACAG 300 
Gata4 R ACGGGACACTACCTGTGCAA 300 
Tbxt F ATGCCAAAGAAAGAAACGAC 300 
Tbxt R  AGAGGCTGTAGAACATGATT 300 
Axin2 F GAGAGTGAGCGGCAGAGC 300 
Axin2 R CGGCTGACTCGTTCTCCT 300 
Fgf4 F CGACCACAGGGACGCTGCTG 300 
Fgf4 R ACTCCGAAGATGCTCACCACG 300 
Hes5 F CACCAGCCCAACTCCAAGCT 300 
Hes5 R GGCGAAGGCTTTGCTGTGT 300 
Hmgn1 F AGAGACGGAAAACCAGAGTCCAG 300 
Hmgn1 R CGTGATGGATGCTTAGTCGGA 300 
Hmgn2 F AAAAGGCCCCTGCGAAGAA 300 
Hmgn2 R TGCCTGGTCTGTTTTGGCA 300 
Gpi1 F TCCGTGTCCCTTCTCACCAT  900 
Gpi1 R TGGCAGTTCCAGACCAGCTT  50 
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2.2.4 Analysis of data and statistics 
Amplification plots and dissociation curves were observed and compared with 
the RT negative controls to determine the specificity and the performance of 
the qRT-PCR reactions. Dissociation curves should show the presence of a unique 
amplicon and in any other cases the product was considered as undetermined. 
Threshold values (Ct) were analysed by the 2-∆∆Ct method, which determined the 
fold change between normalised values from the experimental condition in 
comparison with the control condition. In the present work, the control 
condition for P19 cells was represented by the average of normalised data 
(average ΔCt) displayed by undifferentiated parental cells. For E14 cells, the 
average ΔCt of undifferentiated E14 cells constituted the control condition. The 
normaliser was the house-keeping gene encoding for the enzyme glucose 
phosphate isomerase 1 (GPI1), unless indicated in the figure legend. 
Statistical analysis was performed on undifferentiated P19 samples of Hmgn-
knockout cells and control cells (from 3 to 10 independent cultures) using the 
GraphPad Prism 7 software. The input values corresponded to individual ΔCt per 
gene and cell line. Every gene was analysed separately, constituting an 
independent hypothesis, while all samples from each cell line were compared 
with all samples from parental cells. Statistical significance was determined by 
one-way analysis of variance (ANOVA) and the post-hoc test selected was 
Dunnett’s multiple comparison test. Adjusted p-values were indicated in the 
figure legends.  
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2.3 Immunological techniques 
Table 2.6 Product information related with immunological techniques 
Product Provider Catalogue number 
cOmplete mini EDTA-free 
protease inhibitor 
cocktail 
Sigma-Aldrich 11836170001  
Benzonase Sigma-Aldrich E1014  
Pierce BCA protein assay 
kit 
Thermo Fisher Scientific 23225  
NuPAGE LSD sample 
buffer 
Thermo Fisher Scientific NP0007 
NuPAGE sample reducing 
agent 
Thermo Fisher Scientific NP0004 
NuPAGE 12% bis-tris 
protein gels 
Thermo Fisher Scientific NP0341, NP0342 
NuPAGE antioxidant Thermo Fisher Scientific NP0005 
NuPAGE MOPS-SDS 
running buffer 
Thermo Fisher Scientific NP0001 
Benchmark protein 
ladder 
Thermo Fisher Scientific 10747012 
PVDF membranes Bio-Rad 21703 
SuperSignal West Duro 
Extended Duration 
Substrate 
Thermo Fisher Scientific 34076 
Prolong gold mounting 
media with DAPI 
Thermo Fisher Scientific P36931 
Formaldehyde 16% 
solution 
Thermo Fisher Scientific 28908  
DYNA beads-Protein A Thermo Fisher Scientific 10002D  
Proteinase K Sigma-Aldrich 1001954815 
RNase A Thermo Fisher Scientific ENO531 
Qiagen MinElute PCR 
pufirifiation kit 
Qiagen 28004  
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2.3.1 Western blotting 
2.3.1.1 Protein extraction 
Whole cell extracts were prepared by scrapping the cells in 200 µl of cell lysis 
buffer (45 mM of Tris-HCl pH 7.5, 1 mM EDTA, 1% SDS, 10% glycerol, 2 mM DTT, 
10 mM sodium butyrate, one Mini-tablet of protease inhibitor cocktail (PIK) per 
10 ml of lysis buffer). Samples were stored at -20°C until required. Protein 
quantification was performed by analysing an immunoblot for the detection of 
tubulin beta class I (TUBB), using 10 µl of each sample. 
2.3.1.2 Acid histone extraction 
Cells were washed on plate twice with ice-cold PBS. Then, cells were scrapped 
in 3 ml PBS and counted. Subsequently, cells were centrifuged at 200 RFC and 
4°C for 5 min. The cell pellet was re-suspended in triton extraction solution (4.5 
µ/ml triton X-100, 0.02% w/v NaN3, 4 mM sodium butyrate, all in PBS, and one 
Mini-tablet of PIK per 10 ml of triton extraction solution buffer) to a 
concentration of 107 cells/ml and was incubated on ice with gentle rocking. Cells 
were centrifuged at 300 RFC and 4°C for 10 minutes. The pellet was washed in 
half the previous volume of triton extraction solution, centrifuged in the same 
conditions, and re-suspended in 0.2 M HCl at a concentration of 4 x 106 cells/50 
µl. Samples were incubated for 3 hours at 4°C and centrifuged at 300 RFC and 
4°C for 10 minutes. The supernatant containing the histones was stored at -20°C 
until required. Protein quantification was performed by analysing an immunoblot 
for the detection of H3, using 1 µl of each sample. 
2.3.1.3 Immunoblotting 
Whole cell extracts and acid histone extracts were mixed with LSD buffer and 
reducing agent, and denaturing during 10 min at 70°C. Then, they were loaded 
in 12% bis-tris protein gels. Gels ran at 120 V for 20 min and 150 V for 1 h on 
MOPS-SDS running buffer with antioxidant agent. The separated proteins were 
transferred to PVDF membranes in the Trans-Blot Turbo transfer device (Bio-
Rad). PVDF membranes were blocked with WB buffer (0.1% Tween-20 and 5% 
non-fat milk in PBS) for 1 h at RT on a shaker. After blocking, primary antibody 
dilutions prepared in WB buffer were added to the membranes and the antigen-
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antibody reaction was incubated overnight at 4°C. The next day, the membranes 
were washed four times with 0.1% Tween-20/PBS for 10 min and incubated for 1 
h at RT with the HRP-conjugated secondary antibody dilutions prepared in WB 
buffer. Finally, the antigen-antibody reaction was detected with 
chemiluminescence using a CCD camera imaging system (LAS 3000 Fujifilm). The 
antibody details are listed in Table 2.7. WB quantification of histone 
modifications was performed in Image J. The values were first normalised with 
total H3 and then expressed as relative to parental cells. 
2.3.2 Immunofluorescence 
Cells were fixed with 4% PFA for 30 mins at RT and stored in PBS at 4°C until 
required. Immunofluorescences (IF) were performed as follows: cells were 
permeabilised for 10 min with 0.1% PBS-triton X-100 and then blocked for 1 h in 
IF buffer (5% horse serum and 0.5% triton X-100 in PBS). Subsequently, cells were 
incubated for 2 h with primary antibody dilution prepared in IF buffer. Then, 
cells were washed thrice for 10 min with 0.1% PBS-triton X-100 and incubated for 
1 h with the secondary antibody dilutions prepared in IF buffer, protecting from 
light. Finally, cells were washed thrice for 10 min with PBS and mounted onto 
slides, using mounting media containing DAPI to stain the nuclei. The complete 
protocol was carried at RT on a shaker. Details of the antibodies and dilutions 
are listed in Table 2.7. Slides were observed in an epifluorescence microscope 
(Olympus IX51). 
2.3.3 Fluorescence-activated cell sorting 
Cells were collected using TripLE and washed with PBS. Then, they were stained 
with zombie yellow (dead cells) for 15 min in the dark and gentle rotation. From 
this point onwards, all the steps were performed in the dark. Subsequently, the 
cells were washed with PBS by centrifugation at 200 RFC for 3 min and fixed 
during 30 min with 4% PFA. The 4% PFA was washed with 1 ml 10% FBS-PBS by 
higher centrifugation at 380 RFC for 3 min. For SSEA1 detection, cells were re-
suspended in 200 µl of primary antibody dilution prepared in 2% BSA-PBS and 
incubated for 1.5 h in gentle rotation. The rest of the cells were permeabilised 
and blocked for 15 min in FACS buffer (5% horse serum and 0.5% tween 20 in 
PBS) and washed once with 1 ml 10% FBS-PBS by centrifugation at 380 RFC for 3 
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min. After fix-perm, cells were incubated for 1 h in gentle rotation with 200 µl 
of the primary antibody dilution prepared in FACS buffer. The primary antibody 
dilution was washed as previously described and cells were incubated for 45 min 
in 200 µl of the secondary antibody dilution prepared in of 2% BSA-PBS or FACS 
buffer, in gentle rotation. Finally, cells were washed twice with 2% PBS-BSA and 
re-suspended in 2% PBS-BSA. The IgG isotype controls were included in the 
staining protocol. NSCs derived from E14 ESCs were utilised as a negative control 
for the detection of pluripotency and endodermal markers. Complete details of 
the antibodies and dilutions are listed in Table 2.7. FACS analysis was carried 
using the Attune Focusing Cytometer (Applied Biosystems, Thermo Fisher 
Scientific). The yellow-stained cells were excluded from the data. 
Three independent experiments were performed for quantitative FACS. 
Statistical analysis was carried in the GraphPad Prism 7 software. The median of 
the fluorescence intensity of each immunostaining was normalised dividing the 
value by the median of the fluorescence intensity of the negative control (E14 
derived NSCs). The normalised data constituted the numeric input for the 
statistical tests. Each marker was analysed separately, constituting an 
independent hypothesis, while all samples from each cell line were compared 
with the samples from parental cells. Statistical significance was determined by 
one-way analysis of variance (ANOVA) and the post-hoc test selected was 
Dunnett’s multiple comparison test. Adjusted p-values were indicated in the 
figure legends. 
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Table 2.7 Antibody information for WB, IF, FACS, and ChIP 
Antibody Provider 
Catalogue 
number 
IF/FACS 
dilution 
WB 
dilution 
ChIP 
vol/rxn 
Rb anti POU5F1 Abcam Ab19857 1:500   
Rb anti NANOG Abcam Ab80892 1:200   
Ms anti SSEA1 Abcam Ab16285 1:200   
Rb anti GATA4 Abcam Ab84593 1:500   
Ms anti NES Abcam Ab6142 1:200   
Rb anti FABP7 Abcam Ab27171 1:1000   
Rb anti TUBB3 Abcam Ab18207 1:2000   
Ms anti TUBB3 Millipore MAB1637 1:500   
Ch anti MAP2 Abcam Ab5392 1:2000   
Rb anti GFAP Abcam Ab7260 1:500   
Rb anti HMGN1 Home made 1:1000 1:1000 5 µl 
Rb anti HMGN2 Home made 1:2000 1:1000 5 µl 
Rb anti H3 Millipore 07-690  1:25000 2 µl 
Rb anti H3.cs1 
Active 
Motif 
39574  1:1000  
Rb anti H3K4me3 Millipore 07-473  1:20000 5 µl 
Rb anti H3K27me3 Millipore 07-449   7.5 µl 
Rb anti H3K9ac Millipore 07-352  1:10000 5 µl 
Rb anti H3K27ac Millipore 07-360  1:20000 5 µl 
Rb anti H3K122ac Abcam Ab33309   5 µl 
Ms anti TUBB TFS MA5-16308  1:3000  
rIgG Sigma I5006   7.5 µl 
mIgG Sigma 12-371 1:200   
Gt anti rb-HRP TFS 32460  1:1000  
Dn anti rb-488 TFS A21206 1:1000   
Dn anti rb-594 TFS A11037 1:1000   
Gt anti ms-594 TFS A11020 1:1000   
Gt anti ch-594 TFS A11042 1:1000   
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2.3.4 Chromatin immunoprecipitation-PCR 
2.3.4.1 Chromatin preparation 
P19 cells were seeded onto six 15 cm dishes. One plate was used for cell 
counting, and the others for chromatin collection. Just before starting, 
DMEM/F12 is added to replace the P19 media. The cells were cross-linked on a 
shaker for 5 min by adding 5% formaldehyde dilution (16% formaldehyde solution 
in formaldehyde dilution buffer: 50 mM HEPES pH 8.0, 0.1 M NaCl, 1 mM EDTA 
and 0.5 mM EGTA) directly to the DMEM/F12 media to reach a 0.5% final 
concentration. The cross-linking reactions were quenched with 1 ml of 1.5 M 
glycine, incubating for 5 min on the shaker. Cells were washed with 20 ml of 
chilled PBS and collected with a cell scraper in 5 ml of chilled PBS. The cell 
suspension was centrifuged for 5 min at 200 RFC and 4°C. Then, the pellet was 
washed with PBS by centrifugation and re-suspended in 5 ml of cell lysis buffer 
(10 mM Tris pH 8, 10 mM NaCl, 10 mM EDTA, 0.5 mM EGTA, 0.2% NP40, and one 
cOmplete Mini EDTA-free Cocktail tablet in 10 ml). Following an incubation of 10 
min on ice, the cells were centrifuged in the same conditions, but this time the 
pellet was re-suspended in nuclei lysis buffer (50 mM Tris pH 8.0, 10 mM EDTA, 
0.5% SDS at 2ml per 7.5 x 107 cells) and, after another incubation of 10 min on 
ice, samples were stored at -80°C until required. 
Chromatin samples were then sonicated (Misonic sonicator 3000) for a total time 
of 7.5 min as follows: amplitude 3, amplitude power 10%, sonication ON for 10s, 
sonication OFF for 30s. 
A 50 µl aliquot of sonicated chromatin was used for reverse cross-linking in order 
to verify in a 0.7% agarose gel that the DNA fragments after sonication were 
between 200-1000 bp. DNA was quantified in the Nanodrop. 
Protein content of chromatin samples was determined by BCA assay, using a 
standard curve of BSA. The assay was read in the Nanodrop. 
2.3.4.2 Chromatin immunoprecipitation 
For each chromatin immunoprecipitation (ChIP) reaction, 50 µl of magnetic 
DYNA beads-Protein A were required. First, the magnetic beads were blocked by 
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washing them with blocking buffer (0.5% BSA and 0.5% tween-20 in PBS). Then, 
antibody conjugation of the magnetic beds was carried by adding 2-7.5 µl of 
antibody in 200 µl of blocking buffer and incubating in a rotation rocker for 1 h 
at RT. The supernatant was removed and 400 µl of chromatin diluted in RIPA 
buffer (10 mM Tris-HCl pH 8, 1 mM EDTA pH 8, 0.5 mM EGTA pH 8, 140 mM NaCl, 
0.1% sodium deoxycholate, 0.1% SDS, 1% triton X-100 and 1X PIK) were added to 
the antibody-conjugated magnetic beads. The ChIP reaction was incubated in 
the rotor for 3 h at 4°C. After the incubation, the beads were washed twice with 
500 µl of RIPA buffer, twice with 500 µl of RIPA-500 (10 mM Tris-HCl pH 8, 1 mM 
EDTA pH 8, 0.5 mM EGTA pH 8, 500 mM NaCl, 0.1% sodium deoxycholate, 0.1% 
SDS, 1% triton X-100, 1X PIK), once with 500 µl of  RIPA-LiCl (10 mM Tris-HCl pH 
8, 1 mM EDTA pH 8, 0.5 mM EGTA pH 8, 250 mM LiCl, 0.1% SDS, 0.5% NP40, 1X 
PIK), and twice with 500 µl of TE pH 8 (10 mM Tris-HCl pH 8 and 1 mM EDTA). 
The beads and the input (10 µl of untreated chromatin) were incubated with 70 
µl of elution buffer (10 mM Tris-HCl pH 8, 5mM EDTA, 0.5% SDS, 300 mM NaCl) 
and 4 µl of proteinase K (1µl of RNase A is added only to the input) for 1 h at 
55°C and overnight at 65°C for reverse cross-linking. The next day, DNA was 
purified using the Qiagen MinElute PCR pufirifiation kit and eluted in 50 µl of 
Qiagen elution buffer. Details of the antibodies and dilutions are listed in Table 
2.7. 
2.3.4.3 Real time PCR 
The eluted DNA from each ChIP reaction was diluted 1:5 with 10 mM Tris-HCl pH 
8. Concentration of input DNA was adjusted to 0.1 ng/µl. qPCRs were performed 
in 96- well plates. One qPCR consisted of 5 µl of diluted cDNA or input DNA, 12.5 
µl of FastStart universal SYBR green master (with rox), 5 µl of primer mix, and 
2.5 µl of nuclease-free water. The 96-well plate was centrifuged for 3 min at 
1000 RFC. qPCRs were run in the Stratagen Mx 3000P thermocycler and the 
conditions are indicated in Table 2.4. Primer sequences and concentrations are 
provided in Table 2.8. 
Amplification plots and dissociation curves were observed to determine the 
specificity and the performance of the reactions. Ct values were used in a 
variation of the 2-∆∆Ct method. The first ΔCt was calculated as the difference 
between the Ct of each gene of the chromatin sample and the Ct of the 
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corresponding input DNA from the same sample. Then, the resulting ΔCt was 
divided by the average ΔCt of H3 from the same chromatin sample. Finally, the 
fold change to the input was determined as follows: 2-∆Ct1/∆CtaveH3. The input DNA 
controlled for amplification particularities of each genomic region, while the H3 
average for chromatin amount, acting as a normaliser. Two tailed Student T test 
was used to calculate the statistical significance of the observed differences 
between the qPCR triplicates, per gene and ChIP reaction, of the Hmgn-knockout 
chromatin and the parental. 
Table 2.8 ChIP-PCR primer information 
Primer Sequence (5’-3’) Final conc. (nM) 
Neurog1 F GGTGAGGAAGCTGGACAGG 300 
Neurog1 R CCCTTTGGAGACCTGCATCT 300 
Ascl1 F CGTCTCCACCTTGCTCATCT 300 
Ascl1 R TTGGTCAACCTGGGTTTTGC 300 
Gata4 F CCAACAGGCAAAGTCCATGC 300 
Gata4 R CACTGAGGGCAGAACGGAG 300 
Tbxt F TGTAATCTTTGGGCTCCGCA 600 
Tbxt R  CCTACCCAACAGCCACCTTC 600 
Actb F CGCCATGGATGACGATATCG  300 
Actb R CGAAGCCGGCTTTGCACATG  300 
Pou5f1-1 F GTGAGCATGACAGAGTGGAGGAA 300 
Pou5f1-1 R TCTCTGGCCCTCTCCATGAAT 900 
Pou5f1-2 F GTGGGTAAGCAAGAACTGAGGA 300 
Pou5f1-2 R TGGAGAGCCTAAAACATCCATT  900 
Pou5f1-3 F  CAATGCCGTGAAGTTGGAGA 300 
Pou5f1-3 R TCACTTACCTCCTCGGGAGTTG  900 
Nanog-1 F GGAAGAACCACTCCTACCAATACTCA 300 
Nanog-1 R CGTAACATCTCCCATGTGAAGACTC 900 
Nanog-2 F TCTTTAGATCAGAGGATGCCCCCTAAGC  300 
Nanog-2 R AAGCCTCCTACCCTACCCACCCCCTAT  300 
Nanog-3 F TCAGCCCAGTACTCAGGCTTGT  300 
Nanog-3 R AGCCTAGCAGCCTCTTGGTTCT  300 
Nanog-4 F TAACTGGACCCTCTGACTGGCT 300 
Nanog-4 R CCCACCATCTTTTCTGCTAGTACAAG 300 
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Chapter 3 Hmgn-knockout embryonal carcinoma 
cells spontaneously differentiate at higher 
frequencies and exhibit increased levels of 
lineage-specific markers 
3.1 Introduction 
HMGN1 and HMGN2 share a spatio-temporal expression pattern; they are 
ubiquitously expressed in all adult cells, although their levels are higher in 
embryonic structures and decrease upon differentiation (Crippa et al, 1991; 
Deng et al, 2017; Deng et al, 2013; Furusawa et al, 2006; Lehtonen & Lehtonen, 
2001; Lehtonen et al, 1998; Mohamed et al, 2001; Pash et al, 1990). 
Modelling embryonic development in vitro has been achieved by culturing ECCs 
and ESCs. These cells have unique properties; they are capable of self-renewal 
and can differentiate into all cell types present in an organism. As previously 
reviewed, this great plasticity relies on a transcriptional program orchestrated 
by a network of pluripotency-related transcription factors and their interactions 
with chromatin components and modulators. Furthermore, the chromatin 
structure of stem cells differs from that of differentiated cells in a number of 
ways: it is less tightly compacted (Mattout & Meshorer, 2010), with abundant 
DHSs (Deng et al, 2013) and marks of active transcription (Efroni et al, 2008; 
Guenther et al, 2007; Krejčí et al, 2009; Lee et al, 2003), fewer and less 
condensed heterochromatin loci (Efroni et al, 2008; Meshorer et al, 2006), and 
hyperdynamic binding of major architectural proteins such as linker histones 
(Meshorer et al, 2006) and HMGNs (Deng et al, 2013).  
HMGNs are not only highly abundant and hyperdynamic, but are related with 
other chromatin features of stem cells as these proteins positively influence 
histone acetylation (Lim et al, 2005) and play a role in the establishment and 
maintenance of the DHS landscape of cells (Cuddapah et al, 2011; Deng et al, 
2017; Deng et al, 2013; Deng et al, 2015; Zhang et al, 2016).  
Based on these studies, the hypothesis is that the HMGNs play an important role 
in maintaining the chromatin structure of stem cells, and therefore, in 
safeguarding self-renewal and pluripotency. 
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In order to test this hypothesis, the present work studies P19 monoclonal lines 
lacking either HMGN1 or HMGN2. As cited in the introduction, P19 cells were 
derived from post-implantation embryos (McBurney & Rogers, 1982), capturing a 
later developmental stage than mESCs. It has been suggested that P19 cells 
resemble EpiSCs (Kelly & Gatie, 2017; Mallanna et al, 2008), the primed state of 
pluripotency sharing several features with hESCs (Kinoshita & Smith, 2018; 
Nichols & Smith, 2009; Smith, 2017). Working with P19 offers a number of 
advantages as they are maintained in culture, directed to differentiate, and 
importantly, genetically manipulated with ease (McBurney, 1993).  
The Hmgn-knockout monoclonal lines were generated by previous students in the 
laboratory employing the CRISPR/Cas system. CRISPR stands for clustered 
regularly interspaced short palindromic repeats and Cas for CRISPR associated 
proteins. The CRISPR/Cas system was first described in bacteria and archaea as a 
prokaryotic adaptive immune system that provides resistance against phage 
infections (Barrangou et al, 2007), and has been recently modified to induce 
mutagenesis in mammalian cells (Cong et al, 2013; Mali et al, 2013). Briefly, a 
guide RNA (gRNA), complementary in sequence to the gene of interest in the 
host cell, recruits the Cas9 nuclease to produce a targeted double DNA strand 
break. The DNA repair machinery of the host cell will recognise this double 
strand break and, while repairing it, might introduce mutations, such as 
insertions or deletions, leading to a change in the open reading frame of the 
gene. Hence, if transcription proceeds, aberrant transcripts will be synthesised 
from the mutated gene that either will not translate into proteins or will encode 
for peptides different in sequence and function. 
The strategy used in the laboratory consisted of targeting mutations around the 
ATG start codon at exon 1 of the Hmgn2 gene, with the aim of introducing a 
frameshift switch right at the start of the coding region (Sindi, 2017). P19 cells 
were transfected with three different plasmids; two containing gRNAs targeting 
the parallel and antiparallel DNA strands at the site of interest, and a third one 
encoding for the GFP reporter and the Cas9 nickase, a modified version of the 
Cas9 nuclease that only has a single active site. The concept of the CRISPR 
nickase is to introduce two single strand breaks close enough for the cells to still 
interpret these as a double strand break, while enhancing the specificity of the 
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system and decreasing off target effects (Ran et al, 2013). After transfection, 
cells were sorted by FACS and GFP-positive cells were plated at limiting dilution 
to generate clonal lines. Three genetically distinct lines lacking the HMGN2 
protein (B8ΔN2, B19ΔN2, and B38ΔN2) were isolated, and the Hmgn2 locus was 
sequenced to confirm the gene disruption (Sindi, 2017). Additionally, a 
monoclonal line (B1), which was taken through all the procedures but was found 
to preserve HMGN2, was analysed to confirm the WT genotype and utilised as a 
control line (Sindi, 2017). 
The second strategy employed the WT Cas9 nuclease, a gRNA directed to the 
ATG start codon at exon 1 of the Hmgn1 gene, and an extra gRNA targeting the 
Hprt gene (Eden, West, unpublished). Hypoxanthine phosphoribosyl transferase 
(HPRT) metabolises 6-thioguanine into a toxic product leading to cell death. The 
Hprt-targeted cells are resistant to 6-thioguanine and can be selected, 
guaranteeing the presence of a functional operating CRISPR/Cas system, and 
thus, improving the probabilities of finding an Hmgn1-knockout cell (Liao et al, 
2015). Two cell lines lacking the HMGN1 protein were derived by this method 
(N1-1ΔN1 and D3ΔN1), in parallel with a control line transfected with the Hprt-
gRNA and the Cas9 nuclease (C2) (Eden, West, unpublished). It is worth 
mentioning that these three cell lines were generated later than the Hmgn2-
knockout lines, and therefore not all the experiments shown here have included 
them.  
3.2 Hmgn1- and Hmgn2- targeted embryonal carcinoma 
cells have lost HMGN1 and HMGN2 proteins, 
respectively 
The first task of the present work was to confirm that the different P19 cell lines 
engineered by CRISPR/Cas were in fact expressing or lacking HMGN1 and/or 
HMGN2 proteins, respectively. RNA and protein extracts were prepared from 
multiple independent cultures. Additionally, cells were fixed and IF was 
performed for the detection of the two HMGN variants. Relevant information 
corresponding to these cell lines is summarised in Table 3.1. 
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Table 3.1 Nomenclature and description of the cell lines analysed in the present work 
Cell line Description 
Parental 
A P19 polypopulation of early passage number, from which all the 
following monoclonal lines originated. 
B1 
A control clonal line derived in parallel with the Hmgn2-knockout 
lines, in which the CRISPR/Cas9 nickase failed to induce 
mutagenesis as proven by sequencing. 
C2 
A clonal line in which Hprt was targeted with CRISPR/Cas9 
nuclease and that was selected with 6-thioguanine. 
N1-1ΔN1 Hmgn1-knockout monoclonal lines that were generated by 
targeting Hmgn1 and Hprt genes with the CRISPR/Cas9 nuclease 
system and selecting with 6-thioguanine. 
D3ΔN1 
B8ΔN2 Hmgn2-knockout monoclonal lines that resulted from successful 
mutagenesis in the Hmgn2 gene accomplished by the CRISPR/Cas9 
nickase. 
B19ΔN2 
B38ΔN2 
 
As shown in Figure 3.1A, mutations in the first exon of Hmgn1 significantly 
reduce the gene expression in N1-1ΔN1 and D3ΔN1 cells when compared with 
parental cells. However, there is still an Hmgn1 transcript as determined by 
qRT-PCR and dissociation curve analysis of the amplicon. Similar results are 
observed with Hmgn2 expression, which is three, five, and six fold less expressed 
in B8ΔN2, B19ΔN2, and B38ΔN2 cells, respectively, than in parental cells (Figure 
3.1A).  
Despite the fact that transcription of Hmgn1 or Hmgn2 is not fully blocked, 
neither HMGN1 protein in N1-1ΔN1 and D3ΔN1 cells, nor HMGN2 protein in 
B8ΔN2, B19ΔN2, and B38ΔN2 cells, are synthesised as demonstrated by WB in 
Figure 3.1B and C. 
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Figure 3.1 Gene expression and protein detection of the two major HMGN variants in 
Hmgn1- and Hmgn2-targeted ECCs 
A) Relative expression of Hmgn1 and Hmgn2 as determined by qRT-PCR in control and Hmgn-
knockout cells. The graph represents the fold change in comparison with parental cells, error bars 
symbolise the SEM from 3 to 10 independent cultures (with the cooperation of A. Sindi), the 
statistical significance was calculated by ANOVA and Dunnett’s multiple comparison test (adjusted 
p value ***<0.0001). WB for the detection of (B) HMGN1 and (C) HMGN2 proteins, including TUBB 
as a loading control. 
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Interestingly, Hmgn2-knockout cells do not seem to compensate their loss by 
increasing transcription or translation of HMGN1 (Figure 3.1A and B). Neither do 
D3ΔN1 cells synthesise additional HMGN2 protein/mRNA. The expression of 
Hmgn2 in N1-1ΔN1 cells, in contrast, is three times higher than in parental cells, 
although this is not translated into higher protein levels (Figure 3.1A and C). The 
fact that the overexpression of the residual HMGN variant is only observed in one 
cell line suggests a clonal variation in transcription rates, rather than a general 
mechanism of compensation. Indeed, HMGN1 and HMGN2 protein levels are 
unchanged in cells and tissues derived from Hmgn2- and Hmgn1-knockout mice, 
respectively (Birger et al, 2003; Deng et al, 2015). 
HMGNs are chromatin architectural proteins that bind to nucleosomes, and 
therefore, are actively transported into the nuclei of the cells via an intrinsic 
bipartite nuclear localisation signal (Hock et al, 1998a). When HMGNs are 
detected by IF, the anti-HMGN2 antibody is highly specific resulting in a bright 
nuclear signal, easily distinguishable from the background (Figure 3.2). The 
nuclei of all cells in control and in N1-1ΔN1 and D3ΔN1 cultures contain HMGN2 
(Figure 3.2). In contrast, there is no nuclear signal detected in B8ΔN2, B19ΔN2, 
and B38ΔN2 cells above the background (Figure 3.2).  
The anti-HMGN1 antibody, however, produces a more dispersed signal and a 
higher cytoplasmic background. Nevertheless, the nuclei of parental, B1, C2, 
B8ΔN2, and B19ΔN2 cells are brighter than the cytoplasm (Figure 3.2). 
Conversely, N1-1ΔN1 and D3ΔN1 cells have completely lost the nuclear signal 
(Figure 3.2, magnifications) and merely the cytoplasmic background can be 
detected. 
Chapter 3  65 
 
 
Figure 3.2 Hmgn1- and Hmgn2-targeted ECCs have lost HMGN1 or HMGN2 nuclear proteins 
IF for the detection of HMGN1 and HMGN2 proteins (green). DAPI was used to stain the nuclei 
(cyan). Control cells contain both chromatin binding proteins. B8ΔN2, B19ΔN2, and B38ΔN2 cells 
lack HMGN2, but are positives for HMGN1; whereas N1-1ΔN1 and D3ΔN1 cells retain HMGN2. 
The 3X magnifications of the indicated cells highlight the loss of the nuclear signal corresponding to 
HMGN1 protein in N1-1ΔN1 and D3ΔN1 cells. Scale bar indicates 50 µm. 
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3.3 Hmgn-knockout cultures present reduced 
pluripotency markers and signs of spontaneous 
differentiation 
As described in the introduction, ESCs can be propagated in vitro under feeder-
free conditions and different formulation of the media. The requirement for 
feeder cells is replaced by the addition of LIF to serum-supplemented media 
(Smith et al, 1988); alternatively, ectopic BMPs can substitute for BMPs 
contained in the serum (Ying et al, 2003a). LIF and BMPs work in conjunction to 
support self-renewal by preventing differentiation into non-neural and neural 
lineages, respectively (Ying et al, 2003a). The notion that these factors shield 
ESC cells from differentiation derived from the development of a chemically 
defined media complimented with small molecule inhibitors of two kinases, 
MAP2K and GSK3. These small molecules directly restrict differentiation 
pathways and enhance pluripotency in all cells, as indicated by homogeneous 
morphology and pluripotency-related transcription factor levels (Wray et al, 
2010; Ying et al, 2008).  
P19 cells, in contrast, can self-renew indefinitely in the laboratory under feeder-
free conditions in serum-supplemented media. They have lost the capacity to 
spontaneously differentiate, despite their teratocarcinoma origin, and can be 
propagated as mostly pure cultures of undifferentiated cells. As shown in Figure 
3.3, parental cells are morphologically homogeneous and form colonies where 
only the cells at the edges show minor cytoplasmic protuberances (arrowheads). 
B1 cells also form colonies, although these seem to be more compact, and the 
morphology of the cells located at the centre is uniform, whereas the 
morphology of the cells at the edges or outside the colonies is heterogeneous 
(Figure 3.3).  
The loss of a major HMGN variant, however, severely affects the cellular 
morphology and organisation. Fewer colonies are observed (Figure 3.3, white 
arrows) as a high proportion of Hmgn-knockout cells spread outside the colonies. 
These cells exhibit an extended cytoplasm and resemble differentiated cells, 
such as endothelial flat cells (Figure 3.3, orange arrow), and neural rosettes 
(Figure 3.3, yellow arrow); for examples of differentiated cells see (Trott & 
Martinez Arias, 2013). Interestingly, cells with cytoplasmic protuberances are 
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observed surrounding the round and compact ESC colonies cultured in serum/LIF 
media; these cells have lost alkaline phosphatase reactivity, which indicates 
they have exited the pluripotency state (Wray et al, 2010). Thus, it is possible to 
hypothesise that some of the Hmgn-knockout cells have progressed along 
differentiation programs. Nevertheless, a substantial proportion of cells in the 
Hmgn-knockout cultures can self-renew, as the cell lines can be propagated 
indefinitely, although at smaller split ratios than parental, B1, and C2 cells. 
 
Figure 3.3 Colony morphology reveals substantial differences in cellular shape and 
organisation between control and Hmgn-knockout cells 
Bright field pictures of control and Hmgn-knockout cultures. Parental and B1 cells are 
morphologically homogeneous and form colonies, where the cells at the edges show minor 
cytoplasmic protuberances (arrowheads). Fewer colonies can be observed in the Hmgn-knockout 
cultures (white arrows) as the cells grow spread outside the colonies. The morphology of Hmgn-
knockout cells is heterogeneous and resembles endothelial cells (orange arrow) and neural 
rosettes (yellow arrow). Scale bar indicates 200 µm.  
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To evaluate whether the Hmgn-knockout cells are spontaneously differentiating, 
cells were fixed 24 and 48 h after seeding in normal P19 media, and IF was 
performed for the detection of pluripotency and lineage-specific markers. P19 
cells are passaged every two days, and therefore, the two time points selected 
represent cultures of lower and higher confluency, respectively. 
DAPI staining recapitulates what observed on bright field pictures. At 48 h, 
parental and B1 colonies have uniformly expanded as a monolayer, while Hmgn-
knockout cells grow in three dimensional clusters (Figure 3.4A, arrows) 
surrounded by numerous cells that spread between these clusters (Figure 3.4A, 
arrowheads). 
Stage-specific embryonic antigen 1 (SSEA1) plays a role in cell adhesion and 
migration in the pre-implantation embryo, is widely used as mouse ESC marker, 
and is also expressed by ECCs (Solter & Knowles, 1978; Zhao et al, 2012). As 
shown in Figure 3.4A, numerous Hmgn-knockout cells have lost this pluripotency 
marker, especially those spread between the clusters (arrowheads); some of the 
cells within these clusters, however, retain the signal (arrows), although it not 
as intense as in control cells. 
FACS analysis shows that Hmgn-knockout cells contain variable levels of SSEA1, 
which is particularly evident in the extended D3∆N1 and B8∆N2 populations 
(Figure 3.4B). Importantly, most of D3∆N1 cells are represented in regions of 
lower fluorescence intensity than parental cells (Figure 3.4B). Fluorescence 
intensity is directly proportional to the amount of SSEA1 in the cells, and 
quantification of the median fluorescence intensity of parental, B1, and Hmgn-
knockout populations reveals that all monoclonal lines have reduced levels of 
the pluripotency marker (Figure 3.4C). Hmgn1-knockout cells display the lower 
SSEA1 protein levels, between 40 and 50% of those of the parental cells, while 
Hmgn2-knockout and B1 cells present a 25 to 30% reduction (Figure 3.4C). The 
numerous SSEA1-negative cells that are observed in the Hmgn-knockout cultures, 
especially in D3∆N1 (Figure 3.4A), are expected to contribute to the reduction of 
the total fluorescence intensity of the population.    
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Figure 3.4 The pluripotency marker SSEA1 is lost in numerous Hmgn-knockout cells 
Parental, B1, and Hmgn-knockout cells were fixed 48 h after seeding for the detection of the 
pluripotency marker SSEA1. A) IF show that clustered Hmgn-knockout cells retain higher levels of 
SSEA1 (arrows) than the cells that grow spread outside colonies (arrowheads). DAPI was used to 
stain the nuclei (cyan). Scale bar indicates 50 µm. B) Immunostaining of SSEA1, as determined by 
FACS. The dot plots show the fluorescence intensity displayed by parental, B1, and Hmgn-
knockout cells. C) Quantification of the florescence intensity. The graph represents the relative 
fluorescence intensity (median) of each cell line, error bars symbolise the SEM from 3 independent 
experiments, and the statistical significance was calculated by ANOVA and Dunnett’s multiple 
comparison test (adjusted p values *<0.05, **<0.001, ***<0.0001). 
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The naïve pluripotency transcription factor NANOG is heterogeneously expressed 
by parental cells as observed in Figure 3.5A, where some of the cells are 
brighter than others, mostly located at the edges of the colonies. FACS analysis 
are in line with the previous observations. Two subpopulations are clearly 
distinguished (Figure 3.5B), the larger displaying higher fluorescence intensity 
(arrow) than the shorter (arrowhead). This is in complete agreement with 
previous studies reporting that in pluripotent cell cultures around 20% of the 
population express lower NANOG levels, and suggesting that NANOG 
heterogeneity is related to diverse differentiation potentials within a population 
of pluripotent cells (Abranches et al, 2014; Chambers et al, 2007; Herberg et al, 
2016; Kalmar et al, 2009).  
The fluorescence intensity is 50 to 80% less in Hmgn-knockout cultures, and in B1 
cells, indicating decreased NANOG levels in these cells (Figure 3.5C). However, 
in the IF it is clear that the cultures preserve some cells that have high NANOG 
protein levels (Figure 3.5A arrows) whereas others have completely lost the 
protein (Figure 3.5A arrowheads). The variability in the protein levels is 
consistent with the heterogeneity of this pluripotency transcription factor, while 
the reduction in the total protein levels suggests that pluripotency has moved 
closer to differentiation. As observed with SSEA1, most of the negatively-stained 
cells are those located outside the colonies (Figure 3.5A arrowheads). 
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Figure 3.5 The naïve pluripotency transcription factor NANOG is heterogeneously 
expressed by P19 cells and its levels are reduced in Hmgn-knockout cultures 
Parental, B1, and Hmgn-knockout cells were fixed 48 h after seeding for the detection of the naïve 
pluripotency transcription factor NANOG. A) IF show that NANOG levels are heterogeneous in all 
cell lines, as marked by a higher (arrows) and lower or none (arrowheads) fluorescence intensity. 
DAPI was used to stain the nuclei (cyan). Scale bar indicates 50 µm. B) Immunostaining of 
NANOG, as determined by FACS. The dot plots show the fluorescence intensity displayed by 
parental, B1, and Hmgn-knockout cells. C) Quantification of the florescence intensity. The graph 
represents the relative fluorescence intensity (median) of each cell line, error bars symbolise the 
SEM from 3 independent experiments, and the statistical significance was calculated by ANOVA 
and Dunnett’s multiple comparison test (adjusted p values *<0.05, **<0.001, ***<0.0001). 
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SSEA1 and NANOG immunostaining suggest that pluripotency is compromised in 
Hmgn-knockout cultures. Nevertheless, IF and FACS analysis reveal that the 
master regulator of pluripotency in ESCs, POU5F1, is expressed at similar levels 
in most of the cell lines, and most of the cells display equivalent fluorescence 
intensity (Figure 3.6).  
Some of the Hmgn-knockout cells, however, are completely devoid of POU5F1, 
which are especially abundant in D3ΔN1 cultures, but also can be identified in 
B8ΔN2 cultures (Figure 3.6A arrowheads). Interestingly, FACS analysis shows two 
subpopulations of D3ΔN1 and B8ΔN2 cells (Figure 3.6B). In the case of D3ΔN1, 
the larger subpopulation exhibits lower fluorescence intensity (Figure 3.6B 
arrowhead), which is reflected in a reduced median fluorescence intensity that 
represents approximately 56% of the parental (Figure 3.6C). In contrast, the 
larger subpopulation of B8ΔN2 cells expresses higher levels of POU5F1 (Figure 
3.6B arrow), and therefore, the fluorescence intensity of the total population is 
similar to parental cells (Figure 3.6C).  
In summary, a high proportion of D3ΔN1 cells and few B8ΔN2 cells have 
definitely abandoned pluripotency, while N1-1ΔN1 and B19ΔN2 cells contain 
POU5F1 at similar levels to parental cells. Recent findings have shown that 
POU5F1 is retained in the first stages of ESC differentiation (Kalkan et al, 2017; 
Thomson et al, 2011), therefore, the presence of POU5F1 does not exclude the 
possibility that some of the N1-1ΔN1 and B19ΔN2 cells have abandoned 
pluripotency to initiate differentiation programs. 
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Figure 3.6 The pluripotency transcription factor POU5F1 is reduced in some Hmgn-knockout 
cultures  
Parental, B1, and Hmgn-knockout cells were fixed 48 h after seeding for the detection of the 
pluripotency transcription factor POU5F1. A) IF show that most of the cells are positives for 
POU5F1, except some D3ΔN1 and B8ΔN2 cells (arrowheads). DAPI was used to stain the nuclei 
(cyan). Scale bar indicates 50 µm. B) Immunostaining of POU5F1, as determined by FACS. The 
dot plots show the fluorescence intensity displayed by parental, B1, and Hmgn-knockout cells. C) 
Quantification of the florescence intensity. The graph represents the relative fluorescence intensity 
(median) of each cell line, error bars symbolise the SEM from 3 independent experiments, and the 
statistical significance was calculated by ANOVA and Dunnett’s multiple comparison test (adjusted 
p values *<0.05, **<0.001, ***<0.0001). 
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NES is an intermediate filament used as a classical marker of NSCs (Lendahl et 
al, 1990) that is also transiently expressed by other precursor and endothelial 
cells during development (Sejersen & Lendahl, 1993; Suzuki et al, 2010; 
Wroblewski et al, 1997). P19 undifferentiated cells express NES at basal levels 
(Jin et al, 2009b; Jin et al, 2006); however, as shown in Figure 3.7, NES levels 
seem to be higher in Hmgn-knockout cultures, particularly in cells in the three 
dimensional clusters (arrows). Furthermore, NES immunostaining evidences 
substantial morphological differences between control and Hmgn-knockout cells, 
as the cytoskeleton of the Hmgn-knockout cells is more extended (Figure 3.7, 
magnifications). Whether the NES-positive cells represent undifferentiated cells 
that have altered morphology or differentiation propensities, or whether they 
are neural or other precursor cells is not clear. Hence, the detection of lineage-
specific markers is required to derivate accurate conclusions.  
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Figure 3.7 The intermediate filament NES is increased in Hmgn-knockout cultures 
IF for the detection of the intermediate filament NES. Parental, B1, and Hmgn-knockout cells were 
fixed 24 and 48 h after seeding. C2 cells were just used 24 h after seeding. Fluorescence intensity 
corresponding to NES is higher in Hmgn-knockout cultures, especially in the three dimensional 
clusters (arrows). 2X magnifications of the specified area reveal cytoskeleton projections in Hmgn-
knockout cells. DAPI was used to stain the nuclei (cyan). Scale bar indicates 50 µm. 
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IF for the neurofilament tubulin beta class III (TUBB3) reveals an increased 
frequency of spontaneous neuronal differentiation in Hmgn-knockout cultures as 
early as in 24 h (Figure 3.8). Cellular density and the incubation time impact the 
number of differentiated cells. At 48h, the Hmgn-knockout cultures display 
neuronal cells with complex cytoskeleton morphology, extending numerous 
neurites that may establish cell contacts. In contrast, few neurons are found in 
parental and B1 cultures at the same time point (Figure 3.8). In the Hmgn-
knockout cultures, however, neurons are evident at both time points analysed 
(Figure 3.8), discarding the possibility that high confluence is the main factor 
driving the neuronal differentiation of Hmgn-knockout cells, and supporting the 
hypothesis that the loss of a major HMGN variant leads to spontaneous 
differentiation of ECCs.    
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Figure 3.8 The neurofilament TUBB3 reveal the presence of numerous neurons and neurite 
outgrowth in Hmgn-knockout cultures 
IF for the detection of the neurofilament TUBB3 (red). Parental, B1, and Hmgn-knockout cells were 
fixed 24 and 48 h after seeding. C2 cells were just used 24 h after seeding. DAPI was used to stain 
the nuclei (cyan). Scale bar indicates 50 µm. 
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To test whether Hmgn-knockout cells exclusively follow the neuronal 
differentiation program, or whether they alternatively progress towards other 
lineages, an anti-GATA4 antibody was acquired. GATA4 is expressed by the 
primitive streak, from where the definitive endoderm and the mesoderm arise, 
and also by the primitive endoderm that develops into extra-embryonic tissues 
(Arceci et al, 1993; Fujikura et al, 2002; Laverriere et al, 1994). Very few 
GATA4-positive cells are observed across all cultures and conditions (Figure 
3.9A); the D3ΔN1 line displays the highest proportion of GATA4-positive cells, 
and these are preferentially spread between the clusters (Figure 3.9A arrows). 
These spread cells are highly abundant in D3ΔN1 cultures and are devoid of 
pluripotency markers (Figure 3.4A, Figure 3.5A, and Figure 3.6A), however, not 
all of them are stained with the GATA4 antibody (Figure 3.9A). Furthermore, 
D3ΔN1 cultures show fewer neurons than other Hmgn-knockout cultures (Figure 
3.8), indicating that the commitment to certain lineages may differ between 
Hmgn-knockout lines. 
FACS analysis are in line with the IF results, most of the cell lines display similar 
fluorescence intensity that may correspond to the background of the antibody, 
and are observed in the dot plots as compact populations (Figure 3.9B and C). 
Conversely, D3∆N1 population is extended, which suggests variable GATA4 
protein levels (Figure 3.9B). The previous observation indicates that not all the 
cells are GATA4-positives, as observed in the IF (Figure 3.9A); however, they are 
sufficient to shift the median of the fluorescence intensity 1.5 times higher than 
the parental value (Figure 3.9C).  
Taken together the imaging analyses suggest that the loss of either HMGN1 or 
HMGN2 compromises pluripotency of ECCs, leading to the initiation of 
differentiation programs mainly, but not exclusively, towards neural lineages. 
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Figure 3.9 The protein levels of the endoderm marker GATA4 remain unchanged in most of 
the Hmgn-knockout cultures 
Parental, B1, and Hmgn-knockout cells were fixed 48 h after seeding for the detection of the 
endoderm transcription factor GATA4. A) IF show similar levels of GATA4 in all the cultures, except 
in those of D3ΔN1 cells, where more GATA4-positive cells are identified (arrows). DAPI was used 
to stain the nuclei (cyan). Scale bar indicates 50 µm. B) Immunostaining of GATA4, as determined 
by FACS. The dot plots show the fluorescence intensity displayed by parental, B1, and Hmgn-
knockout cells. C) Quantification of the florescence intensity. The graph represents the relative 
fluorescence intensity (median) of each cell line, error bars symbolise the SEM from 3 independent 
experiments, and the statistical significance was calculated by ANOVA and Dunnett’s multiple 
comparison test (adjusted p values *<0.05, **<0.001, ***<0.0001). 
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3.4 Hmgn-knockout cells express higher levels of 
lineage-specific genes 
To further investigate whether the loss of HMGN1 and HMGN2 compromises 
pluripotency of P19 cells, gene expression analyses were performed by isolating 
RNA 48 h after seeding the cells from several independent cultures.  
Consistent with the immunostaining analyses where most of the cultured cells 
show uniform POU5F1 signal intensity, Pou5f1 transcript levels are similar across 
all cultured lines, except in D3ΔN1 in which Pou5f1 expression is decreased by 
40% (adjusted p value of 0.007) (Figure 3.10A). It is noteworthy that a 
substantial proportion of D3ΔN1 cells have completely lost POU5F1 protein 
(Figure 3.6), raising the possibility that the rest of the cells express Pou5f1 at 
equivalent levels to the parental cells, and that the observed reduction in mRNA 
levels derives from the average of Pou5f1-expressing and Pou5f1-negative cells.  
Sox2 has a similar expression pattern to Pou5f1 along the different pluripotency 
states and early ESC differentiation (Kalkan et al, 2017; Thomson et al, 2011). In 
agreement, Sox2 is downregulated only in D3ΔN1 cultures (Figure 3.10A), where 
its levels are five times less than in parental cultures (adjusted p value <0.0001). 
Intriguingly, SOX2 is a marker of NSCs, and D3ΔN1 cells are not particularly 
neurogenic (Figure 3.8), which perhaps explains the further downregulation of 
Sox2 in these cells. Furthermore, the highly neurogenic N1-1ΔN1 line shows 
higher Sox2 transcript levels (Figure 3.10A, adjusted p value of 0.008). 
In contrast to Pou5f1 and Sox2, the other core pluripotency transcription factor 
NANOG is highly expressed in naïve pluripotency and downregulated upon 
lineage-priming (Kinoshita & Smith, 2018; Nichols & Smith, 2009; Smith, 2017). 
This may explain the 3 to 10 times lower Nanog transcript levels found in D3ΔN1, 
B8ΔN2 and B38ΔN2 cells (Figure 3.10A, adjusted p values <0.001). In N1-1ΔN1 
and B19ΔN2 cells, however, Nanog expression is not altered (Figure 3.10A), 
suggesting that neither HMGN1 nor HMGN2 directly regulate the transcription of 
this gene. Importantly, in B1 cells the Nanog levels are half that observed in the 
parental cells (Figure 3.10A), which is in agreement with the observed reduction 
in the fluorescence intensity (Figure 3.5). As previously mentioned, NANOG is 
heterogeneously expressed in P19 cells, raising the possibility that when 
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generating the B1 monoclonal line, a low Nanog-expressing cell was selected and 
expanded. 
The mRNAs levels of lineage-specific transcription factor were also assessed. 
NEUROG1 and ASCL1 are well-known pro-neural transcription factors (Bertrand 
et al, 2002), while GATA4 and TBXT (T-box) both play important roles in the 
primitive streak, and then in endoderm and mesoderm specification, 
respectively (Arceci et al, 1993; Fehling et al, 2003; Fujikura et al, 2002; 
Laverriere et al, 1994). Consistent with the increased spontaneous neuronal 
differentiation of Hmgn-knockout cells (Figure 3.8), Neurog1 and Ascl1 are 
upregulated in most of the Hmgn-knockout cells when compared with parental 
cells (Figure 3.10B). Neurog1 transcript levels are increased by 5 to 25 fold in 
Hmgn1-knockout and Hmgn2-knockout lines (Figure 3.10B, adjusted p values 
<0.05), while Ascl1 by 8 to 18 fold in Hmgn2-knockout cells and 67 fold in N1-
1ΔN1 cells when compared with parental cells (Figure 3.10B, adjusted p values 
<0.0001). Consistent with previous reports that higher expression of lineage-
specific genes is found in low Nanog-expressing cells (Abranches et al, 2014; 
Chambers et al, 2007; Herberg et al, 2016; Kalmar et al, 2009), Ascl1 and 
Neurog1 levels are four and five fold higher in B1 cells, respectively, than in 
parental P19 cells (Figure 3.10B, adjusted p values of 0.004 and 0.006, 
respectively). 
In the case of Gata4, its expression is 2.5 to 5 times higher in N1-1ΔN1, D3ΔN1, 
and B8ΔN2 cells than in parental cells (Figure 3.10C, adjusted p values <0.01), 
suggesting that HMGN1 and HMGN2 are important for the preservation of stem 
cells rather than for the direct inhibition of differentiation into neural lineages. 
However, the cells do not prefer mesoderm lineages, since Tbxt expression is 
either unchanged or downregulated in Hmgn-knockout cells (Figure 3.10C). 
As most of the Hmgn-knockout cells mainly prefer neural fates, the transcript 
levels of neural-specific markers were evaluated. NES, as previously mentioned, 
is a NSC marker that is also transiently expressed by precursors for other 
lineages and endothelial cells (Lendahl et al, 1990; Sejersen & Lendahl, 1993; 
Suzuki et al, 2010; Wroblewski et al, 1997). TUBB3 and MAP2 are neuronal-
specific cytoskeleton or cytoskeleton-associated proteins (Kevenaar & 
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Hoogenraad, 2015). The neural markers are found at higher levels in most of the 
Hmgn-knockout cultures; however, the changes are not as dramatic as for the 
pro-neural transcription factors (Figure 3.10D). A possible explanation is that 
NES, TUBB3 and MAP2 are markers of already specified cells, whereas NEUROG1 
and ASCL1 are required for initiating the neuronal differentiation program. 
Interestingly, D3ΔN1 cells only overexpress the promiscuous marker Nes, 
reinforcing the idea that these cells may prefer other fates than the neuronal. 
In summary, the gene expression profiling demonstrates that the loss of either of 
the two HMGN major variants results in the upregulation of lineage-specific 
genes and, in some cases, the downregulation of the naïve pluripotency 
transcription factor NANOG. 
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Figure 3.10 Hmgn-knockout cells express higher levels of lineage-specific genes 
Relative expression of the (A) pluripotency transcription factors Pou5f1, Sox2, and Nanog; (B) 
lineage-specific transcription factors Neurog1, Ascl1, Gata4, and Tbxt; and (C) neural-specific 
markers Nes, Tubb3, and Map2, as determined by qRT-PCR. The graphs represent the fold 
change in comparison with parental cells, error bars symbolise the SEM from 3 to10 independent 
cultures (with the cooperation of A. Sindi), the statistical significance was calculated by ANOVA 
and Dunnett’s multiple comparison test (adjusted p values *<0.05, **<0.001, ***<0.0001). 
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3.5 Re-expression of HMGN2 using a retroviral system 
In order to test whether the previous observations were specifically due the loss 
of a major HMGN variant, HMGN2 was ectopically re-expressed in B8ΔN2 and 
B19ΔN2 cells using the second generation pBABE hygromycin retroviral vector 
system by the Master’s students Mariarca Bailo and Faika Laz Banti. Briefly, the 
retroviral packing cell line Phoenix-Eco was transfected with the retroviral 
vectors pBABE-hygro or pBABE-hygro-HMGN2 (Morgenstern & Land, 1990). The 
latter plasmid expresses the human HMGN2 cDNA. In this system, retroviral 
particles are secreted into the media, which is then used to transduce P19 cells. 
Hygromycin was used to select for transduced P19 cells.  
Re-expression of HMGN2 in B8ΔN2 and B19ΔN2 cells was confirmed by WB, and 
show that HMGN2 levels are comparable to those in parental cells (Figure 
3.11A). Furthermore, HMGN2 nuclear localisation was confirmed by IF (Figure 
3.11B). Intriguingly, the nuclei of the cells transfected with the pBABE vector, 
either the empty vector or carrying the HMGN2 cDNA, seem to be heterogeneous 
in shape and size, and in particular, they are larger than the nuclei of B8ΔN2 and 
B19ΔN2 cells as evidenced by DAPI staining (Figure 3.2 and Figure 3.11B). 
Additionally, the cells grow completely spread out and do not form either 
compact colonies, or three dimensional clusters, as previously observed (Figure 
3.4 and Figure 3.11B).  
Gene expression analyses demonstrated that the methodology employed to re-
express HMGN2 promotes major changes in the transduced cells. In general, cells 
carrying either the empty vector or the pBABE-HMGN2 and selected with 
hygromycin show substantial differences in pluripotency and lineage-specific 
marker steady state mRNA levels compared to parental, B8ΔN2, and B19ΔN2 
cells (Figure 3.11C). Little difference is observed between cells transduced with 
the empty pBABE plasmid and the pBABE-HMGN2 plasmid. The pluripotency 
genes Pou5f1, Sox2, and Nanog are downregulated in all the transduced cells, as 
exemplified by Nanog expression (Figure 3.11C and data not shown). In contrast, 
the pro-neural genes Neurog1 and Ascl1, and the neural-specific genes Nes and 
Map2 are either unchanged or upregulated in parental cells and mostly reduced 
in B8ΔN2 and B19ΔN2 cells, as observed from Ascl1 expression (Figure 3.11C and 
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data not shown). Additionally, Gata4 is either unchanged or upregulated in 
transduced cells whereas Tbxt is downregulated (data not shown). This 
expression pattern resembles that of differentiating P19 cells. 
The data indicate that cells transduced with the control vector have substantial 
changes in morphology and gene expression, which dwarf any effects arising 
from re-expression of HMGN2. It is possible that these effects are due to 
continued culture in the presence of hygromycin, so the cultures could be re-
analysed after a several passages in the absence of hygromycin.  Alternatively, 
the third generation pGIPZ lentiviral vector system could be used, as this lacks 
the truncated Gag sequence that is present in the pBABE vector that might be 
causing a problem (Morgenstern & Land, 1990). In conclusion, the retroviral 
methodology employed for the re-expression of HMGN2 failed to produce useful 
data that could support or refute the hypothesis that the major HMGN variants 
safeguard pluripotency in ECCs.   
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Figure 3.11 Re-expression of HMGN2 achieved with the pBABE-hygro retroviral vector 
Detection of HMGN2 protein by (A) WB and (B) IF. DAPI was used to stain the nuclei. Scale bar 
indicates 50 µm. C) Relative expression of the pluripotency and pro-neural transcription factors 
Nanog and Ascl1, respectively, as determined by qRT-PCR. The graph represents the fold change 
in comparison with parental non-transduced cells and error bars symbolise the SEM from three 
independent cultures. 
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3.6 Discussion 
This chapter studied the phenotypical alterations of P19 cells after the loss of 
HMGN1 and HMGN2. P19 cells are transformed pluripotent cells from embryonal 
origin that exhibit a distinct and mostly uniform morphology, express 
pluripotency markers, indefinitely self-renew, and do not differentiate unless 
stimulated (Jones-Villeneuve et al, 1982; McBurney, 1993; McBurney & Rogers, 
1982). Hmgn1- and Hmgn2-knockout lines, in conjunction with control lines, 
were subjected to imaging and immunostaining analyses capturing the 
morphology and organisation of the cells, and detecting pluripotency and 
differentiation markers by IF. Additionally, steady state mRNA levels of 
pluripotency transcription factor and lineage-specific genes were assayed by 
qRT-PCR.  
Hmgn-knockout cells are morphologically heterogeneous and grow in a more 
dispersed manner than the parental cells (Figure 3.3), resembling the 
differentiated cells in ESC cultures (Trott & Martinez Arias, 2013; Wray et al, 
2010). Indeed, differentiating cells are observed in Hmgn-knockout cultures as 
evidenced by NES and TUBB3 immunostaining (Figure 3.7 and Figure 3.8). In 
addition, a high proportion of Hmgn-knockout cells is devoid of the pluripotency 
markers SSEA1 and NANOG (Figure 3.4 and Figure 3.5), while retaining POU5F1 
(Figure 3.6). Unlike NANOG, POU5F1 and SOX2 are retained during the early 
stages of differentiation where they interact with different lineage-specific 
transcription factors to influence fate commitment (Kalkan et al, 2017; Thomson 
et al, 2011), raising the possibility that some of the observed POU5F1-positive 
cells have abandoned pluripotency and initiated differentiation programs. 
Gene expression analyses are consistent with the previous observations. Hmgn-
knockout cultures show higher levels of lineage-specific transcripts, in some 
cases accompanied by a reduction in Nanog expression (Figure 3.10). Pou5f1 and 
Sox2, however, are comparable among control and Hmgn-knockout lines (Figure 
3.10A). Interestingly, a set of pluripotency genes including Nanog is 
downregulated in the transition from the naïve pluripotency to the primed state 
for differentiation (Kinoshita & Smith, 2018; Nichols & Smith, 2009; Smith, 
2017). Furthermore, NANOG is heterogeneously expressed in ESC and P19 
cultures and the low-NANOG cells show higher lineage-specific gene expression 
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(Abranches et al, 2014; Chambers et al, 2007; Herberg et al, 2016; Kalmar et al, 
2009). Although the low-NANOG cells are more prone to differentiate, they have 
not abandoned pluripotency as they indefinitely self-renew and even originate 
daughter cells with higher NANOG levels (Abranches et al, 2014; Chambers et al, 
2007; Herberg et al, 2016; Kalmar et al, 2009). 
In the cited works, the proportion of low-NANOG cells among the population 
varies around 20%. In fact, when deriving monoclonal lines from WT P19 cells, 
one out of six shows lower Nanog expression accompanied by higher levels of 
Neurog1 and Ascl1 transcripts (Supplementary Figure, Appendix). This may be 
also the case of B1 monoclonal line, as Nanog is downregulated whereas Neurog1 
and Ascl1 are upregulated in these cells (Figure 3.10); nevertheless, B1 cells do 
not spontaneously differentiate like the Hmgn-knockout lines, which can be 
confirmed by IF for NES and TUBB3 (Figure 3.7 and Figure 3.8). Interestingly, this 
one-in-six proportion seems to be altered in the Hmgn-knockout lines as three 
out of five monoclones express Nanog in lower levels (Figure 3.10A). Whether 
the reduction in Nanog expression is the driver for the increased propensity to 
differentiate is not clear. However, these chromatin architectural proteins do 
not seem to directly regulate Nanog transcription as N1-1ΔN1 and B19ΔN2 cells 
display normal transcript levels, while expressing higher levels of lineage-
specific markers (Figure 3.10) and presenting numerous differentiating cells 
(Figure 3.7 and Figure 3.8). 
In fact, reports suggest that HMGNs do not act as specific regulators of gene 
expression, but fine-tune the existing gene expression profile and, in their 
absence, cumulative changes lead to altered phenotypes (Deng et al, 2017; Deng 
et al, 2013; Deng et al, 2015; Kugler et al, 2013). In the present work, a high 
proportion of ECCs exits pluripotency and initiates differentiation programs, 
mainly towards neural fates, in the absence of a major HMGN variant. 
These observations, however, contrast with previous works performed in ESCs 
derived from Hmgn1 single- and Hmgn1 and Hmgn2 double-knockout mice, 
where alkaline phosphatase reactivity and the cellular and colony morphology 
show no significant changes compared to ESCs derived from WT mice (Deng et 
al, 2017; Deng et al, 2013). Furthermore, the authors did not observe changes in 
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gene expression that suggest a higher frequency of spontaneous differentiation 
of Hmgn1 single- and Hmgn1 and Hmgn2 double-knockout ESCs to differentiate, 
not even towards neural fates. 
Several reasons can account for the exposed differences. Unlike P19 cells that 
indefinitely self-renew in serum-supplemented media and do not spontaneously 
differentiate, ESCs require further support of different factors for their 
propagation. As previously mentioned, feeder cells or LIF, serum or BMPs, and 2i 
sustain ESC self-renewal mainly by preventing differentiation (Smith et al, 1988; 
Wray et al, 2010; Ying et al, 2003a; Ying et al, 2008). Deng and collaborators 
(2013, 2017) cultured the cells with feeders or under feeder-free conditions 
including knockout serum replacement, LIF, and, in their most recent work, also 
2i. It is possible to speculate that the loss of a major HMGN variant facilities the 
response of the P19 cells to inductive differentiation cues, and that this 
response is ultimately blocked in ESCs by LIF and 2i. Alternatively, the loss of 
HMGN1 or HMGN2 might also increase the spontaneous differentiation of ESC, 
however, this cannot be observed as in 2i media only naïve ESCs form colonies 
and their differentiating progeny is eliminated (Kalkan et al, 2017). 
It is also worth considering the differences in the developmental stages from 
which ESCs and P19 cells were derived. ESCs capture the naïve state of 
pluripotency from pre-implantation embryos; once the embryo is implanted, the 
cells continue towards differentiation and the derived cell lines, such as EpiSCs, 
represent a pluripotency state primed for differentiation (Kinoshita & Smith, 
2018; Martello & Smith, 2014; Nichols & Smith, 2009; Smith, 2017). Previous 
works support the idea that P19 cells resemble EpiSCs (Kelly & Gatie, 2017; 
Mallanna et al, 2008), and these cells were derived from post-implantation 
embryos, raising the possibility that they can immediately commit to 
differentiation, whereas ESCs first exit the naïve pluripotency to later respond 
to inductive cues (Kinoshita & Smith, 2018; Mulas et al, 2017; Smith, 2017). 
Therefore, HMGNs may not be relevant for the preservation of the naïve 
pluripotency, that in vitro is enhanced by culturing the cells in 2i; rather, these 
chromatin architectural proteins may be important for keeping the primed cells 
unresponsive to misplaced inductive differentiation cues. 
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Interestingly, ESCs start losing their identity upon withdrawal of the factors that 
maintain them in a pluripotency state and differentiate mostly into neural 
lineages (Ying et al, 2003b). This is in complete agreement with the default 
model of neural differentiation proposing that the cells commit to neural fates 
unless instructed otherwise (Hemmati-Brivanlou, 1997; Munoz-Sanjuan & 
Brivanlou, 2002; Wilson & Edlund, 2001). This may explain the preference of 
Hmgn-knockout cells towards neural lineages over others. 
The following chapter investigates whether the proportion of differentiating 
cells in the Hmgn-knockout cultures is triggered by inductive differentiation 
cues. 
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Chapter 4 Inhibition of signalling pathways 
relevant for neurogenesis does not reverse the 
Hmgn-knockout phenotype 
4.1 Introduction 
In the previous chapter, it was suggested that the loss of a major HMGN variant 
increases the differentiation propensity of ECCs, leading to a higher expression 
of lineage-specific genes and increased spontaneous differentiation, mainly 
towards neural lineages. Additionally, it was speculated that Hmgn-knockout 
cells might respond more readily to inductive differentiation cues. 
A major event in the differentiation of ESCs is the autocrine stimulation of FGF 
signalling through the activation of the MAPK cascade. As previously mentioned, 
POU5F1 and SOX2 seem to play a dual role controlling pluripotency and 
developmental programs. These two transcription factors promote Fgf4 
expression in ESCs (Yuan et al, 1995). Autocrine stimulation of the FGF receptor 
by FGF4 is required for the proper commitment of ESCs to neuronal 
differentiation after withdrawal of the factors that sustain pluripotency (Ying et 
al, 2003b). Interestingly, ESCs treated with pharmacological inhibitors of the 
FGF receptor and Fgf4-null ESCs resist neural and non-neural induction, 
suggesting that the FGF signalling initiates commitment into multiple lineages in 
ESCs before specification (Kunath et al, 2007; Ying et al, 2003b). Furthermore, 
pharmacological inhibition of the FGF receptor impairs MAPK activation, and an 
inhibitor of the MAP2K that activates MAPK also impedes neural and non-neural 
specification of ESCs, identifying MAPK as the downstream effector of the FGF 
signalling in ESC differentiation (Stavridis et al, 2007). Indeed, this MAP2K 
inhibitor is included in the 2i formulation to prevent ESC differentiation (Ying et 
al, 2008). Importantly, MAPK signalling is also upregulated upon differentiation 
in P19 cells and proper neural induction of these cells relies on the presence of 
FGF4 and FGF8 (Wang et al, 2006). These observations raise the possibility that 
HMGN1 or HMGN2 may be important for modulating events related to the 
activation of the FGF signalling.  
WNT signalling is also relevant in ESC and P19 differentiation, although the 
scenario is complex. Canonical WNT signalling activation leads to catenin beta 1 
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(CTNNB1) stabilisation and translocation to the nuclei of the cells where it 
promotes transcription of target genes (MacDonald et al, 2009). When WNT 
signalling is inactive, CTNNB1 is sequestered and targeted for degradation in the 
cytoplasm by a complex containing, among others, GSK3 and AXIN2 (MacDonald 
et al, 2009). Self-renewal of ESCs is enhanced by pharmacological inhibition of 
GSK3 (Sato et al, 2004; Ying et al, 2008). Therefore, a GSK3 inhibitor is included 
in the 2i formulation (Ying et al, 2008), where it resists exit from naïve 
pluripotency through a mechanism that includes CTNNB1-mediated de-repression 
of relevant pluripotency genes (Wray, 2011). However, in the mouse embryo, 
WNT signalling is required during differentiation but not in the pre-implantation 
stages from which ESCs are derived (Huelsken et al, 2000), raising the possibility 
that the WNT requirement for ESC self-renewal is an artificial culture condition. 
In fact, a recent study shows that WNT signalling is not very active in ESCs; 
however, a subpopulation express a WNT reporter and a target gene, Axin2, in 
combination with lower levels of pluripotency factors and higher differentiation 
gene expression (Trott & Martinez Arias, 2013). The results suggest that WNT 
signalling activation occurs in early stages of differentiation, when ESCs just exit 
pluripotency (Trott & Martinez Arias, 2013). In agreement, previous studies in 
P19 cells have shown that different Wnt genes are upregulated upon RA 
induction of neuronal differentiation, and that overexpression of WNT1 in the 
absence of RA promotes SSEA1 loss and increments in neuronal-specific markers 
and transcription rates pro-neural genes (Smolich & Papkoff, 1994; Tang et al, 
2002). Canonical WNT signalling is likely to be responsible for these observations 
as inhibition of GSK3 and overexpression of CTNNB1 also initiate neuronal 
differentiation of P19 cells (Ding et al, 2003; Israsena et al, 2004), and of ESCs 
(Otero et al, 2004), through direct transcriptional regulation of Neurog1 
(Hirabayashi et al, 2004; Israsena et al, 2004). 
Interestingly, CTNNB1 and HMGN2 have been shown to collaborate in the 
modulation of homeodomain target gene expression (Amen et al, 2008). In this 
study, the presence of CTNNB1 switches the homeodomain/HMGN2 complex 
from a transcriptional repressor to a ternary activator complex, providing a link 
between HMGNs and WNT signalling that, in conjunction with the roles of WNT 
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during pluripotent stem cell differentiation, potentially influences cell fate 
decisions, favouring neural specification. 
Finally, NOTCH signalling activates the HES family of transcriptional repressors, 
regulating lineage-specific stem or progenitor cell maintenance and fate 
decisions (Kageyama et al, 2007). Particularly, NOTCH signalling promotes self-
renewal of NSCs, through a mechanism in which HES1 and HES5 antagonise the 
expression of pro-neural genes, and therefore, the commitment to neurogenesis 
(Kageyama et al, 2007; Ohtsuka et al, 1999). However, NOTCH signalling is 
neither required for maintaining ESC identity, nor changes the phenotype of 
ESCs when constitutively active (Lowell et al, 2006). Nevertheless, there is 
substantial evidence that NOTCH signalling operates during early ESC 
differentiation. NOTCH components are expressed by ESCs, and constitutive 
expression of NICD promotes an accelerated and exclusive neuronal 
differentiation of ESCs upon withdrawal of self-renewal stimuli; conversely, its 
genetic or pharmacological interference inhibits neural fates (Kobayashi & 
Kageyama, 2010; Lowell et al, 2006). These observations suggest a role for 
NOTCH signalling in the early cell fate decisions of ESCs, which may also 
determine the neural fate of P19 cells after the loss of HMGN1 or HMGN2. 
The aim of this chapter is to evaluate whether inductive cues trigger 
differentiation programs in P19 cells after the loss of a major HMGN variant.  
4.2 Inhibition of WNT, FGF and NOTCH signalling 
reduces the transcription rates of reporter genes 
The strategy used in the following experiments consists of culturing control and 
Hmgn2-knockout cells in normal conditions and under inhibition of WNT, FGF, 
and NOTCH signalling. The tankyrase inhibitor XAV-939 stabilises AXIN2 (Huang 
et al, 2009), enhancing CTNNB1 degradation, and therefore, impeding canonical 
WNT signalling and target gene expression. SU5402 is widely used as a 
competitive FGF receptor inhibitor (Mohammadi et al, 1997) that interferes with 
FGF signalling. DAPT selectively inhibits γ-secretase (Dovey et al, 2009), which is 
the enzyme responsible for NOTCH receptor cleavage, releasing the NICD to 
promote transcription of target genes.  
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In a first approach, parental P19 cells were exposed to the inhibitors, and 
additionally, to activators of two of the pathways, testing the response of the 
selected reporter genes. P19 cells were allowed to attach overnight in the usual 
media, and the day after, the three inhibitors and two activators were used 
independently. After 24 h of exposure to the different treatments, RNA was 
collected, and relative expression of selected target genes was determined by 
qRT-PCR in comparison with untreated cells. 
Figure 4.1 demonstrates that the selected target genes effectively report the 
inhibition of the respective pathways. Activation of WNT signalling using a GSK3 
inhibitor results in a 10 fold upregulation of Axin2, whereas inhibition of WNT 
signalling using the tankyrase inhibitor (iWNT) causes a 70% reduction in Axin2 
expression (Figure 4.1). Fgf4 levels are increased by 60% after FGF8 exposure 
and reduced by 30% after FGF receptor blockade (iFGF; Figure 4.1). Hes5 
expression is decreased by 40% under DAPT treatment (iNOTCH; Figure 4.1).  
It is worth noting that manipulation of WNT and FGF signalling modifies the 
expression of target genes from other pathways, whereas inhibition of NOTCH 
only affects Hes5 expression (Figure 4.1). This is in complete agreement with 
previous works reporting that ESCs cultured in the undifferentiated state are 
sensitive to inhibitors of WNT and FGF signalling (Kunath et al, 2007; Stavridis et 
al, 2007; Wray et al, 2010; Ying et al, 2008), but not to NOTCH inhibitors (Lowell 
et al, 2006). Interestingly, WNT and FGF signalling seem to act in opposite 
directions in P19 cells (Figure 4.1), as previously reported in developmental 
studies (Dyer et al, 2014; Wurst & Bally-Cuif, 2001). Furthermore, stimulation of 
FGF signalling leads to an increase in Hes5 (Figure 4.1), consistent with the idea 
that FGF signalling is required for proper ESC commitment into neural 
progenitors (Ying et al, 2003b), where HES5 regulates NSC fate decisions 
(Kageyama et al, 2007). In addition, previous findings show that NOTCH effectors 
can be modulated by different pathways in particular situations (Doetzlhofer et 
al, 2009; Dyer et al, 2014; Nakayama et al, 2008). 
It can be concluded that the selected genes are capable of reporting changes in 
the activity of the WNT, FGF, and NOTCH signalling pathways in P19 cells. 
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Figure 4.1 Target genes of WNT, FGF, and NOTCH signalling can report the inhibition or 
activation of the respective pathways 
Relative expression of the reporter genes Axin2, Fgf4, and Hes5, which are targets of WNT, FGF, 
and NOTCH signalling pathways, respectively, as determined by qRT-PCR. P19 cells were allowed 
to attach overnight and exposed for 24 h to activators and inhibitors of the mentioned pathways. 
The graph represents the logarithm of the fold change in comparison with untreated cells and error 
bars symbolise the SD from technical triplicates. 
  
Chapter 4  96 
 
4.3 Inhibition of WNT, FGF or NOTCH signalling does not 
reduce lineage-specific gene expression in Hmgn2-
knockout cells 
To investigate whether, after the loss of a major HMGN variant, P19 cells initiate 
differentiation programs triggered by inductive cues, FGF, WNT, and NOTCH 
signalling pathways were inhibited in control and Hmgn2-knockout cells using the 
conditions described above. The expression of the reporter genes was assayed in 
order to demonstrate effective inhibition of the signalling pathways.  
The basal levels of Axin2 are similar in all the cell lines, although slightly higher 
in B8ΔN2 and lower in B38ΔN2, suggesting that WNT signalling is not altered in a 
particular direction after the loss of HMGN2 (Figure 4.2A). When the cells are 
treated with the tankyrase inhibitor, Axin2 is reduced by 60% in all the lines 
except for B38ΔN2, in which the basal levels are lower, and the reduction is 
around 40% (Figure 4.2A). Thus, iWNT indeed impedes WNT signalling. 
Fgf4 basal expression is variable in the different lines tested, with a 60% 
reduction in control B1 and B19ΔN2 cells compared to the parental cells (Figure 
4.2B). This suggests that autocrine stimulation of FGF signalling varies between 
clonal lines, regardless the presence of HMGN2. After inhibition of the FGF 
receptor, Fgf4 levels are reduced by 40-50% in all cases (Figure 4.2B), indicating 
that iFGF successfully restricts FGF signalling. 
The Hes5 transcript is barely detectable in all the cell lines, which is consistent 
with previous work demonstrating that NOTCH signalling is required for proper 
ESC differentiation rather than for maintaining ESC identity (Kobayashi & 
Kageyama, 2010; Lowell et al, 2006). In B8ΔN2 and B19ΔN2 cells, Hes5 is further 
reduced in comparison with parental cells (Figure 4.2C), providing a partial 
explanation for the upregulation of pro-neural genes observed in these cells 
(Figure 3.10B and Figure 4.3B and C), as Hes1 and Hes5 reduce the transcription 
rates of pro-neural transcription factors (Ohtsuka et al, 1999). iNOTCH 
treatment effectively interferes with NOTCH activity as demonstrated by the 
downregulation of Hes5 by 40-70% in all lines (Figure 4.2C). 
Chapter 4  97 
 
 
Figure 4.2 Interference of WNT, FGF, and NOTCH signalling in control and Hmgn2-knockout 
cells 
Relative expression of the reporter genes Fgf4, Axin2, and Hes5 under inhibition of FGF, WNT, 
and NOTCH signalling pathways, respectively, as determined by qRT-PCR. The graphs represent 
the fold change in comparison with untreated parental cells and error bars symbolise the SEM from 
2 to 3 independent cultures. 
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Three of the genes previously shown to be altered in Hmgn2-knockout cells, 
Nanog, Neurog1 and Ascl1, were assayed following signalling inhibition. The logic 
behind was that if the increased Neurog1 and Ascl1 expression was due to 
increased WNT, FGF, or NOTCH signalling in the Hmgn2-knockout cells, then 
inhibition of these pathways should reduce these genes back to the levels 
observed in the parental P19 cells. 
As previously shown (Figure 3.10A), Nanog is significantly downregulated in B1, 
B8ΔN2, and B38ΔN2 cells. iWNT treatment reduces Nanog levels by around a half 
in all cell lines (Figure 4.3A), irrespective of the presence of HMGN2. This is in 
agreement with previous findings where activation of WNT signalling enhances 
the transcription rates of naïve pluripotency transcription factors (Wray et al, 
2010; Ying et al, 2008). Conversely, iFGF roughly doubles Nanog expression in all 
cases (Figure 4.3A). This opposite effect to iWNT is in agreement with Figure 4.1 
and previous developmental studies (Dyer et al, 2014; Wurst & Bally-Cuif, 2001). 
Furthermore, interfering with FGF signalling seems to re-establish Nanog levels 
in B1, B8ΔN2, and B38ΔN2 cells to that observed in untreated parental cells. 
However, consistent with the idea that inhibiting the MAPK cascade leads to 
upregulation of naïve pluripotency transcription factors (Kunath et al, 2007; 
Stavridis et al, 2007; Ying et al, 2008) and impedes RA-induced neuronal 
differentiation of P19 cells (Wang et al, 2006), iFGF also increases Nanog levels 
in parental cells, thus the differences between the cell lines are maintained. 
NOTCH signalling does not seem to be relevant for the transcriptional regulation 
of Nanog (Figure 4.3A), consistent with previous data that NOTCH is not required 
for the maintenance of the ESC identity (Lowell et al, 2006). 
Conversely, Neurog1 and Ascl1 are upregulated in B1, B8ΔN2, B19ΔN2, and 
B38ΔN2 cells in comparison with parental cells (Figure 3.10B and Figure 4.3B and 
C). Interfering with WNT signalling has little effect on the transcription rates of 
pro-neural transcription factors, which contrasts previous findings where 
overexpression of WNT1 or CTNNB1 leads to neuronal differentiation of P19 cells 
by directly targeting the Neurog1 promoter (Hirabayashi et al, 2004; Israsena et 
al, 2004; Smolich & Papkoff, 1994; Tang et al, 2002). It is possible to speculate 
that WNT signalling operates differently in undifferentiated P19 cells than during 
differentiation, and that WNT signalling is not important for transcriptional 
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regulation of Neurog1 in the undifferentiated state. Indeed, previous studies 
show that WNT signalling becomes active after implantation in mouse embryos 
(Huelsken et al, 2000) and when ESCs exit pluripotency (Trott & Martinez Arias, 
2013). Additionally, the canonical WNT signalling antagonist, AXIN2, reduces the 
formation of neurite-like structures in RA-induced neuronal differentiation of 
P19 cells, rather than impeding the initiation of differentiation (Lyu et al, 2003). 
Blockade of FGF receptor activity increases the transcription rates of pro-neural 
transcription factor, as Neurog1 and Ascl1 levels are 7 to 13 and 3 to 5 fold 
higher, respectively, than in untreated cells (Figure 4.3B and C). This is an 
unexpected result, as iFGF upregulates Nanog, raising the possibility that FGF 
signalling operates differently in individual cells from control and Hmgn2-
knockout cultures. Similarly to ESCs maintained in serum, P19 cells constitute a 
heterogeneous population in which different cells have different propensities to 
differentiate. This is evidenced by the heterogeneous Nanog levels and the 
reciprocal lineage-specific gene expression (Kalmar et al, 2009). Furthermore, 
these wide-ranging pluripotency states respond differently to FGF signalling, 
since in the two ends, naïve pluripotent cells proceed to EpiSCs whereas EpiSCs 
self-renew (Nichols & Smith, 2009). In such a scenario, inhibition of FGF 
signalling possibly enhances naïve pluripotency, and therefore, Nanog 
expression, while in EpiSCs compromises self-renewal, leading to differentiation 
and lineage-specific gene expression. An alternative explanation arises from the 
observation that stimulation of FGF signalling increase the levels of Hes5 (Figure 
4.1). Although Hes5 does not seem to be relevant for embryonic pluripotent cells 
(see above), it is possible to speculate that FGF signalling influences the 
expression of other HES family members important for embryonic pluripotent 
cells, such as Hes1 (Kobayashi & Kageyama, 2010; Kobayashi et al, 2009), 
indirectly impacting on the transcription rates of pro-neural transcription 
factors. 
Neurog1 and Ascl1 levels are also higher after iNOTCH treatment, since they are 
2 to 4 and 1.5 to 2 fold the levels of untreated cells, respectively (Figure 4.3B 
and C). The magnitude of the changes is lower than after FGF inhibition and no 
differences are observed in parental cells. However, this is consistent with 
previous work demonstrating that NOTCH effectors antagonise the pro-neural 
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gene expression (Kageyama et al, 2007; Ohtsuka et al, 1999). It is worth 
mentioning that this work used NSCs as NOTCH does not seem to be relevant for 
ESCs (Lowell et al, 2006). A potential explanation is that NOTCH signalling 
becomes active in the cells with higher differentiation propensity and the 
differentiating P19 cells, and therefore, these cells gain responsiveness to 
NOTCH signalling. Nevertheless, the effects of iNOTCH in the pro-neural 
transcription factor mRNA levels do not support that NOTCH signalling triggers 
neural induction of Hmgn-knockout cells. 
The previous results show that interfering with the main pathways related to 
neuronal differentiation does not revert lineage-specific gene expression in 
Hmgn2-knockout cells, suggesting that spontaneous neuronal differentiation 
after the loss of a major HMGN variant is not under the control of WNT, FGF, or 
NOTCH signalling. 
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Figure 4.3 Interfering with WNT, FGF and NOTCH signalling does not reduce the lineage-
specific gene expression in Hmgn2-knockout cells 
Relative expression of (A) the pluripotency transcription factors Nanog and the pro-neural 
transcription factors (B) Neurog1, and (C) Ascl1, under inhibition of WNT, FGF, and NOTCH 
signalling pathways as determined by qRT-PCR. The graphs represent the fold change in 
comparison with untreated parental cells and error bars symbolise the SEM from 2 to 3 
independent cultures. 
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4.4 Discussion 
This chapter investigated whether the spontaneous differentiation, mainly 
towards neural lineages, observed in P19 cells after the loss of a major HMGN 
variant is triggered by inductive cues. WNT, FGF, and NOTCH signalling are 
involved in embryonic pluripotent cell differentiation events such as 
multilineage commitment and neural specification. Control and Hmgn2-knockout 
cells were treated with inhibitors of the three pathways, and the inhibition was 
confirmed using validated reporter genes prior to further analysis (Figure 4.2) by 
(Figure 4.1). 
The loss of HMGN2 does not appear to either enhance or diminish the three 
signalling pathways, as expression of their target genes does not change in a 
consistent pattern in Hmgn2-knockout lines when compared with parental cells 
(Figure 4.2). Furthermore, there are differences in the levels of Fgf4 between 
parental and B1 cells (Figure 4.2B), indicating clonal variability. FGF4 stimulates 
FGF signalling in an autocrine manner, allowing embryonic pluripotent cell 
commitment to differentiation (Kunath et al, 2007; Stavridis et al, 2007). 
Lineage-priming precedes the initiation of differentiation and is denoted by 
naïve pluripotency factor downregulation (Kalkan et al, 2017; Kinoshita & Smith, 
2018; Smith, 2017). In agreement, Nanog is upregulated in all cell lines after 
blockade of FGF receptor (Figure 4.3A), suggesting that at least some of the 
cultured cells can revert to a naïve pluripotency state under FGF signalling 
inhibition (Kalkan et al, 2017; Marks et al, 2012; Ying et al, 2008).  
Intriguingly, Neurog1 and Ascl1 are also increased by iFGF in all cell lines (Figure 
4.3B and C), raising the possibility that at least a subset of P19 cells respond 
differently to FGF signalling compared to naïve ESCs, perhaps reflecting the 
different developmental stage from which P19 cells were derived. Indeed, 
EpiSCs and hESCs proliferate in the presence of FGF2 and differentiate upon FGF 
withdrawal, in contrast to mouse ESCs (Tesar et al, 2007), providing evidence 
that the independence of FGF signalling for self-renewal is a unique 
characteristic of naïve pluripotency and that the developmental stage influences 
the responsiveness to FGF signalling (Kinoshita & Smith, 2018; Smith, 2017). The 
fact that interfering with FGF signalling has similar effects in the different cell 
lines, including higher pro-neural gene expression, indicates that the 
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spontaneous neuronal differentiation of Hmgn2-knockout cells is not explained 
by changes in FGF signalling.    
WNT signalling neither seem to be responsible for the neuronal differentiation of 
P19 cells after the loss of HMGN2, as iWNT has little effect on pro-neural gene 
expression (Figure 4.3B and C). This observation contrasts previous works 
showing that canonical WNT signalling promotes Neurog1 expression (Hirabayashi 
et al, 2004; Israsena et al, 2004; Tang et al, 2002). However, similar to FGF 
signalling, canonical WNT signalling has shown to work differently in 
undifferentiated state than along differentiation.  
In ESCs, the activation of canonical WNT signalling enhances self-renewal, 
through CTNNB1-mediated de-repression of pluripotency genes (Sato et al, 2004; 
Wray et al, 2010; Ying et al, 2008). In agreement, iWNT reduces Nanog levels 
(Figure 4.3A). Nevertheless, WNT signalling is not operating at the blastocyst 
stage from which ESCs are derived, rather it is activated at early differentiation 
stages (Huelsken et al, 2000). These observations suggest that the requirement 
of WNT signalling for ESC self-renewal is an artificial culture condition. When 
ESCs are allowed to differentiate by withdrawing the factors sustaining 
pluripotency, the cells gain WNT responsiveness and activates WNT signalling 
early after exiting pluripotency, and WNT supports differentiation (Kalkan et al, 
2017; Trott & Martinez Arias, 2013). Then, it is possible that the neurogenic 
effect of WNT signalling starts in later developmental stages, and thus, WNT 
does not trigger differentiation of P19 cells. 
Similarly, NOTCH is not relevant for pluripotency (Lowell et al, 2006), which 
explains the fact that Nanog expression is not influenced by iNOTCH in any of 
the cell lines, and that iNOTCH does not affect Neurog1 and Ascl1 transcript 
levels in parental cells (Figure 4.3). Interestingly, Neurog1 and Ascl1 are 
upregulated following NOTCH inhibition in all monoclonal lines, which have an 
increased differentiation propensity (Figure 4.3B and C). It has been previously 
shown that NOTCH components are upregulated upon neural induction 
(Kobayashi & Kageyama, 2010), and that the NOTCH effectors HES1 and HES5 act 
as transcriptional repressors of the pro-neural transcription factors in NSCs 
(Kageyama et al, 2007). It is possible that spontaneously differentiating P19 cells 
have increased levels of NOTCH signalling components, so that inhibition of 
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NOTCH leads to even greater increases in pro-neural gene expression. The 
direction of the change in the pro-neural gene expression, however, discards the 
possibility that precocious activation or responsiveness to NOTCH signalling in 
Hmgn-knockout cells triggers neuronal differentiation. 
In conclusion, the data of this chapter indicate that none of the tested signalling 
pathways triggers differentiation of P19 cells after the loss of HMGN2, as 
inhibiting these pathways does not re-establish lineage-specific gene expression 
to the levels seen in parental levels. WNT and NOTCH signalling seem to act 
downstream of the ECC commitment to certain lineages, rather than initiating 
differentiation. FGF stimulation has different effects within the range of 
pluripotency states; however, these do not include directly promoting neuronal 
differentiation. These observations suggest that the loss of a major HMGN 
variant is permissive for the initiation of differentiation following an intrinsic 
and cell-autonomous program, in agreement with the default model of neural 
induction. 
The next chapter studies the process of neural induction of P19 cells after the 
loss of a major HMGN variant and evaluates the potential consequences of a 
higher differentiation propensity when the cells are subject to neuronal 
differentiation protocols and converted to NSCs. 
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Chapter 5 Loss of HMGN1 or HMGN2 alters cell 
fate decisions of derived neural stem cells 
5.1 Introduction  
The previous chapters showed that loss of HMGN1 or HMGN2 increases the 
spontaneous neuronal differentiation of P19 cells, and additionally, that this is 
not mediated by signalling pathways relevant for embryonic neurogenesis. These 
observations lead to the proposition that P19 cells are more prone to 
differentiate after the loss of a major HMGN variant following an intrinsic and 
cell-autonomous program along mainly, but not exclusively, the neural pathway. 
This chapter studies whether the higher differentiation propensity of Hmgn-
knockout cells influences their performance in response to neuronal 
differentiation protocols. In addition, it evaluates whether HMGNs are required 
for proper cell fate decisions of other stem cells, specifically of NSCs, or 
whether this is a unique feature of embryonic pluripotent cells. 
During development, neural induction of embryonic cells occurs during 
gastrulation under BMP/SMAD signalling inhibition when the cells apparently 
execute an intrinsic default program of differentiation (Hemmati-Brivanlou, 
1997; Munoz-Sanjuan & Brivanlou, 2002; Wilson & Edlund, 2001). The 
neuroectoderm is the first neural structure and comprises cells that turn into 
NSCs (Kriegstein & Alvarez-Buylla, 2009). The NSCs are multipotent tissue-
specific stem cells capable of self-renewal that can generate the main nervous 
system cell lineages: neurons and glia (Gage, 2000; Kriegstein & Alvarez-Buylla, 
2009; Temple, 2001). Once the NSC population is established, the production of 
neurons and glia occurs in a spatio-temporal specific manner, which is crucial for 
the development of neural tissues with the correct size and morphology 
(Hirabayashi & Gotoh, 2005; Miller & Gauthier, 2007). 
In the first neural development stage called the expansion phase, the population 
of NSCs increases in number by symmetric divisions. Subsequently in the 
neurogenic phase, NSCs undergo asymmetric divisions resulting in the production 
of neurons without extinguishing the NSC pool. Finally in the gliogenic phase, the 
NSCs proceed towards glial fates at expense of neuronal production (Qian et al, 
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2000). Astrocytes appear in late embryonic stages and their generation is a 
continuous process that peaks peri- and postnatally. In contrast, oligodendrocyte 
differentiation occurs in waves along the period of astrocyte differentiation 
(Kessaris et al, 2005). The precise timing of nervous system development 
involves changes in NSC features that limit their neurogenic potential (Qian et 
al, 2000). In fact, NSC isolated from early stages and late stages differ in their 
chromatin conformation (Kishi et al, 2012) and responsiveness to signalling 
pathways as, for example, NOTCH promotes self-renewal of early-stage NSCs, 
but favours glial versus neuronal differentiation in later stages (Morrison et al, 
2000). 
Neural development has been modelled in vitro using ESCs and ECCs. The first 
aim of this chapter is to reproduce previous neuronal differentiation protocols. 
5.2 In vitro systems of neuronal differentiation of ESCs 
and ECCs 
In ESCs, neural induction is achieved in chemically defined media by withdrawing 
the factors that maintain pluripotency (Ying et al, 2003b), consistent with the 
default model. ESC differentiation is asynchronous (Kalkan et al, 2017; Mulas et 
al, 2017; Ying et al, 2003b); however, after six days of factor withdrawal, most 
of the cells in the culture are positive for the NSC marker NES and show classical 
bipolar morphology (Figure 5.1). At this time point, early neurogenesis can be 
detected by immunostaining for the neurofilament TUBB3 (Figure 5.1). By day 
12, the NSCs are arranged in structures that resemble the neural rosettes 
observed during neural development (Figure 5.1, box), in which the dividing 
cells occupy the centre (Figure 5.1, arrow), while the differentiated cells 
migrate to the edges. The production of neurons continues towards later stages 
without extinguishing the NSC pool and, mimicking the timing of neuronal 
development in vivo, the onset of gliogenesis occurs later, at around day 16 
(Figure 5.1). 
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Figure 5.1 ESC differentiation along neural lineages 
ESCs grow as round, compact colonies in 2i/LIF chemically defined media, and are positive for 
POU5F1 (green). Conversion to NSCs is initiated after withdrawal of 2i/LIF. IF at days 6, 12, 16, 
and 20 are presented for the detection of the NSC marker NES (red), the neurofilament TUBB3 
(green), and the glial filament GFAP (green). DAPI was used to stain the nuclei (cyan). The box 
highlights a structure resembling neural rosettes and the arrow indicates a dividing cell located at 
the centre. Scale bars represent 200 µm in bright field pictures and 50 µm in IF.   
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P19 cells progress into NSCs in response to RA stimulation (Jones-Villeneuve et 
al, 1982). In this system, RA acts as a trigger of differentiation rather than as a 
neural inducer, as when P19 cells are exposed to RA and BMP, they do 
differentiate, but into non-neural fates (Hoodless & Hemmati-Brivanlou, 1997). 
Nevertheless, highly efficient protocols of neuronal differentiation from P19 
cells have been developed and most of them include the addition of RA in 
combination with factors that facilitate neurogenesis. The protocol used here 
consists of seeding P19 cells in serum-free media containing RA, FGF8, and DAPT 
(Nakayama et al, 2014). As mentioned in previous chapters, serum contains BMPs 
that inhibit neurogenesis (Ying et al, 2003a), FGF8 is important for neuronal 
differentiation of P19 cells (Wang et al, 2006), and DAPT blocks NOTCH signalling 
(Dovey et al, 2009). NOTCH maintains the pool of NSCs in early stages by 
antagonising pro-neural transcription factors, and therefore, neurogenesis 
(Kageyama et al, 2007); thus, the addition of DAPT promotes neuronal 
differentiation of NSCs. 
As shown in Figure 5.2, P19 cells undergo conversion to NSC by three days after 
induction (dai) as revealed by NES immunostaining. Similarly to ESCs, early 
neurogenesis is observed at this time point (Figure 5.2). The aim of this protocol 
is the rapid generation of mature neurons, and it therefore utilises AraC to kill 
diving cells between days four and six after induction. Hence, the NSC pool 
extinguishes towards later time points (Figure 5.2), and consequently, 
gliogenesis is abolished (Nakayama et al, 2014). Meanwhile, neurons are 
maturing in the cultures as shown by immunostaining for the mature neuron 
marker MAP2 (Figure 5.2). 
Chapter 5  109 
 
 
Figure 5.2 Rapid and efficient method of P19 neuronal differentiation 
P19 cells grow as colonies with mostly defined edges in serum-supplemented media. They are all 
positive for the pluripotency marker POU5F1 (green). Neural induction is stimulated by RA, FGF8, 
and DAPT in serum-free media. AraC is added to the media from 4 to 6 dai. IF images are shown 
for the NSC marker NES (red), the neurofilament TUBB3 (green), and the neuronal-specific 
microtubule associated protein MAP2 (red) at 3 and 10 dai, respectively. DAPI was used to stain 
the nuclei (cyan). Scale bars represent 200 µm in bright field pictures and 50 µm in IF.    
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5.3 Neuronal differentiation of Hmgn-knockout cells 
The next aim of this chapter is to determine whether the higher differentiation 
propensity of the Hmgn-knockout cells influences their performance in response 
to neuronal differentiation protocols. The method described above (Nakayama 
et al, 2014) was selected as it is rapid, efficient, and well characterised. The 
focus was on the initial steps just before the AraC treatment (days 1 to 4), as 
these comprise the period of neural induction and early neurogenesis. Parental, 
B1, and Hmgn-knockout cells were dissociated from one flask each and induced 
to differentiate by plating the cells in four different dishes, each one with a 
different end point at 1, 2, 3, or 4 dai. The entire procedure was performed 
twice and monitored by imaging and RNA analyses. 
As shown in Figure 5.3, morphological changes are evident as early as 1 dai. 
Parental and B1 cells spread out from the colonies that are observed in the 
undifferentiated cultures (Figure 3.3) and develop cytoplasmic protuberances 
(Figure 5.3). Hmgn-knockout cells already displayed these features before neural 
induction (Figure 3.3), consistent with a more differentiated phenotype; 
however, they spread out even more at 1 dai (Figure 5.3).  
By 4 dai, the cells seem to concentrate in clusters that are more compact in 
parental and B1 cells than in Hmgn-knockout cells (Figure 5.3). A network of 
neuronal projections connects these clusters (Figure 5.3). These observations 
suggest that the clusters of cells work as differentiation centres, perhaps 
mimicking the function of neural rosettes during neural development. Although 
no major changes are observed when comparing control and Hmgn-knockout 
neuronal differentiation, there are more cells growing outside the clusters in the 
Hmgn-knockout cultures, thus at least some part of the process is different after 
the loss of a major HMGN variant. Interestingly, neural induction appears less 
efficient in D3ΔN1 cells, as the arrangement of the cells at 4 dai is completely 
different and a layer of flattened cells can be observed below the undefined 
clusters of cells (Figure 5.3). This result is consistent with previous data 
suggesting that these cells are prone to differentiate towards non-neural 
lineages (see chapter 3); thus, this propensity seems to interfere with the 
neurogenic potential of some D3ΔN1 cells. 
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Figure 5.3 Morphological changes in control and Hmgn-knockout cells during a rapid and 
efficient method of neuronal differentiation  
Bright field pictures at 1 and 4 dai of a rapid and efficient method of neuronal differentiation. Control 
and Hmgn-knockout cells were induced to differentiate in two independent experiments. Scale bar 
indicates 200 µm. 
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To further evaluate the neuronal differentiation process in control and Hmgn-
knockout cells, RNA was collected at different ending points including 1, 2, 3, 
and 4 dai, and the expression of relevant genes was determined. It is worth 
mentioning that the system is not completely reproducible, and therefore, 
variations from one dish to another and from one experiment to another are 
observed. Taking this into consideration, the two independent experiments are 
presented separately, with data from the first experiment in Figure 5.4, and 
data from the second experiment in Figure 5.5. 
The expression of the naïve pluripotency transcription factor Nanog is 
downregulated upon neural induction of parental cells; there is a 50% reduction 
by 1 dai that continues to decrease in 2 and 3 dai to approximately 100 and 1000 
fold less than the initial levels, respectively (Figure 5.4). A similar expression 
pattern is observed in B1 cells (Figure 5.4 and Figure 5.5), although there is 
little change between 0 and 1 dai (Figure 3.10A). B8ΔN2, B38ΔN2, N1-1ΔN1 and 
D3ΔN1 cells have similar responses to B1 cells, while in B19ΔN2 cells Nanog is 
downregulated at 1 dai in a similar manner to parental cells (Figure 3.10A, 
Figure 5.4, and Figure 5.5). There are no consistent differences in Nanog 
expression when comparing the controls with the Hmgn-knockout samples, 
suggesting that all the cells abandon pluripotency with similar timing. 
Neural induction of parental cells is also accompanied by changes in Nes 
expression; this NSC marker is upregulated in the first few days and tends to 
decrease again by 4 dai, although the timing of this is variable (Figure 5.4). Nes 
induction is also observed in B1 cells; however, the transcript levels are not as 
high as in parental cells and are comparable to the increased basal levels of 
B8ΔN2, B19ΔN2, N1-1ΔN1, and D3ΔN1 cells (Figure 3.10D, Figure 5.4, and Figure 
5.5). Interestingly, Nes expression remains unchanged the first couple of days 
after neural induction of Hmgn-knockout cells, perhaps indicating that the basal 
transcript levels are sufficient for neural induction of these cells (Figure 5.4 and 
Figure 5.5). However, the downregulation of the NSC marker at 3 dai is observed 
in all cell lines, especially in the second experiment (Figure 5.5), suggesting that 
the process of neural induction is complete by this point and the NOTCH 
inhibitor DAPT is promoting neurogenesis from NSCs at the expense of self-
renewal. 
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Neurog1 and Ascl1 are strongly induced in all cases, even though their initial 
levels vary between the cell lines (Figure 5.4 and Figure 5.5). The pro-neural 
transcription factors reach their highest transcript levels at 2 to 3 dai, when 
Neurog1 transcript is up to 2000 fold and Ascl1 up to 600 fold more abundant 
than at basal levels (Figure 5.4 and Figure 5.5). Although both are required for 
neuronal differentiation, Neurog1 induction is much higher than Ascl1 in all cell 
lines during this protocol. Moreover, their induction is preceded by Nes 
expression and their levels are maintained while Nes is downregulated (Figure 
5.4 and Figure 5.5). These observations are consistent with the developmental 
switch from the expansion to the neurogenic phase, which is enhanced by DAPT. 
Notably, the biological variability observed between experiments (Figure 5.4 and 
Figure 5.5) is higher than any potential influence of HMGN proteins.  
The original neuronal differentiation protocol that was adapted for the current 
experiments aimed to maximise the rapid generation and maturation of neurons 
(Nakayama et al, 2014). At 1 dai, the cells are induced to convert into NSCs and 
by 3 dai a switch from expansion to neurogenic phase is achieved. Subsequently, 
the newborn neurons start maturing, which is evidenced by branching and 
neurite formation, involving complex cytoskeleton changes and projections. 
Neurofilament proteins are an important part of this process, and in agreement, 
Tubb3 expression is induced after Neurog1 and Ascl1 (Figure 5.4). However, in 
the second experiment either the efficiency or timing of the differentiation 
process was not sufficient to detect a peak in Tubb3 levels (Figure 5.5). 
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Figure 5.4 Gene expression analyses of control and Hmgn-knockout cultures along a rapid 
and efficient neuronal differentiation method: first experiment 
Relative expression of the naïve pluripotency transcription factor Nanog, the NSC marker Nes, the 
pro-neural transcription factors Neurog1 and Ascl1, and the neurofilament Tubb3 along a rapid and 
efficient neuronal differentiation method as determined by qRT-PCR. The graphs represent the fold 
change in comparison with undifferentiated parental cultures and error bars symbolise the SD of a 
PCR triplicate. 
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Figure 5.5 Gene expression analyses of control and Hmgn-knockout cultures along a rapid 
and efficient neuronal differentiation method: second experiment 
Relative expression of the naïve pluripotency transcription factor Nanog, the NSC marker Nes, the 
pro-neural transcription factors Neurog1 and Ascl1, and the neurofilament Tubb3 along a rapid and 
efficient neuronal differentiation method as determined by qRT-PCR. The graphs represent the fold 
change in comparison with undifferentiated parental cultures and error bars symbolise the SD of a 
PCR triplicate. 
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Taken together, the bright field images and the RNA analyses reveal that the loss 
of HMGN1 or HMGN2 influence neither the efficiency of P19 neuronal 
differentiation, nor the timing and the sequence of the events. All the cell lines 
follow a process whereby first of all, the cells spread out of compact colonies, 
Nanog expression drops and Nes levels are sufficient for neural induction. Then, 
Nes is downregulated, while the pro-neural transcription factors are induced. 
Consequently, the cells concentrate in clusters functioning as differentiation 
centres that are connected by neuronal projections. Simultaneously, Neurog1 
and Ascl1 are reduced and, in some cases, higher transcript levels of Tubb3 are 
detected. 
Further information is provided by IF performed at 4 dai. Figure 5.6 shows that 
the pluripotency marker SSEA1 is mostly lost by the end of the experiment in B1 
and Hmgn-knockout cells. Although a few SSEA1-positive cells are still observed, 
most of the cells are positive for NES, evidencing the highly efficient ECC to NSC 
conversion (Figure 5.6). Importantly, NSCs with high NES protein levels are still 
numerous at 4 dai, when Nes transcript levels are already reduced (Figure 5.4 
and Figure 5.5). Indeed, changes in gene expression precede both variations at 
the protein level and differentiation events (Kalkan et al, 2017). 
Immunostaining of TUBB3 confirms that the induction of the pro-neural 
transcription factors and the conversion to NSCs progresses into neurogenesis 
(Figure 5.7). The protocol promotes the rapid generation and maturation of 
neurons, which involves branching, neurite formation, and synaptogenesis 
(Nakayama et al, 2014). In agreement, many projections are observed in B1, 
B8ΔN2, B19ΔN2, and N1-1ΔN1 cultures at 4 dai (Figure 5.7). However, the 
cytoskeleton complexity of D3ΔN1 cells is lower, suggesting alterations in either 
neurite formation or neurogenesis (Figure 5.7). This constitutes further evidence 
that the preference of D3ΔN1 cells is more likely towards non-neural lineages. 
Nevertheless, some of the D3ΔN1 cells are still capable of neuronal 
differentiation since TUBB3-positive cells are identified (Figure 5.7).  
Consistent with the above observations and the bright field images showing 
different cell types in D3ΔN1 cultures (Figure 5.3), considerable numbers of 
GATA4-positive cells are identified in D3ΔN1 cultures at 4 dai, and interestingly, 
in B8ΔN2 cultures (Figure 5.8). These cells are located outside the large clusters 
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of cells where most neurogenesis is happening, and therefore, are spatially 
separated from NSCs and neurons. GATA4-positive cells are also detected in 
D3ΔN1 and B8ΔN2 undifferentiated cultures with higher frequencies than in 
parental (Figure 3.9). Furthermore, Gata4 expression is upregulated in the 
undifferentiated state of these two Hmgn-knockout lines (Figure 3.10C). Hence, 
a subset of D3ΔN1 and B8ΔN2 cells are predisposed towards endodermal 
lineages, reinforcing the idea that HMGNs influence the differentiation 
propensity of P19 cells rather than inhibiting neurogenesis. 
 
Figure 5.6 Neural induction of control and Hmgn-knockout cells results in loss of 
pluripotency and conversion into NSCs 
IF for the detection of the pluripotency marker SSEA1 (left, red) and the NSC marker NES (right, 
red). B1 and Hmgn-knockout cells were fixed at 4 dai of a rapid and efficient neuronal 
differentiation method. DAPI was used to stain the nuclei (cyan). Scale bar indicates 50 µm. 
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Figure 5.7 Neural induction of control and Hmgn-knockout cells generates neurons with 
complex cytoskeleton projections 
IF for the detection of the neurofilament TUBB3 (red) reveals complex cytoskeleton architecture in 
all cell lines, except in D3ΔN1 cells. B1 and Hmgn-knockout cells were fixed at 4 dai of a rapid and 
efficient neuronal differentiation method. DAPI was used to stain the nuclei (cyan). Scale bar 
indicates 50 µm. 
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Figure 5.8 Identification of endodermal cells in Hmgn-knockout cultures induced to 
differentiate into neural fates 
Double IF for the detection of the neurofilament TUBB3 (centre, red) and the endodermal 
transcription factor GATA4 (right, green). B1 and Hmgn-knockout cells were fixed at 4 dai of a rapid 
and efficient neuronal differentiation method. DAPI was used to stain the nuclei (cyan). Scale bar 
indicates 50 µm.  
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Important conclusions can be derived from these experiments. First, the higher 
neuronal differentiation propensity of Hmgn-knockout cells cultured under non-
differentiating conditions does not enhance or accelerate the process of neural 
induction under active stimulation. Secondly, the propensity towards non-neural 
fates in the undifferentiated state may decrease the responsiveness to neural 
inductive cues. Finally, although there is a subset of cells differentiating towards 
non-neural lineages, there is another subset of cells that retains the potential to 
undergo neuronal differentiation. Overall, it can be concluded that the loss of a 
major HMGN variant does not limit pluripotency of embryonic cell cultures and 
does not seem to favour or inhibit a specific cell lineage. 
5.4 HMGN1 and HMGN2 along neural induction of P19 
cells 
As reviewed in the introduction, the two major HMGN variants are progressively 
downregulated in the entire embryo during development; however, tissue-
specific stem cells and other transiently amplifying precursor cells retain high 
levels of these proteins (Furusawa et al, 2006; Lehtonen & Lehtonen, 2001; 
Lehtonen et al, 1998). 
The neuronal differentiation protocol presented above comprises all the stages 
of a differentiation process (see Figure 5.2, Figure 5.6, and Figure 5.8). At 1 dai, 
there are embryonic pluripotent cells committing to or even starting 
differentiation towards a certain lineage, in this case the neural lineage. Then 
by 2 to 3 dai, tissue-specific stem cells, here NSCs, appear in the cultures. 
Subsequently, differentiated cells, such as neurons, become highly abundant and 
are expected to mature fully over time. The sequential phases of the protocol 
facilitate the evaluation of HMGN1 and HMGN2 protein and mRNA levels during 
neuronal differentiation. 
IF for the detection of HMGN1 and HMGN2 in B1, B8ΔN2, B19ΔN2 and B1, N1-
1ΔN1, D3ΔN1 cells, respectively, reveals a mosaic expression pattern of the 
proteins at 4 dai (Figure 5.9A). These results differ from the homogenous 
distribution observed in undifferentiated cells (Figure 3.2) and are in complete 
agreement with a developmental regulation of the two major HMGN variants. 
There is a general trend that the cells in the middle of the differentiation 
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centres exhibit a brighter signal than the cells at the edges; however, numerous 
cells escape this trend (Figure 5.9A, see arrows for examples). Determining the 
identity of high- and low-expressing HMGN cells by IF is not simple considering 
the high cell density of the differentiation centres and the complex cytoskeleton 
architecture of the NSCs and neurons. Therefore, different experiments are 
required to derive accurate associations between the higher or lower HMGN 
levels and the specific cell types. 
Gene expression analyses during neuronal differentiation show that the Hmgn1 
transcript is upregulated in B1, B8ΔN2, B19ΔN2 cells in early stages of the 
process, corresponding to the NSC conversion of embryonic pluripotent cells 
(Figure 5.9B). Subsequently, a progressive downregulation causes a 40 to 70% 
reduction in Hmgn1 transcript levels by 4 dai, when fully differentiated cells 
represent a high proportion of the cultures (Figure 5.9B). Similarly, Hmgn2 
expression is induced at 1 dai in B1, N1-1ΔN1, D3ΔN1 cells, followed by a decline 
of 70 to 90% in comparison with the initial levels in undifferentiated cells (Figure 
5.9C). 
The previous results recapitulate what observed along embryonic development 
(Crippa et al, 1991; Furusawa et al, 2006; Lehtonen & Lehtonen, 2001; Lehtonen 
et al, 1998; Pash et al, 1990), as Hmgn1 and Hmgn2 transcript levels are higher 
in embryonic pluripotent cells (0 dai) than in cultures containing fully 
differentiated cells (4 dai). However, the NSCs seem to express higher levels of 
HMGNs than the undifferentiated cells (Figure 5.9B and C). Although this finding 
has been previously reported, it has not been highlighted or further investigated 
(Deng et al, 2013; Lehtonen & Lehtonen, 2001). Nevertheless, these observations 
suggest that HMGNs are important for tissue-specific stem cell biology, 
particularly for NSCs. 
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Figure 5.9 HMGN1 and HMGN2 protein and mRNA expression pattern along neuronal 
differentiation 
B1 and Hmgn-knockout cells were induced to differentiate following a rapid and efficient method of 
neuronal differentiation. A) IF for the detection of HMGN1 and HMGN2 (green) at 4 dai are 
presented. DAPI was used to stain the nuclei (cyan). Arrows highlight cells at the edges of the 
clusters expressing high levels of HMGNs. Scale bar indicates 50 µm. Relative expression of 
Hmgn1 (B) and Hmgn2 (C) along neuronal differentiation as determined by qRT-PCR. The graphs 
represent the fold change in comparison with undifferentiated parental cultures and error bars 
symbolise the SD of a PCR triplicate. 
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5.5 Loss of a major HMGN variant influences P19 
differentiation after serum withdrawal 
It was previously shown that the higher neuronal differentiation propensity of 
Hmgn-knockout cells does not accelerate the process of neural induction 
following a rapid and efficient method of neuronal differentiation for P19 cells. 
This finding contrasts what was expected; however, it is possible to hypothesise 
that the active stimulation of differentiation results in an efficient process 
whatever the initial propensity of the cells. To investigate differentiation in the 
absence of active stimulation, the cells were subjected to a gentler process that 
is based on the protocol of ESC differentiation along neural lineages (Ying et al, 
2003b). Briefly, P19 cells are routinely propagated in serum-supplemented 
media and is reasonable to believe that the factors sustaining self-renewal of 
these cells are contained in the serum. Hence, the serum was replaced by the 
N2-supplement containing chemically defined factors required for the survival of 
the cells without preventing them from differentiation. B1 and Hmgn-knockout 
cells were seeded in N2 chemically defined media; bright field images and RNA 
were collected after 48 h. 
As shown in Figure 5.10A, the arrangement of B1 cells cultured in N2 chemically 
defined media differs from the round compact colonies characteristic of the 
undifferentiated state (Figure 3.3). Furthermore, some neural projections can be 
observed in the cells at the edges (Figure 5.10A, magnification), although most 
of the cells maintain a homogeneous morphology lacking cytoplasmic 
protuberances, especially those located at the centre. In contrast, most of the 
B19ΔN2 and N1-1ΔN1 cells have acquired a bipolar morphology (Figure 5.10A, 
magnifications). D3ΔN1 and, to a lesser degree B8ΔN2, cultures are 
heterogeneous; however, all the cells exhibit cytoplasmic protuberances as a 
feature of differentiation and cells with bipolar morphology are also identified 
(Figure 5.10A, magnifications).  
At the gene expression level, Nanog is downregulated although in the range of 
tens of fold instead of hundreds, as was seen during induced neuronal 
differentiation protocol (Figure 5.5 and Figure 5.10B). This suggests either an 
inefficient or a delayed differentiation. This scenario might be useful for 
identifying different responses of the cells to serum withdrawal according to 
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their diverse differentiation propensities. The variations in Nanog levels among 
the cell lines in N2 chemically defined media may be explained by the variations 
in the levels of the undifferentiated state, which are lower in B1, B8ΔN2, and 
D3ΔN1 cells than in B19ΔN2 and N1-1ΔN1 (Figure 3.10A).  
Nes transcript levels do not change substantially, similar to the induced 
differentiation protocol. However, differences among the cell lines that show 
spontaneous neuronal differentiation (B8ΔN2, B19ΔN2, and N1-1ΔN1) and those 
that does not (B1 and D3ΔN1) (Figure 3.8) are highlighted after 48 h in N2 
chemically defined media (Figure 5.10B). 
Neurog1 and Ascl1 transcripts are strongly induced in all cell lines, although 
their levels do not reach the highest point observed during the induced protocol 
(Figure 5.5 and Figure 5.10B). This supports the idea of an inefficient or delayed 
differentiation that might be useful to identify particularities. Indeed, the gene 
expression of the pro-neural transcription factors is much higher in B19ΔN2 and 
N1-1ΔN1 than in other lines, in agreement with their increased neuronal 
differentiation propensity (Figure 5.10B). Furthermore, D3ΔN1 cells that prefer 
non-neural lineages show the lowest change in Neurog1 and Ascl1 levels (Figure 
5.10B). Surprisingly, the pro-neural transcription factors are less induced in 
B8ΔN2 cells than in B1 (Figure 5.10B). The fact that at least a subpopulation of 
B8ΔN2 cells prefers endodermal lineages (Figure 5.7) may account for this 
observation. 
Considering all of the above data, it can be concluded that the different cell 
lines initiate differentiation programs after serum withdrawal, and that the 
efficiency of neural specification seems to be in agreement with the respective 
basal neuronal differentiation propensity, which in turn, is influenced by the loss 
of a major HMGN variant. 
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Figure 5.10 Loss of HMGN1 or HMGN2 influences P19 differentiation after serum withdrawal 
B1 and Hmgn-knockout cells were allowed to differentiate by withdrawing the serum from the 
culture media. A) Bright field pictures of cultures at 48 h after serum withdrawal. 2X magnifications 
highlight neural morphology. Scale bar indicates 200 µm. B) Relative expression of the naïve 
pluripotency transcription factor Nanog, the NSC marker Nes, and the pro-neural transcription 
factors Neurog1 and Ascl1 as determined by qRT-PCR. The graphs represent the fold change in 
comparison with undifferentiated parental cells and error bars symbolise the SD of a PCR triplicate. 
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5.6 Neural stem cell derivation from embryonal 
carcinoma and embryonic stem cells 
It was previously observed that Hmgn1 and Hmgn2 transcript levels are higher 
after conversion of ECCs to NSCs, and before fully differentiated cells represent 
a high proportion in the differentiating cultures (Figure 5.9). This finding leads 
to the proposition that HMGNs are important for NSC biology. 
To gain further insights into this, a method of NSC derivation from P19 cells was 
developed in the laboratory based on an established protocol of NSC derivation 
from ESCs (Conti et al, 2005). Briefly, ESCs are allowed to differentiate in 
chemically defined media by withdrawing the factors that sustain pluripotency 
(Ying et al, 2003b). At day 6, when most of the population express the NSC 
marker NES (Figure 5.1), the cells are dissociated and seeded onto uncoated 
dishes in chemically defined media containing FGF2 and EGF, allowing the 
formation of neurospheres. These two growth factors ensure the propagation of 
NSCs in the laboratory (Gage, 2000). Then, the cells are plated onto gelatine-
coated dishes and propagated routinely in the presence of FGF2 and EGF. After a 
few passages, differentiated progeny are removed from the population and a 
homogeneous NSC population is established (Conti et al, 2005). 
Based on this method, P19 cells are induced to differentiate in serum-free media 
by the addition of RA, FGF8, and DAPT, following the rapid and efficient method 
of neuronal differentiation (Nakayama et al, 2014). At 3 dai, most of the cells 
are positive for the NSC marker NES (Figure 5.2), and therefore, this time point 
was selected for the switch to the chemically defined media containing FGF2 
and EGF. The next day, the cells are dissociated and plated onto gelatine-coated 
dishes and propagated routinely in the presence of FGF2 and EGF. 
NSCs derived from P19 cells and the ESC line, E14, are passaged 8 to 10 times 
before further evaluation. Bipolar cells are observed under the microscope, 
forming geometric figures with their cytoplasmic projections that extend from 
small growing centres (Figure 5.11A). The P19-derived NSCs present thicker 
cytoplasmic projections and higher cell density in the growing centres (Figure 
5.11A, arrows). However, most of the cells are identified as NSC by double 
immunostaining for the detection of the NSC markers NES and FABP7 (Figure 
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5.11B). FACS analyses show a mostly homogeneous population expressing NES in 
P19- and E14-derived NSC cultures. Nevertheless, NSC derivation from P19 cells 
appears to be less efficient than from E14 cells, since the peak of the population 
is wider, revealing certain heterogeneity in NES levels. Furthermore, the peak 
overlaps with the isotype negative control, which indicates that not all the cells 
are NSCs (Figure 5.11C). 
Chapter 5  128 
 
 
Figure 5.11 NSCs derived from P19 and E14 cells 
A) Bright field pictures of NSCs derived from P19 (left) and E14 (right) cells. Arrows show growing 
centres. Scale bar indicates 200 µm. B) Double IF for the detection of the NSC markers FABP7 
(green) and NES (red). DAPI was used to stain the nuclei (cyan). Scale bar indicates 50 µm. C) 
FACS analyses for the identification of the NSC marker NES in NSCs derived from P19 cells (left, 
blue) and from E14 cells (right, red), in comparison with the isotype negative control (purple).  
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E14-derived NSCs are capable of generating the main cell lineages of the nervous 
system, neurons and glia (Conti et al, 2005). To test whether P19-derived NSCs 
are also capable of differentiation, growth factors were withdrawn from P19 and 
E14-derived NSCs, and neurogenesis was observed by immunostaining for the 
neuron-specific markers TUBB3 and MAP2 (Figure 5.12A). In the presence of 
serum, the cells differentiate into glial cells with classical stellar morphology 
that, upon maturation, replaces the NES intermediate filament with the glial 
fibrillary acidic protein (GFAP) (Figure 5.12B). Interestingly, the differentiating 
P19 cultures exhibit higher proliferation rates, which results in the emergence of 
growing and differentiation centres (Figure 5.12A, arrows) and neural rosette-
like structures (Figure 5.12B, box). 
Gene expression analyses show that the pluripotency transcription factor Pou5f1 
is downregulated in the transition from embryonic pluripotent cell to NSCs in 
both cell lines, although greater downregulation in E14-derived NSCs is 
observed. Pou5f1 transcript levels are 100,000 fold less in E14-NSCs in 
comparison with the undifferentiated state, while in P19-NSCs they are 1,000 
fold less (Figure 5.12C). Upon growth factor withdrawal from the NSC cultures, 
E14 cultures maintain silenced Pou5f1 expression, while P19 cultures show 
increased Pou5f1 expression (Figure 5.12C). It is possible that Pou5f1 expression 
is misregulated in NSCs and neuronal cells derived from P19 cells, due to their 
oncogenic mutations. Alternatively, it may be that residual undifferentiated 
pluripotent cells are present in the P19-NSC cultures, and that these cells 
continue to proliferate after the removal of growth factors, thus making up a 
larger proportion of the population. The latter hypothesis may explain the NES-
negative cells detected by FACS (Figure 5.11). 
Nes and Map2 transcript levels are much higher in the NSC stage than in the 
undifferentiated cells, reflecting the self-renewal and neurogenic features of 
NSCs (Figure 5.12C). These two transcripts are at comparable levels in P19- and 
E14-derived NSCs, despite the higher basal levels detected in the 
undifferentiated ECCs. After growth factor withdrawal, Nes and Map2 are 
downregulated exclusively in differentiating P19-NSCs (Figure 5.12C), although 
greater numbers of NSCs and neurons are observed in P19 cultures than in E14. It 
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is possible that other cell types, i.e. embryonal cells, might be present in P19 
cultures that are decreasing the proportion of the neural lineage cells. 
Gfap expression is negligible in the undifferentiated and the NSC stages. 
However, it is induced upon factor withdrawal in both cell lines (Figure 5.12C), 
which is in agreement with a gain of gliogenic potential and a reduction of 
neurogenic potential in the late stage NSCs. 
Finally, Hmgn2 levels are higher in NSCs derived from both P19 and E14 cells and 
drop upon NSC differentiation (Figure 5.12C). This is consistent with previous 
observations (Figure 5.9) and supports the hypothesis that HMGNs are important 
for NSC biology. 
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Figure 5.12 P19- and E14-derived NSCs possess neurogenic and gliogenic potential 
NSCs derived from P19 and E14 were allowed to differentiate by growth factor withdrawal for six 
days (A and C), or induced to generate glia (B). Co-immunostaining was performed to detect (A) 
TUBB3 (green) and MAP2 (red), or (B) GFAP (green) and NES (red). DAPI was used to stain the 
nuclei (cyan). Arrows show growing and differentiation centres and a neural rosette-like structure is 
highlighted by the box. Scale bar indicates 50 µm. C) Relative expression of relevant genes as 
determined by qRT-PCR. The graph represents the log10 of the fold change in comparison with 
undifferentiated E14 or P19 cells, respectively. Actb was utilised as the reference gene. Error bars 
symbolise the SD of a PCR triplicate. 
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5.7 Neural stem cells lacking HMGN proteins differentiate 
with higher frequency and exhibit altered gene 
expression 
In order to test the hypothesis that HMGNs are important for NSC biology, NSCs 
were derived from parental, B1, and Hmgn-knockout cells, following the method 
described above. After 8 to 10 passages, bipolar cells that are positive for the 
NSC marker NES represent the majority of the population in all lines (Figure 
5.13). Although D3ΔN1 cells prefer non-neural fates, they are capable of 
generating NSCs (Figure 5.13), supporting the idea that the loss of a major HMGN 
variant does not limit pluripotency to a certain lineage in a population of P19 
cells. 
In B1 cells, the transition from the undifferentiated state to NSCs recapitulates 
what is observed in parental cells (Figure 5.12, blue columns and Figure 5.14A, 
light blue columns); Pou5f1 expression decreases by approximately 1,000 fold, 
Nes expression is induced by 30 fold, and Map2 transcript levels are around 65 
fold higher than the undifferentiated state. Furthermore, Sox2 transcript levels 
are similar to those of undifferentiated parental cells, as SOX2 is a marker of 
both ESCs and NSCs (Figure 5.14A, light blue columns). Conversely, Neurog1 
expression is downregulated (Figure 5.14A, light blue columns), possibly due to 
NOTCH signalling that maintains NSC self-renewal by antagonising the 
transcriptional activation of pro-neural transcription factors (Kageyama et al, 
2007). 
In Hmgn-knockout NSCs, Sox2 transcript levels are comparable to those in B1-
NCSs, even when the individual cultures prior to differentiation had varying 
steady state mRNA levels (Figure 5.14A). Nes and Map2 are induced in all cases, 
reaching similar levels despite the initial variability (Figure 5.14A). The 
expression pattern of these three genes is consistent with the NSC identity of 
these cells. Nevertheless, important alterations are observed in the NSCs derived 
from Hmgn-knockout cells: Pou5f1 is only slightly downregulated and its 
expression is not even 10 fold less than in the undifferentiated populations, 
while Neurog1 expression remains 5 to 7.5 times higher than in undifferentiated 
parental cells (Figure 5.14A). Interestingly, Pou5f1 and Neurog1 levels of NSCs 
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lacking HMGN1 or HMGN2 are similar to those observed after growth factor 
withdrawal in parental-NSCs (Figure 5.14B). 
 
Figure 5.13 NSCs derived from parental and Hmgn-knockout cells 
Parental and Hmgn-knockout cells were induced to differentiate following a rapid and efficient 
method of neuronal differentiation (Nakayama et al, 2014). At 3 dai, there is a switch to chemically 
defined media containing FGF2 and EGF. The next day, the cells were dissociated and seeded 
onto gelatine-coated dishes in the presence of FGF2 and EGF. After 8 to 10 passages in the 
mentioned conditions, the cells were fixed and IF were performed for the detection of the NSC 
marker NES (red). DAPI was used to stain the nuclei (cyan). Scale bar indicates 50 µm. 
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Figure 5.14 NSCs lacking a major HMGN variant exhibit altered gene expression 
A) Relevant gene expression changes along the transition from the undifferentiated to the NSC 
state in B1 and Hmgn-knockout cells, as determined by qRT-PCR. B) Relative expression of the 
pluripotency transcription factor Pou5f1 and the pro-neural transcription factor Neurog1 in NSCs 
derived from parental, B1, and Hmgn-knockout cells in comparison to differentiating parental-
NSCs, as determined by qRT-PCR. The graphs represent the log10 of the fold change in 
comparison with undifferentiated embryonal carcinoma parental cells and error bars symbolise the 
SD of a PCR triplicate. 
 
To further evaluate the alterations presented by the NSCs lacking HMGN1 or 
HMGN2, IF was performed for POU5F1 and TUBB3. Notably, the growing and 
differentiation centres previously identified in P19-derived NSCs (Figure 5.11A, 
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arrows) contain cells expressing POU5F1 (Figure 5.15, arrows). Numerous 
clustered POU5F1-positive cells are also observed in NSCs derived from Hmgn-
knockout cultures (Figure 5.15, arrows). Immunostaining for the intermediate 
neurofilament TUBB3 reveals the presence of increased numbers of neurons in 
the growing centres in all Hmgn-knockout cell lines (Figure 5.16).  
The data show that the growing and differentiation centres observed in P19 and 
Hmgn-knockout derived NSCs appear to contain POU5F1-positive cells (Figure 
5.15), NES-positive cells (Figure 5.13), and TUBB3-positive neurons (Figure 5.16). 
It seems likely that these cell clusters work as differentiation centres in a similar 
manner to the clusters observed during induced neuronal differentiation (Figure 
1.7). However, it is not possible to say from the data whether these clusters 
comprise three different cell types growing side by side, or whether individual 
cells express all three genes. Dual-colour FACS analysis of NSC and differentiated 
cell populations would be required to investigate this further. Nevertheless, it is 
possible to hypothesise that undifferentiated P19 cells expressing POU5F1 are 
present in these clusters of NSC cells, and that after growth factor withdrawal 
and neuronal differentiation, these cells continue to proliferate, leading to a 
relative increase in overall Pou5f1 transcript levels (Figure 5.12C). This would 
mean that P19 cells do not respond as efficiently as E14 cells to the conditions 
for deriving and maintaining NSCs.  
Similarly, the increased Pou5f1 transcript levels in NSCs derived from Hmgn-
knockout lines could reflect an increase in the number of pluripotent 
undifferentiated cells in these populations. This leads to the proposition that 
after the loss of a major HMGN variant, the cells are even less responsive than 
parental cells to the growth factor conditions that selectively promote NSC 
maintenance and propagation. Residual undifferentiated cells lacking either 
HMGN1 or HMGN2 survive and proliferate in response to these growth factors at 
higher rates than parental cells as evidenced by the numerous POU5F1-positive 
cells (Figure 5.15), and the higher Pou5f1 expression (Figure 5.14). Furthermore, 
the Hmgn-knockout cells that successfully undergo NSC conversion are not 
propagated with the same efficiency, as higher neuronal differentiation events 
are observed (Figure 5.16), consistent with the upregulation of the pro-neural 
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transcription factor NEUROG1 (Figure 5.14). Therefore, HMGNs seem to be 
required for the maintenance of the cellular identity of NSCs. 
 
Figure 5.15 NSC cultures lacking a major HMGN variant contain numerous pluripotent cells 
NSCs derived from parental and Hmgn-knockout cells were fixed after 8 to 10 passages under 
NSC propagation conditions and IF were performed for the detection of the pluripotency 
transcription factor POU5F1 (green). DAPI was used to stain the nuclei (cyan). Arrows show the 
growing centres. Scale bar indicates 50 µm. 
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Figure 5.16 NSC cultures lacking a major HMGN variant contain numerous neurons 
NSCs derived from parental and Hmgn-knockout cells were fixed after 8 to 10 passages under 
NSC propagation conditions and IF were performed for the detection of the neurofilament TUBB3 
(green). DAPI was used to stain the nuclei (cyan). Scale bar indicates 50 µm. 
5.8 Discussion 
The loss of a major HMGN variant does not have a major influence on the neural 
induction of P19 cells after stimulation with factors relevant for neurogenesis 
(see Figure 5.3 to Figure 5.8). Nevertheless, the higher propensity of 
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unstimulated cells to differentiate towards neural fates following serum 
withdrawal (mainly observed in N1-1ΔN1 and B19ΔN2) increases the transcription 
rates of pro-neural transcription factors (Figure 5.10), which could result in the 
induction of neuronal differentiation. Moreover, the propensity of some Hmgn-
knockout cells to differentiate into non-neural fates (mainly observed in D3ΔN1 
cells) interferes with their neuronal differentiation upon stimulation. However, 
there are some D3ΔN1 cells that respond to these neurogenic cues, suggesting 
that the loss of HMGNs does not restrict the pluripotency of all P19 cells within 
the population.  
Previous studies have tested the neurogenic potential of ESCs lacking a single or 
double HMGN variant. The first study implemented a standard protocol of 
dopaminergic neuron differentiation of ESCs derived from Hmgn1-knockout mice 
and their control littermates, which includes the addition of growth, selection, 
and specification factors (Deng et al, 2013). The authors did not observe either 
differences in the efficiencies of NSC and neuron production, or major gene 
expression changes in the NSCs and neurons derived from them (Deng et al, 
2013). These findings are consistent with the results presented in Figure 5.3 to 
Figure 5.8, supporting that the loss of a major HMGN variant neither enhance, 
nor extinguish the neurogenic potential of embryonic pluripotent cell cultures. 
In a more recent work, the authors tested the neurogenic potential of double-
knockout ESCs lacking both HMGN1 and HMGN2 (Deng et al, 2017). This time the 
cells were allowed to differentiate by withdrawing the factors that sustain 
pluripotency, similar to the strategy utilised in Figure 5.10. Several genes 
showed altered expression along the protocol in the double-knockout cells. Gene 
ontology is a bioinformatic resource utilised for the identification of affected 
biological pathways considering a set of missregulated genes. The gene ontology 
analysis of the upregulated genes failed to recognise specific related pathways; 
however, it revealed alterations in neuron differentiation, neuron 
morphogenesis, neuron projection development, neuron projection 
morphogenesis, transmission of nerve impulse, synaptic transmission, and 
axogenesis, when considering the downregulated genes (Deng et al, 2017). These 
findings suggest that HMGNs are involved in neuron maturation processes, which 
are out of the scope of the present and the cited works. Nevertheless, D3ΔN1 
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cultures exhibit fewer projections at 4 dai (Figure 5.7 and Figure 5.8), and 
therefore, it would be interesting to further investigate whether HMGNs are 
indeed required for the processes identified by gene ontology analyses. 
The fact that HMGN1 and HMGN2 are progressively downregulated along 
development (Crippa et al, 1991; Furusawa et al, 2006; Lehtonen et al, 1998; 
Pash et al, 1990), does not rule out the possibility that these proteins play an 
important role in fully differentiated cells as they are ubiquitously expressed in 
all adult tissues (Johns, 1982). However, it highlights their relevance in ESCs and 
other stem cells. As observed in Figure 5.9, Hmgn1 and Hmgn2 expression is 
induced in the ECC to NSC transition, consistent with higher transcription rates 
of Hmgn1 in NSCs derived from control ESCs during dopaminergic neuron 
differentiation (Deng et al, 2013). Indeed, previous reports have emphasised the 
presence of HMGN proteins in progenitor cells committed to differentiate but 
still capable of self-renewal (Furusawa et al, 2006; Lehtonen & Lehtonen, 2001). 
However, these findings have not been further investigated. 
NSCs can be derived in the laboratory from P19 cells following the induction of 
neuronal differentiation and selection with FGF2 and EGF (Figure 5.11). The 
presence of the NSC markers FABP7 and NES confirm the identity of the cells, 
further supported by higher Nes transcript levels and downregulation of 
pluripotency transcription factors (Figure 5.12C, solid blue). Moreover, the 
derived NSCs seem to activate NOTCH signalling as Neurog1 expression is 
reduced (Figure 5.14, solid blue), and this pathway promotes self-renewal at 
expenses of neurogenesis. Nevertheless, they are capable of neuronal, and 
additionally, glial differentiation (Figure 5.12A and B), in line with their in vivo 
counterparts (Temple, 2001). The ability to derive NSCs from P19 cells allowed 
the evaluation of the potential role of HMGNs in these tissue-specific stem cells. 
NSC lacking a major HMGN variant show increased Neurog1 and Pou5f1 
expression than control NSCs, resembling the differentiation process followed by 
parental cells after growth factor withdrawal (Figure 5.14B). Furthermore, 
numerous events of spontaneous neuronal differentiation are observed in NSCs 
derived from Hmgn-knockout cells (Figure 5.16), suggesting that the HMGNs are 
important for the balance between self-renewal and differentiation of tissue-
specific stem cells. Indeed, limb bud mesenchymal progenitor cells derived from 
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Hmgn1-knockout mice differentiate faster into chondrocytes (Furusawa et al, 
2006).    
The proper timing of neurodevelopment is essential for the size, morphology and 
function of neural tissues, which is guaranteed by molecular switches between 
expansion, neurogenic, and gliogenic phase of NSC differentiation (Hirabayashi 
and Gotoh, 2005, Miller and Gauthier, 2007). It is possible to speculate that the 
spontaneous neuronal differentiation of NSC lacking a major HMGN variant leads 
to precocious neuronal differentiation in vivo that might compromise the pool of 
NSCs and the subsequent generation of glia. In line with this speculation, 
Hmgn1-knockout mice contain fewer NSCs in the SVZ (Deng et al, 2013), a widely 
known neurogenic niche where the developing and adult NSCs reside (Bjornsson 
et al, 2015). In addition, siRNA-mediated downregulation of Hmgn1, Hmgn2, or 
Hmgn3 in mouse NSCs results in increased neurogenesis at expenses of astrocyte 
differentiation both in vitro and in vivo (Nagao et al, 2014), which may be 
explained by a reduced NSC pool at late stages when gliogenesis starts. 
Furthermore, the Hmgn1 and Hmgn2 double-knockout mice exhibit reduced 
numbers of oligodendrocytes in the spinal cord and related behavioural 
alterations (Deng et al, 2017). The mechanism proposed by the authors, 
however, involves the accumulation of a post-translational histone modification 
repressive for gene expression at the promoter regions of Olig1 and Olig2, the 
master regulators of oligodendrocyte differentiation. It would be interesting to 
test whether the accumulation of repressive marks is related with a neurogenic 
fate of cells and with a precocious neuronal differentiation.      
In conclusion, the present experiments suggest that HMGNs are necessary for the 
maintenance of the stem cell identity, which relies in mechanisms promoting 
self-renewal and inhibiting differentiation. As previously reviewed, 
developmental fate decisions rely on the interaction between extrinsic cues and 
intrinsic programs, and epigenetic events are important mediators of this 
interaction. The HMGNs are chromatin architectural proteins that modify local 
chromatin structure and mediate chromatin accessibility for other epigenetic 
players. This may explain the changes in gene expression and the altered cell 
fate decisions of Hmgn-knockout cells. The next chapter investigates the 
epigenetic landscape of these cells. 
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Chapter 6 HMGN1 and HMGN2 support an open 
chromatin conformation in embryonal 
carcinoma cells 
6.1 Introduction 
The data shown in the previous chapters indicate that HMGN proteins are 
important for safe warding the identity of stem cells. Specifically, the loss of a 
major HMGN variant increases the propensity of stem cells to differentiate into 
the lineages dictated by intrinsic programs, at expenses of their self-renewal. 
Self-renewal of ESCs is influenced by chromatin modulators. As reviewed in the 
introduction, chromatin of ESCs exhibits a globally open conformation that is 
permissive for the particularly high transcriptional activity of these cells (Efroni 
et al, 2008). Accordingly, histone modifications associated with open and active 
chromatin, such as acetylation and H3K4me3, are enriched in ESCs (Azuara et al, 
2006; Efroni et al, 2008; Krejčí et al, 2009). Interestingly, increasing histone 
acetylation through HDAC inhibition promotes self-renewal and prevents 
differentiation of ESCs (Lee et al, 2003; Qiao et al, 2015; Ware et al, 2009), 
while reducing HAT activity in ESCs leads to differentiation (Fang et al, 2014). 
Additionally, H3K4me3 is highly abundant in ESCs and its levels drop during 
differentiation; maintenance of this modification is required for ESC self-
renewal, and optimises somatic cellular reprograming into iPSCs (Ang et al, 
2011). 
At the same time as maintaining a globally open chromatin conformation, the 
silencing of developmental genes is important for preventing the precocious 
lineage commitment of pluripotent stem cells (Boyer et al, 2006). The 
abundance of the transcriptional repressive mark H3K27me3 is lower in ESCs 
than in their differentiated progeny (Marks et al, 2012), consistent with a 
globally open chromatin conformation; however, it is enriched at promoters of 
developmental genes (Boyer et al, 2006). Interestingly, some of these promoters 
are also marked with H3K4me3, and are thought to be poised for transcriptional 
activation if required for initiating differentiation programs (Azuara et al, 2006; 
Bernstein et al, 2006). These bivalent domains tend to resolve into monovalent 
domains during differentiation (Bernstein et al, 2006; Mikkelsen et al, 2007). 
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The above mechanisms seem to be conserved in P19 cells. For instance, HDAC 
inhibitors decrease Neurod1 expression (Fang et al, 2010), which is in agreement 
with previous findings that inhibition of HDAC prevents differentiation of ESCs 
(Lee et al, 2003). Furthermore, the enrichment of PcG proteins and their 
deposited histone modification H3K27me3 around the Neurod1 TSS is higher in 
undifferentiated P19 cells than after RA-induced neuronal differentiation 
(Yellajoshyula et al, 2012). The presence of H3K4me3 at the Neurod1 TSS in 
undifferentiated P19 cells suggests that Neurod1 is bivalently marked 
(Yellajoshyula et al, 2012). Likewise, other genes relevant for neurogenesis show 
bivalent marks in undifferentiated P19 cells and their transcriptional activation 
during P19 neuronal differentiation involves loss of PcG-mediated repression and 
enrichment of H3K4me3 and H3K9ac (Yellajoshyula et al, 2012). 
HMGN1 and HMGN2 proteins are known to influence histone modifications (Deng 
et al, 2017; Lim et al, 2005; Ueda et al, 2006). In particular, they are required 
to maintain proper cellular levels of H3 acetylation, in a mechanism that 
involves enhancing HAT function (Lim et al, 2005; Ueda et al, 2006). 
Furthermore, HMGNs indirectly prevent H3K27me3 accumulation at lineage-
specific genes (Deng et al, 2017). The mechanism consists of antagonising the 
binding of linker histone H1 to chromatin; bound H1 recruits PcG to specific gene 
loci, increasing H3K27me3 local levels (Deng et al, 2017). 
Considering the above information, the aim of this chapter is to investigate 
whether the loss of a major HMGN variant influences the histone modification 
landscape of P19 cells, in particular the levels of H3 acetylation, H3K4me3, and 
H3K27me3. The first objective focuses on histone modifications at specific gene 
loci, as changes in local chromatin architecture might explain the alterations in 
the expression of pluripotency and lineage-specific genes observed in Hmgn-
knockout cells. The second objective investigates whether the loss of HMGN2 
influences the global levels of certain histone modifications. 
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6.2 Chromatin preparation and immunoprecipitation 
controls 
To achieve the first objective, quantitative ChIP-PCR for the detection of 
histone modifications at promoters and regulatory regions of pluripotency and 
lineage-specific genes was performed. Chromatin samples from parental, 
B19ΔN2, and B38ΔN2 cells were previously prepared by a Master student in the 
laboratory, Mariarca Bailo, and stored for further analysis. The present work 
utilised the stored samples. Briefly, chromatin was sonicated to produce DNA 
fragments of adequate sizes for PCR amplification (between 100 to 1000 bp). 
Figure 6.1 shows that the sizes of the DNA fragments are comparable between 
parental, B19ΔN2, and B38ΔN2 chromatin preparations and rely within the 
required range. 
 
Figure 6.1 Sizes of DNA fragments after sonication of chromatin samples 
Gel electrophoresis of DNA from parental, B19ΔN2, and B38ΔN2 chromatin samples. After 
sonication, chromatin samples were subjected to a reverse cross-linking reaction to release the 
DNA. Histones and chromatin bound proteins were enzymatically degraded and the DNA was 
purified in order to analyse the length of the fragments by gel electrophoresis. The DNA ladder 
flanks the samples and contains bands of the indicated sizes in bp. 
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DNA and protein concentrations of chromatin samples were determined by 
standard methods and results are provided in Table 6.1. Although there are some 
discrepancies between the two methods, both were considered for calculating 
the volume of each sample required to yield comparable results. The volumes 
per reaction indicated in Table 6.1 were maintained in all ChIP-PCR 
experiments. 
Table 6.1 Chromatin amount loaded per ChIP reaction 
Chromatin 
sample ID 
DNA 
(ng/µl) 
Protein 
(µg/µl) 
Vol/rxn 
(µl) 
DNA/rxn 
(µg) 
Protein/rxn 
(µg) 
Parental 172.6 2.8 30 5.2 84 
B19ΔN2 108.4 2.3 40 4.3 92 
B38ΔN2 101.1 2.2 40 4.0 88 
 
Chromatin was immunoprecipitated with antibodies targeting H3K4me3, 
H3K27me3, H3K9ac, H3K27ac, and H3K122ac. In addition, antibodies recognising 
HMGN1 and HMGN2 proteins determined whether B19ΔN2 and B38ΔN2 chromatin 
is in fact devoid of HMGN2, and investigated whether there is functional 
compensation by HMGN1 in the Hmgn2-knockout cells (Deng et al, 2015). An 
antibody that binds the unmodified C-terminal tail of H3 was used to compare 
chromatin levels between samples and was subsequently used as a normaliser. 
Finally, since all antibodies were raised in rabbit, rabbit IgG (rIgG) was used as a 
negative control to detect non-specific binding during the ChIP protocol. 
After ChIP, the DNA was purified and the enrichment relative to input DNA or H3 
enrichment was determined for specific genomic regions by qPCR. Primer sets 
targeting these genomic regions were designed considering mouse ES Bruce4 
information deposited in the UCSC genome browser and generated by the Ren 
lab as part of the ENCODE/LICR project (http://genome.ucsc.edu) (Consortium, 
2012; Kent et al, 2002). Several locations along the pluripotency genes Pou5f1 
and Nanog were investigated, especially those corresponding to H3K4me3 peaks, 
which mark active promoters, and to sites of colocalisation of both H3K4me1 and 
H3K27ac, which is characteristic of active enhancers. Specifically, Pou5f1-1 
primer set targets a potential enhancer marked by H3K4me1 and H3K27ac, while 
Pou5f1-2 and Pou5f1-3 amplify regions upstream and downstream of the first 
exon, respectively, both highly enriched in H3K4me3 (Figure 6.2). Similarly, 
Nanog-1 primer set is located in a region enriched in H3K4me1, Nanog-2 and 
Nanog-3 flank the first exon occupied by H3K4me3, and Nanog-4 targets an 
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intronic region that is also enriched in H3K4me3 (Figure 6.2). Primer sets for the 
lineage-specific genes Neurog1, Ascl1, Gata4, and Tbxt target potential bivalent 
domains near each TSS that are enriched in both H3K4me3 and H3K27me3 
(Figure 6.2). In addition, Actb serves as a control for active transcription. 
 
Figure 6.2 ChIP-PCR primer positioning along pluripotency and lineage-specific genes 
ChIP-PCR primer positions are indicated along the pluripotency genes, Pou5f1 and Nanog, and at 
the lineage-specific genes Neurog1, Ascl1, Gata4, and Tbxt. Sequences were aligned to the mm9 
mouse genome. Data for mouse ES Bruce4 cells were obtained from the UCSC genome browser 
and was generated by the Ren lab as part of the ENCODE/LICR project (http://genome.ucsc.edu) 
(Consortium, 2012; Kent et al, 2002). Y-axis maxima are 30 for H3K4me3, 4 for H3K27me3, 15 for 
H3K9ac, 25 for H3K27ac, and 3 for H3K4me1. 
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H3 ChIP-PCR shows that the amount of chromatin loaded per reaction is 
comparable between the three different preparations from parental, B19ΔN2, 
and B38ΔN2 cells; however, it is not identical (Figure 6.3A). The average 
enrichment of H3 in the parental, B19ΔN2, and B38ΔN2 chromatin samples was 
2.65, 1.72 and 2.1 respectively. These observations indicate that less amount of 
chromatin from Hmgn2-knockout lines was utilised, which is particularly evident 
at the actively transcribed genes Actb, Pou5f1, and Nanog (Figure 6.3A). In order 
to control for these differences, the average H3 enrichment across all primer 
sets tested was used to normalise the data from different chromatin samples in 
subsequent experiments. 
The isotype control is a negative control that reveals the background levels of 
non-specific immunoprecipitation at the genomic locations tested. The data 
show that PCR signal from rIgG is less than 1% of that for H3 at most of the 
primer sets, although in some cases the signal approximates to 10% of the H3 
signal (i.e. relative enrichment of less than 0.35, Figure 6.3B). In these 
reactions, however, dissociation curve analysis reveals that the signal does not 
derive from the correct amplicon (not shown). The previous data demonstrate 
that enrichment above these background levels corresponds to selective 
immunoprecipitation by the antibodies tested, and confirm primer specificity. 
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Figure 6.3 ChIP-PCR controls for chromatin loading and antibody/primer specificity 
Chromatin samples were prepared from parental, B19ΔN2, and B38ΔN2 cells and 
immunoprecipitated with an antibody targeting (A) the C-terminal tail of H3 or (B) using the isotype 
control rIgG. The resulting DNA was purified and assayed by qPCR using primers corresponding to 
the promoter and/or regulatory regions of pluripotency and lineage-specific genes. The graphs 
represent the enrichment in the immunoprecipitated sample compared to that of input data. Error 
bars symbolise (A) the SEM from three independent experiments or (B) the SD from a PCR 
triplicate.  
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6.3 HMGN1 and HMGN2, chromatin architectural proteins 
Recent ChIP-seq studies suggest an enrichment of HMGN1 and HMGN2 at DHSs, 
the hallmark of regulatory regions such as promoters and enhancers (Martínez de 
Paz & Ausió, 2016), in mammalian cells (Deng et al, 2013; Deng et al, 2015; 
Zhang et al, 2016). In addition, a more recent paper shows that HMGN1 and 
HMGN2 colocalise with histone modifications related to decondensed and active 
chromatin such as H3K4me3, H3K9ac, H3K27ac, and H3K4me1, while the 
proteins are nearly depleted from condensed and transcriptionally silent 
chromatin regions marked by H3K9me3 and H3K27me3 in three different cell 
types derived from mouse (He et al, 2018).   
In this work, ChIP-PCR detected HMGN1 and HMGN2 bound at pluripotency and 
lineage-specific genes (Figure 6.4). Importantly, all the PCR primer sets 
encompass regions enriched in histone modifications characteristics to active 
chromatin (Figure 6.2), and therefore, the presence of the proteins was 
expected. In parental cells, HMGN1 and HMGN2 are bound at similar levels at all 
the Nanog and Pou5f1 gene primer sets (Figure 6.4). Interestingly, HMGN binding 
is around a third higher at the actively transcribed genes (Actb, Pou5f1, and 
Nanog) than at the poised lineage-specific genes Neurog1, Gata4 and Ascl1 
(Figure 6.4). Although the profile of HMGN1 distribution mimics that of HMGN2 
(Figure 6.4A and B), the HMGN1 enrichment is approximately 70% lower. This 
suggests that HMGN2 binding is higher than HMGN1, or alternatively, that the 
anti-HMGN2 antibody is more efficient at immunoprecipitating chromatin. 
Figure 6.4A shows that in the Hmgn2-knockout lines, B19ΔN2 and B38ΔN2, the 
levels of HMGN2 bound to chromatin are reduced to approximately one third of 
that observed in parental cells. This confirms that the HMGN2 binding detected 
in parental cells is specific. The residual binding in the Hmgn2-knockout cells is 
likely to be due to non-specific chromatin binding to the antibody or the beads, 
as western blotting shows that HMGN2 protein synthesis is completely abolished 
in B19ΔN2 and B38ΔN2 cells (Figure 3.1 and Figure 3.2).  
Previous studies found that, although gene expression and protein levels of 
HMGN1 in Hmgn2-knockout cells and tissues remain the same as in control 
littermates, there is some functional compensation, and an anti-HMGN1 antibody 
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precipitates twice as much chromatin from Hmgn2-knockout cells than from 
control cells (Deng et al, 2015). Figure 6.4B shows that the HMGN1 binding to 
chromatin increases in B19ΔN2 and B38ΔN2 cells, specifically at the genes that 
are actively transcribed in pluripotent cells (Actb, Pou5f1, and Nanog) and at 
the pro-neural transcription factors that are also expressed in Hmgn-knockout 
cells. Hence, it seems that increased HMGN1 binding partially compensates for 
the loss of HMGN2, particularly at actively transcribed genes.  
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Figure 6.4 HMGN1 and HMGN2 binding to chromatin at pluripotency and lineage-specific 
genes in parental cells and after the loss of HMGN2 
Chromatin samples were prepared from parental, B19ΔN2, and B38ΔN2 cells and 
immunoprecipitated with antibodies for (A) HMGN2 and (B) HMGN1. The resulting DNA was 
purified and tested for promoter and regulatory regions of pluripotency and lineage-specific genes 
by qPCR. The graphs represent the fold change in comparison with H3, error bars symbolise the 
SD from a PCR triplicate, and the statistical significance was calculated by two-tailed Student T test 
and Bonferroni correction for multiple comparisons, considering two comparisons per gene and 
immunoprecipitation (p value *<0.025).  
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6.4 H3K4me3 and H3K27me3, marks of transcriptional 
activation and repression, respectively, and bivalent 
domains 
H3K4me3 is a modification associated with active transcription (Sims et al, 
2003). Conversely, H3K27me3 is preferentially deposited at genes that require 
transcriptional silencing (Sims et al, 2003). In addition, both modifications are 
found in bivalent domains, which ensures transcriptional repression while poising 
the genes for transcriptional activation in later developmental stages (Azuara et 
al, 2006; Bernstein et al, 2006; Mikkelsen et al, 2007). 
Most of the primer sets utilised in the present study target regions enriched in 
H3K4me3 in ESCs, indicating either active transcription or bivalent domains 
(Figure 6.2). Accordingly, H3K4me3 is enriched by up to 25 fold relative to H3 at 
the genomic regions tested (Figure 6.5A). In parental cells, the distribution of 
H3K4me3 along Nanog is in agreement with the classical pattern observed in the 
laboratory (West, unpublished) and in ESCs (Figure 1.2), where the mark is low 
at the potential upstream enhancer (Nanog-1), higher in the proximal promoter 
(Nanog-2), highest just after the first exon (Nanog-3), and lower towards the 
centre of the first intron (Nanog-4) (Figure 6.5A). Data from ESCs also support a 
peak of H3K4me3 at the end of the first exon of Pou5f1 (Pou5f1-3, Figure 6.2). 
The enrichment of H3K4me3 is lower at Nanog than at Pou5f1 and lineage-
specific genes (Figure 6.5A), which is not related with transcription rates since 
Nanog transcript levels are considerable higher than those of lineage-specific 
genes in parental cells, although Nanog gene expression is indeed lower than 
that of Pou5f1. 
Loss of HMGN2 influences the accumulation of H3K4me3, since some or most of 
the chromatin regions tested in B19ΔN2 and B38ΔN2 cells, respectively, exhibit 
reduced levels of this modification compared to parental cells (Figure 6.5A). The 
lower H3K4me3 signal is not a simple consequence of reduced gene expression, 
as Pou5f1 transcript levels are similar in Hmgn2-knockout and parental cells 
(Figure 3.10A). However, there is some correlation between gene expression and 
H3K4me3 at the other genes tested. For example, in B38ΔN2 cells, the levels of 
Nanog mRNA and H3K4me3 along Nanog gene are both reduced, whereas in 
B19ΔN2 cells, Nanog mRNA levels are unchanged and the reduction in H3K4me3 
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is restricted to the region targeted by Nanog-3 primer set (Figure 3.10A and 
Figure 6.5A). Similarly, Neurog1 and Ascl1 are highly expressed in B19ΔN2 cells 
(Figure 3.10B) and higher accumulation of H3K4me3 is detected (Figure 6.5A), 
while Gata4 and especially Tbxt transcripts are found at lower levels (Figure 
3.10C), correlating with lower H3K4me3 (Figure 6.5A). 
H3K27me3 levels are low in undifferentiated ESCs and increase during 
differentiation (Marks et al, 2012). Consistent with the repressive nature of this 
modification, its accumulation at the active pluripotency genes in parental P19 
cells is negligible (Figure 6.5B). In fact, dissociation curve analysis fails to 
identify the desired amplicon when using Pou5f1 and Nanog primer sets, except 
in the case of Nanog-4. In contrast, H3K27me3 is detected at lineage-specific 
genes (Figure 6.5B).   
As mentioned above, H3K27me3 is part of the mechanism to silence lineage-
specific genes in ESCs (Boyer et al, 2006). The pro-neural genes are highly 
expressed in B19ΔN2 and B38ΔN2 cells (Figure 3.10B), although changes in the 
pattern of H3K27me3 do not seem to be the reason, since it is not affected by 
the loss of HMGN2 (Figure 6.5B). Previous studies on ESCs lacking both HMGN1 
and HMGN2 report a substantial accumulation of H3K27me3 at lineage-specific 
genes as a result of increased nucleosome binding by H1 (Deng et al, 2017). In 
the Hmgn2-knockout P19 cells, the compensatory activity of HMGN1 (Figure 6.4) 
may be sufficient to compete with H1, providing a possible explanation for this 
contrasting result.  
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Figure 6.5 H3K4me3 and H3K27me3 accumulation at pluripotency and lineage-specific 
genes of parental cells and after the loss of HMGN2 
Chromatin samples were prepared from parental, B19ΔN2, and B38ΔN2 cells and 
immunoprecipitated with antibodies specifically targeting (A) H3K4me3 and (B) H3K27me3. The 
resulting DNA was purified and tested for promoter and regulatory regions of pluripotency and 
lineage-specific genes by qPCR. The graphs represent the fold change in comparison with H3, 
error bars symbolise the SD from a PCR triplicate, and the statistical significance was calculated by 
two-tailed Student T test and Bonferroni correction for multiple comparisons, considering two 
comparisons per gene and histone modification (p value *<0.025).  
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6.5 Histone acetylation, characteristic of open and active 
chromatin 
HMGN1 and HMGN2 proteins enhance histone acetylation (Ueda et al, 2006) and 
loss of HMGN1 is associated with a marked reduction of this modification in cells 
and tissues (Lim et al, 2005). ESC self-renewal is compromised when HAT activity 
is abolished (Fang et al, 2014), while self-renewal is supported by inhibition of 
histone deacetylation (Qiao et al, 2015; Ware et al, 2009). To evaluate whether 
histone acetylation is reduced after the loss of HMGN2, which may provide a 
partial explanation for the changes in self-renewal of Hmgn2-knockout cells, 
ChIP-PCR was performed for the detection of H3K9ac, H3K27ac, and H3K122ac.    
Acetylation of H3K9 is prevalent in ESCs and drops dramatically upon 
differentiation (Efroni et al, 2008; Krejčí et al, 2009; Lee et al, 2003; Qiao et al, 
2015). Figure 6.6A shows that H3K9ac is highly enriched at the actively 
transcribed genes Actb and Pou5f1 of parental P19 cells, with the highest 
enrichment at the primer set downstream of the Pou5f1 TSS (Pou5f1-3). Indeed, 
previous work reports that accumulation of H3K9ac tends to be particularly high 
at around 1 kb downstream of gene TSSs (Qiao et al, 2015). Likewise, the region 
targeted by Nanog-3 primer set shows the highest H3K9ac accumulation at Nanog 
gene locus (Figure 6.6A), even though H3K9ac levels are lower at this gene, in 
line with the H3K4me3 data (Figure 6.5A). 
Importantly, B19ΔN2 and B38ΔN2 cells display lower H3K9ac levels in comparison 
with parental cells (Figure 6.6A). The reduction varies between 50 and 70% at 
most of the regions evaluated in this study, suggesting a global effect following 
the loss of HMGN2 (Figure 6.6A). In line with the H3K4me3 data (Figure 6.5A), 
this excludes the pro-neural genes (Figure 6.6A) that are highly expressed in 
B19ΔN2 and B38ΔN2 cells (Figure 3.10B). However, at all other genomic regions 
investigated, the lower H3K9ac accumulation does not seem to correlate with 
changes in gene expression, as most of the genes are expressed at similar levels 
among the three cell lines (Figure 3.10). These observations suggest that loss of 
HMGN2 interferes with H3K9ac deposition or maintenance, which in turn might 
destabilise the pluripotency transcriptional network. In fact, a growing body of 
evidence suggest that the master regulators of the pluripotency transcriptional 
network recruit HATs as coactivators of their target genes (Fang et al, 2014; 
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Göke et al, 2011; Zhong & Jin, 2009). Importantly, this mechanism is also part of 
the positive feedback loop that potentiates the transcription rates of the master 
regulators (Zhong & Jin, 2009).  
POU5F1, SOX2, and NANOG strongly colocalise with the HATs CREBBP/EP300 at 
enhancers (Göke et al, 2011). Active enhancers are usually marked by the 
colocalisation of H3K4me1 and H3K27ac, and recently, of H3K122ac (Pradeepa et 
al, 2016). In agreement, the Pou5f1-1 primer set reports the highest 
accumulation of both H3K27ac (Figure 6.6B) and H3K122ac in parental P19 cells 
(Figure 6.6C). Interestingly, similar enrichments are detected by Pou5f1-2 
primer set (Figure 6.6B and Figure 6.6C) and may be explained by interactions 
between enhancer and promoter that propagate the modifications (Fang et al, 
2014). In contrast with H3K27ac, H3K122ac is also detected in promoter and 
genic regions (Tropberger et al, 2013), which may explain the presence of 
H3K122ac at lineage-specific genes poised for transcriptional activation, while 
H3K27ac is barely detected (Figure 6.6B and Figure 6.6C). 
H3K27ac and H3K122ac are substantially reduced in B19ΔN2 and B38ΔN2 cells at 
most of the evaluated genomic regions (Figure 6.6 and Figure 6.6C). Nanog 
shows the lowest accumulation of these modifications in the Hmgn2-knockout 
cells, which correlates with the reduced transcript levels in B38ΔN2 cells (Figure 
3.10A). However, the reduced acetylation at the Pou5f1 and Gata4 genes does 
not correlate with gene expression (Figure 3.10). Importantly, Tbxt displays less 
histone acetylation and H3K4me3 in the Hmgn2-knockout cells, while retaining 
H3K27me3 (Figure 6.5 and Figure 6.6). This may result in a more repressive 
chromatin state that is consistent with the reduced Tbxt transcript levels (Figure 
3.10C). Conversely, Neurog1 and Ascl1 retain normal levels of modifications 
associated with active transcription (Figure 6.5 and Figure 6.6), and therefore, 
the chromatin structure at these genes may be permissive for transcription in 
B19ΔN2 and B38ΔN2 cells (Figure 3.10B). 
Chapter 6  156 
 
 
Figure 6.6 H3 acetylation in pluripotency and lineage-specific genes of parental cells and 
after the loss of HMGN2 
Chromatin samples were prepared from parental, B19ΔN2, and B38ΔN2 cells and 
immunoprecipitated with antibodies specifically targeting (A) H3K9ac, (B) H3K27ac, and (C) 
H3K122ac. The resulting DNA was purified and tested for promoter and regulatory regions of 
pluripotency and lineage-specific genes by qPCR. The graphs represent the fold change in 
comparison with H3, error bars symbolise the SD from a PCR triplicate, and the statistical 
significance was calculated by two-tailed Student T test and Bonferroni correction for multiple 
comparisons, considering two comparisons per gene and histone modification (p value *<0.025). 
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Taken together, the ChIP-PCR experiments suggest that HMGN2 promotes open 
chromatin conformations in P19 cells at all genomic regions tested, as its loss 
results in lower accumulation of modifications related with active transcription, 
such as histone acetylation and H3K4me3. The pattern of histone modifications 
does not always correlate with gene expression, suggesting that there are other 
factors regulating transcription. Furthermore, histone acetylation and 
methylation does not exclusively rely on the presence of HMGN2, since the genes 
encoding pro-neural transcription factors display normal levels of these 
modifications. 
6.6 Loss of a major HMGN variant leads to global 
reduction of H3 acetylation 
The maintenance and potentiation of a global open chromatin conformation 
seems to be crucial for pluripotency (Ang et al, 2011; Qiao et al, 2015; Ware et 
al, 2009). Therefore, in order to extend the observations made at individual 
genomic locations, the global levels of several histone modifications were 
investigated. Acid histone extracts were prepared from control and Hmgn-
knockout cells and immunoblotting for the detection of H3K4me3, H3K9ac, and 
H3K27ac was performed. 
Figure 6.7 shows that the total levels of H3K4me3 are not affected after the loss 
of HMGN1, since they are comparable in N1-1ΔN1, D3ΔN1 and B1 control cells. In 
addition, B8ΔN2 cells display similar total levels of this modification (Figure 6.7). 
However, a large reduction of 75% in total H3K4me3 is observed in B19ΔN2 cells 
(Figure 6.7), which is consistent with the lower accumulation at pluripotency 
and lineage-specific genes detected by ChIP-PCR (Figure 6.5). 
In the case of H3K9ac, the levels exhibited by B1, N1-1ΔN1, and D3ΔN1 cells 
correspond to approximately half of the levels in parental cells (Figure 6.7). 
Further reduction is observed after the loss of HMGN2, since total H3K9ac in 
B8ΔN2 and B19ΔN2 cells represent around 35% and 25% of parental, respectively 
(Figure 6.7). This is in complete agreement with previous reports showing that 
the effect of HMGN2 on histone acetylation is greater than that of HMGN1 (Ueda 
et al, 2006). However, the fact that B1 cells also contain reduced total levels of 
H3K9ac (Figure 6.7) suggest that the lack of a major HMGN variant is not the 
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only factor regulating this modification. Chapter 3 shows that B1 cells display 
lower Nanog and higher pro-neural transcription factor mRNA levels without 
resulting in spontaneous differentiation. Considering the previous data, it is 
possible to speculate that B1 cells represent a stable pluripotency state that is 
positioned one step further towards differentiation in comparison with parental 
cells. Indeed, loss of H3K9ac is an early event in ESC differentiation (Krejčí et al, 
2009; Qiao et al, 2015). Perhaps there is a lower threshold in the level of histone 
acetylation that correlates with the initiation of differentiation programs, and 
the loss of a major HMGN variant may contribute to reaching that threshold (see 
below). 
H3K27ac preferentially colocalises with active enhancers. Total H3K27ac is 
substantially reduced in Hmgn-knockout cells (Figure 6.7). Although B1 cells also 
display lower levels of this modification than parental cells, the reduction is 
greater after the loss of a major HMGN variant (Figure 6.7). Previous ChIP-seq 
studies show that HMGN1 and HMGN2 are enriched at DHSs particularly marking 
enhancers (Deng, 2015). This may explain the greater changes in total H3K27ac 
than in H3K9ac observed in Hmgn-knockout cells (Figure 6.7). 
As previously mentioned, loss of histone acetylation correlates with the 
initiation of differentiation programs in ESCs (Krejčí et al, 2009; Qiao et al, 
2015). Another major epigenetic event during ESC differentiation is the clipping 
of histone H3, which may represent an efficient mechanism for removing histone 
modifications (Duncan et al, 2008; Vossaert et al, 2014). In mouse, proteolysis of 
the N-terminal tail of H3, mainly at the residue 21, is developmentally regulated 
(Duncan et al, 2008). Accordingly, the abundance of this H3 cleavage product 
(H3.cs1) is slightly higher in Hmgn-knockout cells than in parental and B1 (Figure 
6.7). Importantly, H3 clipping does not explain the global reduction in histone 
acetylation, as the acetylation of the globular domain of H3 at K122 is conserved 
in all cleavage products and is also reduced after the loss of a major HMGN 
variant (Figure 6.6). Furthermore, H3K27 lies after the main cleavage site at 
position 21 (Duncan et al, 2008). Finally, the small increase in H3 clipping does 
not correlate with the large reductions in global H3 acetylation (Figure 6.7). 
Chapter 6  159 
 
 
Figure 6.7 Global reduction of histone acetylation in Hmgn-knockout cells 
WB for the detection of histone modifications related to active transcription, H3K4me3, H3K9ac, 
H3K27ac, and the proteolytic product after clipping at residue 21 of H3 (H3.cs1). Acid histone 
extracts were prepared in duplicate from two different cell passages of parental, B1, and Hmgn-
knockout cells and separated by SDS-PAGE. WB for each histone modification and sample set 
was performed twice or three times. Representative images are displayed (left). The graphs 
represent the average result from the densitometry relative to parental cells and error bars 
symbolises the SEM of two independent samples. 
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6.7 Discussion 
The present chapter investigated the epigenetic landscape in parental and 
Hmgn2-knockout cells at pluripotency genes, silenced lineage-specific genes, 
and lineage-specific genes that are activated after the loss of a major HMGN 
variant. This includes the accumulation of histone acetylation, H3K4me3, 
H3K27me3, and the binding of HMGN1 and HMGN2. In addition, it evaluated 
global levels of histone modifications associated with active transcription in 
ECCs lacking HMGN2. 
Pou5f1 and Nanog are actively transcribed in pluripotent cells, and accordingly, 
they are devoid of the repressive mark H3K27me3, and enriched in H3K4me3 and 
histone acetylation (Figure 6.5 and Figure 6.6). In addition, the binding of 
HMGN1 and HMGN2 is slightly higher at these genes than at the poised lineage-
specific genes in parental cells (Figure 6.4). In agreement, previous ChIP-seq 
data of NSCs show higher enrichment of HMGN1 at the top 40 expressed genes in 
comparison with the bottom 40 (Deng et al, 2013).  
Loss of HMGN2 leads to increased HMGN1 binding along Pou5f1 and Nanog 
(Figure 6.4), consistent with functional compensation between the two major 
HMGN variants (Deng et al, 2015). Nevertheless, these proteins are not fully 
redundant, and changes in the epigenetic landscape of pluripotency genes are 
observed in Hmgn2-knockout cells. In particular, histone modifications related to 
transcriptional activation, such as H3K4me3, H3K9ac, H3K27ac, and H3K122ac 
are reduced (Figure 6.5 and Figure 6.6). The lower accumulation of these 
modifications does not influence Pou5f1 expression but might relate to Nanog 
downregulation in B38ΔN2 cells (Figure 3.10A). Unlike Pou5f1, Nanog is 
transcribed in bursts (Abranches et al, 2014; Kalmar et al, 2009), which may 
increase the dependence of its transcription on histone modifications that 
promote an open local chromatin conformation. In fact, Nanog is downregulated 
when the HAT/co-activator protein  CREBBP/EP300 is knocked down, while 
Pou5f1 remains unchanged (Qiao et al, 2015). Furthermore, EP300 regulates 
Nanog expression, but not that of Pou5f1 (Zhong & Jin, 2009). These 
observations lead to the proposition that HMGNs support an open chromatin 
conformation that enhances transcription at pluripotency genes, particularly at 
genes that rely on their histone acetylation status. 
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The endodermal and mesodermal transcription factors, Gata4 and Tbxt, are 
expressed at low levels in parental cells, which correlates with the bivalent 
modifications found at both promoters, i.e. H3K4me3 and H3K9ac for activation, 
and H3K27me3 for repression (Figure 6.2 and Figure 6.5). As studied in chapter 
3, Gata4 transcript and protein levels remain unchanged in B19ΔN2 and B38ΔN2 
cells, while Tbxt expression is lower than in parental cells (Figure 3.9 and Figure 
3.10C). Importantly, the accumulation of H3K27me3 at promoters of both genes 
remains comparable before and after the loss of HMGN2, while H3K4me3, 
H3K9ac, and H3K122ac are less abundant (Figure 6.5 and Figure 6.6). The 
prevalence of H3K27me3 may result in a repressive chromatin environment, 
explaining the reduced Tbxt transcript levels. This resembles what was 
previously described for pluripotency genes, suggesting that HMGN2 enhances 
modifications related to active transcription without influencing H3K27me3, 
resulting in an open chromatin conformation at several genomic regions. These 
observations contrast with recent work reporting higher enrichment of 
H3K27me3 at lineage-specific genes in Hmgn1 and Hmgn2 double-knockout mice; 
however, the presence of HMGN1 may be sufficient to antagonise the deposition 
of H3K27me3 (Figure 6.4). 
A different scenario is observed at the genes encoding pro-neural transcription 
factors. Similar to endodermal and mesodermal transcription factors, Neurog1 
and Ascl1 transcripts are scarce in parental cells and their gene promoters are 
bivalently marked (Figure 6.2 and Figure 6.5). However, loss of HMGN2 does not 
modify this bivalent signature, as enrichment of H3K27me3, H3K4me3, H3K9ac, 
and H3K122ac is maintained in B19ΔN2 and B38ΔN2 cells at parental levels 
(Figure 6.5 and Figure 6.6). Interestingly, HMGN1 binding increases at Neurog1 
and Ascl1 genes in B19ΔN2 and B38ΔN2 cells, similar to what was observed at the 
actively transcribed genes (Figure 6.4). Perhaps HMGN1 and other epigenetic 
players maintain an open chromatin conformation at pro-neural genes in the 
absence of HMGN2. Since the bivalent domains silence genes, while poising them 
for activation (Azuara et al, 2006; Bernstein et al, 2006), other mechanisms 
should induce Neurog1 and Ascl1 expression in B19ΔN2 and B38ΔN2 (Figure 
3.10B). As these mechanisms operate in the absence of HMGN2, this protein may 
indirectly regulate lineage-specific gene expression in P19 cells (see below). 
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Although the pro-neural genes escape the rule, the loss of HMGN2 leads to lower 
accumulation of H3K4me3 and histone acetylation at several genomic regions in 
P19 cells (Figure 6.5 and Figure 6.6). WB of acid histone extracts from parental, 
B1, and Hmgn-knockout cells confirms a global reduction of H3K9ac and H3K27ac 
in cells lacking a major HMGN variant (Figure 6.7). Lower total levels of these 
modifications are also observed in B1 cells without perturbing self-renewal in 
these cells. However, the changes in Hmgn-knockout lines are greater (Figure 
6.7), perhaps reaching a threshold in which pluripotency is no longer stable. It is 
known that the pluripotency transcription factors POU5F1, SOX2, and NANOG 
promote gene expression by recruiting CREBBP/EP300 to target genes in ESCs, 
especially at enhancers (Fang et al, 2014). It is possible that in P19 cells, HMGNs 
optimise HAT activity, as previously reported for other systems (Lim et al, 2005; 
Ueda et al, 2006). The loss of HMGN proteins would then lead to lower H3K27ac 
at enhancers and lower H3K9ac at promoters and gene bodies of POU5F1, SOX2, 
and NANOG targets (Figure 6.6 and Figure 6.7), which consequently destabilises 
pluripotency gene expression. In this regard, the inhibition of HDACs has been 
shown to increase both H3K9ac and pluripotency gene expression (Qiao et al, 
2015). In addition, there is growing body of evidence suggesting that global 
histone acetylation and open chromatin conformation support ESC self-renewal 
(Mattout & Meshorer, 2010; Niwa, 2007). 
In conclusion, HMGN proteins promote an open chromatin conformation by 
influencing the accumulation of histone modifications related to active 
transcription, such as H3K4me3, H3k9ac, H3K27ac, and H3K122ac. Loss of a 
major HMGN variant leads to changes at local and global levels of the mentioned 
modifications, and therefore, of chromatin structure. At local levels, those 
changes directly influence gene expression, while at a global level they seem to 
perturb the pluripotency transcriptional network. Importantly, intrinsic cellular 
programs compensate or potentiate the effects triggered by the loss of HMGN1 
or HMGN2, which ultimately results in the perturbation of the stem cell identity. 
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Chapter 7 Conclusions and future work 
7.1 Summary and conclusions 
The present work studied the phenotypical alterations of P19 cells after the loss 
of HMGN1 or HMGN2. P19 cells represent a widely used model of embryonal 
pluripotent cells that express pluripotency markers, consistent with their 
embryonal identity. These cells indefinitely self-renew and do not differentiate 
unless stimulated, and accordingly, they present a mostly uniform morphology 
(Jones-Villeneuve et al, 1982; McBurney, 1993; McBurney & Rogers, 1982). In 
contrast, P19 cells lacking HMGN1 or HMGN2 are morphologically heterogeneous 
and grow in a more dispersed manner than control cells, resembling the 
differentiated cells in ESC cultures (Trott & Martinez Arias, 2013; Wray et al, 
2010). Indeed, a proportion of Hmgn-knockout cells spontaneously differentiate 
into mainly, but not exclusively, neural lineages. Furthermore, Hmgn-knockout 
cultures display lower levels of pluripotency markers and higher lineage-specific 
gene expression, particularly of pro-neural transcription factors, which suggest a 
higher propensity towards differentiation. These observations support a relevant 
role for HMGNs in maintaining ECC identity.  
Inhibition of the main signalling pathways involved in neuronal differentiation, 
such as WNT, FGF, and NOTCH (Martynoga et al, 2012), does not re-establish 
pluripotency and pro-neural gene expression of Hmgn-knockout cells, suggesting 
that the cells that initiate neuronal differentiation follow an intrinsic and cell-
autonomous program that is consistent with the default model of neural 
induction (Hemmati-Brivanlou, 1997; Munoz-Sanjuan & Brivanlou, 2002; Wilson & 
Edlund, 2001). 
Loss of a major HMGN variant does not have a major influence on neuronal 
differentiation of P19 cells after active stimulation of neurogenesis (Nakayama 
et al, 2014). However, the higher propensity of unstimulated cells to 
differentiate towards neural fates following serum withdrawal increases the 
induction of pro-neural transcription factors, which could result in increased 
neuronal differentiation (Busskamp et al, 2014; Farah et al, 2000; Reyes et al, 
2008; Thoma et al, 2012; Velkey & O'Shea, 2013). Furthermore, NSCs derived 
from Hmgn-knockout cells display higher pro-neural gene expression and 
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spontaneous neuronal differentiation, suggesting that HMGNs are important for 
proper cell fate decisions of all the stem cells, including ECCs and NSCs, with 
their presence favouring the preservation of the stem cell identity. 
A growing body of evidence supports an essential role for chromatin structure 
and modifiers during developmental decisions and transitions, that is beyond 
simply stabilising the expression profile driven by transcription factors (Chen & 
Dent, 2013). Indeed, the precise control of gene expression in cell fate 
determination requires collaborative interactions, and the master regulators of 
pluripotency recruit chromatin modifiers to achieve both target gene expression 
and feedback loops (Ang et al, 2011; Chen et al, 2008; Fang et al, 2014; Göke et 
al, 2011; Zhong & Jin, 2009). Furthermore, chromatin structure has been shown 
to act as a buffer where the chromatin modifiers fine-tune gene expression 
(Wang et al, 2009). This function becomes particularly relevant in pluripotent 
cells that have inherent transcriptional noise (Efroni et al, 2008). The chromatin 
of pluripotent cells has a remarkable plasticity that becomes more limited in 
differentiated cells (Deng et al, 2013; Efroni et al, 2008; Guenther et al, 2007; 
Krejčí et al, 2009; Meshorer et al, 2006). Chromatin plasticity and 
developmental potential have been directly correlated (Kishi et al, 2012), and 
seem to be supported by mechanisms that maintain an open chromatin state 
(Mattout & Meshorer, 2010; Niwa, 2007). 
In this sense, HMGNs have been shown to fine-tune gene expression (Deng et al, 
2013; Deng et al, 2015; Kugler et al, 2013; Zhang et al, 2016), to dampen the 
magnitude of the transcriptional response (Zhang et al, 2016), and to promote 
an open chromatin conformation at particular genomic regions (Cuddapah et al, 
2011; Deng et al, 2017; Deng et al, 2013; Deng et al, 2015; Zhang et al, 2016). 
However, little is known about the mechanisms underlying these observations.  
In the present work, HMGN proteins influence the accumulation of histone 
modifications related to active transcription, such as H3K4me3, H3K9ac, 
H3K27ac, and H3K122ac. Loss of a major HMGN variant disrupts the active 
histone modification landscape, and therefore, chromatin structure at local and 
global levels. Locally, those changes directly influence gene expression of 
pluripotency and lineage-specific transcription factors, while globally they may 
restrict chromatin plasticity. Importantly, intrinsic cellular factors compensate 
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or potentiate the effects triggered by the loss of HMGN1 or HMGN2, thus the 
HMGNs are not the only proteins modulating chromatin structure. The present 
data support a role for HMGNs in contributing to chromatin plasticity of stem 
cells by promoting an active histone modification landscape and an open 
chromatin conformation that are essential for preserving the self-renewal and 
developmental potential of stem cells. 
The hypothesis of this project was that the two major members of the HMGN 
family, HMGN1 and HMGN2, play an important role in the establishment and/or 
maintenance of the active chromatin conformation and histone modification 
landscape of pluripotent cells, which in turn are essential for the preservation of 
the self-renewal and the differentiation potential of these cells. The results 
confirm the hypothesis since loss of HMGN1 or HMGN2 in ECCs, and additionally 
in NSCs, leads to increased spontaneous differentiation, mainly towards neural 
fates, to higher lineage-specific gene expression, and to reduced accumulation 
of histone modifications associated with active and decondensed chromatin, 
which ultimately implies that, at least, a high proportion of cells loses their 
stem cell identity. 
7.2 Future work 
A major issue during the development of the present work was the clonal 
variation. The derivation of Hmgn1- and Hmgn2-knockout lines, previously 
performed in the laboratory, included the selection and expansion of monoclonal 
lines lacking either HMGN1 (Eden, West, unpublished) or HMGN2 (Sindi, 2017). 
Two different methods were used after the transfection of the P19 population 
with the CRISPR/Cas system; selection with 6-thioguanine facilitated the 
expansion of exclusively Hprt- and Hmgn1-knockout single-cell colonies (Eden, 
West, unpublished), while plating at limiting dilution allowed the expansion of 
single-cell colonies that subsequently were screened by IF and WB, selecting 
those lacking HMGN2 (Sindi, 2017). As a result, seven monoclonal lines including 
two Hmgn1-knockout, three Hmgn2-knockout, and two controls, constituted the 
object of study of this work, in addition to the parental cells.  
Inconsistencies in the prevalence and abundance of pluripotency and lineage-
specific markers are observed among B8∆N2, B19∆N2, and B38∆N2 cells, and 
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strikingly, between N1-1∆N1 and D3∆N1 cells (see chapter 3). Furthermore, the 
accumulation of H3K4me3 after the loss of HMGN2 differs in B19∆N2 and B38∆N2 
cells (Figure 6.5). These inconsistencies are attributed to clonal variations for 
the reasons presented below. First, the pluripotency of P19 cells is not 
homogeneous, which is evidenced by the cytoplasmic protuberances of the cells 
at the edges of the colonies (Figure 3.3, arrowheads) that are absent in the cells 
at the centre. In addition, P19 cells contain different levels of the naïve 
pluripotency transcription factor NANOG, and therefore, the reciprocal rates of 
transcription of lineage-specific genes within a population (Kalmar et al, 2009). 
Second, the cloning process required to derivate monoclonal lines involves 
phenotypical adaptations that allow the colony expansion from individual cells, 
regardless of the presence of other cells and of cell-to-cell communication. 
These adaptations are conserved and propagated in the monoclonal line. Then, 
it is possible to speculate that D3∆N1 cells originated from a pluripotent cell 
with a transcriptional profile biased to endodermal lineages, while N1-1∆N1 cells 
were poised to neuronal differentiation before CRISPR editing. In such a 
scenario, the loss of HMGNs disturbs pluripotency and the cells differentiate into 
the lineages dictated by their pre-existing transcription profile. Alternatively, 
the cloning process could apply a selection force to an Hmgn2-knockout cell that 
resulted in B19∆N2 cells with Nanog transcript levels similar to parental cells, 
rather than to B8∆N2 and B38∆N2 cells (Figure 3.10A).  
To overcome these inconsistencies that introduce noise to the data and 
challenge its credibility, it is worth to consider other systems for the derivation 
of Hmgn1- and Hmgn2-knockout cells. Huge improvements have been achieved 
from the start date of the present project in the application of the CRISPR/Cas 
system for genome editing and regulation, developing strategies that do not 
require monoclonal derivation and screening. Cas9-induced homology directed 
repair has been successfully used to tag endogenous genes with GFP (Leonetti et 
al, 2016) among other tags, raising the possibility of using GFP as a donor DNA 
that replaces the target gene. In this sense, Hmgn1- and Hmgn2-knockout cells 
could be sorted by FACS after transfection and immediately propagated and 
characterised as polypopulations, overcoming the clonal variability. Moreover, 
Hmgn1 and Hmgn2 double-knockout cells could be generated and selected with 
ease by using two different fluorescent reporters, which would extend the 
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knowledge generated in this work by circumventing the functional redundancy 
between the two major HMGN variants (Deng et al, 2015).  
Another strategy would be the application of the CRISPR interference (CRISPRi) 
system, which utilises a deactivated version of the Cas9 lacking endonuclease 
activity that is targeted by a gRNA to the gene of interest to repress its 
expression either allosterically or by recruiting transcriptional repressors 
(Dominguez et al, 2015). Therefore, P19 cells could be transfected with the 
deactivated Cas9 and gRNAs targeting the gene promoters of Hmgn1 and Hmgn2, 
resulting in their transcriptional silencing. The phenotypical alterations could be 
directly evaluated in the polypopulation, which circumvents the clonal 
variability. Interestingly, numerous gRNAs targeting the promoters of the genes 
coding for all HMGN variants would generate the first cells depleted of all 
HMGNs. Furthermore, CRISPRi represents a reversible system, since the 
deactivated Cas9 allow the manipulation of gene expression without altering the 
DNA sequence (Dominguez et al, 2015), which is suitable for the analysis of the 
role of HMGNs during differentiation processes. In this regard, NSCs can be 
derived from P19 cells and their identity and homogeneity can be ensured before 
the application of CRISPRi targeting HMGNs. The previous strategy would 
guarantee that the phenotypical alterations observed in the targeted NSCs are 
exclusively caused by the loss of HMGNs, rather than by previous phenotypes in 
the pluripotent state or by problems in the neural induction. 
Beyond the clonal variability, the five Hmgn-knockout monoclonal lines present 
higher transcriptional rates of lineage-specific genes, especially of pro-neural 
transcription factors, in comparison with control lines (Figure 3.10). In addition, 
numerous cells have lost pluripotency markers and are positive for the neuronal 
marker TUBB3 (Figure 3.8). The previous data support a relevant role of HMGN1 
and HMGN2 in the maintenance of the ECC identity, at least in a proportion of 
ECCs. Nevertheless, there is not enough evidence to conclude that the loss of 
HMGNs increases the propensity of all ECCs to differentiate, since the present 
work evaluated the expression of limited genes and few differentiation markers.  
Broader methods such as RNA-seq would elucidate whether the loss of HMGNs in 
P19 cells switches their pluripotency state towards another closer to 
differentiation. CRISPRi can target Hmgn1, Hmgn2, and both genes in different 
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P19 cell cultures. A pilot experiment would inform about the timing required to 
deplete HMGN proteins from P19 cells and to observe the first differentiated 
cells. Collection of RNA samples would be performed just before the appearance 
of the first differentiated cells that can alter the expression profile of the 
remaining ECC population. RNA-seq data from these cultures can be used in GO 
enrichment analysis to reveal whether Hmgn-knockout cells moved from the 
parental state of pluripotency to a poised pluripotency biased to certain cellular 
lineages. Single-cell RNA-seq carried would complement the previous 
experiments by showing the frequencies in which a cell prefers one lineage or 
another, perhaps identifying functional differences between HMGN1 and HMGN2. 
Considering the observations of the present work, it would be expected that 
most of the Hmgn-knockout cells are found in a pluripotency state poised to 
neuronal differentiation. However, single-cell RNA-seq results may explain the 
phenotypical differences of D3∆N1 cells in comparison with the other Hmgn-
knockout lines studied in this work. 
Developmental specification is accompanied by epigenetic restriction and 
chromatin condensation (Kishi et al, 2012). ChIP-PCR carried out in B19∆N2, 
B38∆N2, and parental cells shows that, there is a reduction in H3 acetylation and 
H3K4me3 accumulation at different putative regulatory regions of pluripotency 
and lineage-specific genes after the loss of HMGNs (Figure 6.5 and Figure 6.6). 
Chromatin can be collected from P19 cultures in which Hmgn1, Hmgn2, and both 
genes are repressed by CRISPRi at the same time point of the collection of RNA 
for RNA-seq experiments. The working hypothesis is that HMGNs are relevant for 
the ECC identity, and therefore, their loss switches the pluripotency state of P19 
cells to a poised pluripotency biased to neural lineages. In addition to expression 
profiles that correspond to a transition state between pluripotency and early 
neuronal differentiation potentially identified by RNA-seq, ChIP-seq data would 
reveal chromatin condensation in Hmgn-knockout cells in comparison with 
parental. It is expected a reduced accumulation of H3K4me3, H3K9ac, H3K27ac, 
and H3K4me1 in several regulatory regions, especially in those of pluripotency 
genes, which may destabilise the pluripotency network lowering the threshold in 
which Hmgn-knockout cells respond to differentiation. Conversely, pro-neural 
genes, that are expected to orchestrate neuronal differentiation, would retain 
the active histone modifications at their regulatory regions.  
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In summary, alternative knockdown or knockout approaches in combination with 
broader systems for the analysis of gene expression profiles and histone 
modification landscapes would reinforce the findings and conclusions of the 
present work. In such scenario, the interpretation would be that HMGNs 
maintain P19 cell identity by promoting an active chromatin organisation that 
optimises the pluripotency network and protect the cells from precocious 
differentiation. Interestingly, a very recent paper from Bustin lab shows that the 
binding of HMGN to cell-specific enhancers stabilises cell identity (He et al, 
2018). The authors observed that loss of HMGNs enhances the rate of 
reprogramming of MEFs into iPSCs following the ectopic expression of POU5F1, 
SOX2, KLF4, and MYC (He et al, 2018). Beyond the application that this finding 
can have in cellular reprogramming, the paper demonstrates that HMGNs are 
required to maintain a chromatin organisation that respond adequately to 
biological cues (He et al, 2018), which is complete agreement with the 
propositions of the present work. The emerging picture is that HMGNs increase 
the threshold required for cells to respond to signalling events inducing different 
cellular fates by providing an active histone modification landscape and open 
chromatin conformation at regulatory regions of cell-type specific genes, 
stabilising the transcriptional networks. 
Although it seems to be concordance in the conclusions of other works and the 
present work, there are certain discrepancies in the data. Bustin lab has not 
observed neither important differences in the expression profiles of ESCs derived 
from Hmgn1 and Hmgn2 double-knockout and WT mice, nor changes in the 
steady state levels of H3K27ac and H3K4me3 (Deng et al, 2017; Deng et al, 2013; 
Deng et al, 2015; He et al, 2018). However, the culturing conditions for ESCs are 
designed to sustain pluripotency and prevent differentiation. Then, it is possible 
to speculate that the extrinsic stimulation is sufficient to stabilise the 
pluripotency network regardless the presence of HMGNs. In this regard, P19 cells 
are closer to the primed state of pluripotency, EpiSCs and hESCs, rather than to 
the naïve pluripotency achieved by culturing ESCs in 2i. Perhaps the threshold of 
P19 to undergo differentiation is lower than that of ESCs, and therefore, the 
cells are more sensitive to epigenetic perturbations. 
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ECCs constituted the first capture of pluripotency in vitro, however, their 
transformed nature questions their suitability as a stem cell model. As previously 
discussed, the P19 system was permissive for the identification of a phenotype 
after the loss of HMGNs that has not been identified in highly stable systems. 
Importantly, the experiments carried in P19 cells derived in similar conclusions 
of a recent work (He et al, 2018), which supports the suitability of P19 cells as a 
model to investigate the function of HMGNs in mammalian cells. Therefore, P19 
cells can be further exploited to investigate the molecular mechanisms by which 
these proteins stabilise an active chromatin conformation, and therefore, the 
pre-existing transcriptional networks, impeding chromatin remodelling that 
result in precocious cellular conversion.  
Nevertheless, P19 cells might not be the model of choice to conduct 
experiments aiming to understand the role of HMGNs in an entire organism. In 
this sense, the findings of the present work contrast the apparently normal 
development of Hmgn1-knockout, Hmgn2-knockout, and double-knockout mice. 
As previously reviewed, these mice are viable and do not present strong or 
obvious phenotypes (Birger et al, 2003; Deng et al, 2015). However, the pre- and 
post-implantation mouse epiblast is remarkably flexible. For instance, it is 
capable to rapidly adjust increases or decreases in cell number, which allow 
embryological perturbation and transplantation, and additionally, it shows cell 
fate re-specification by heterotopic grafting (Martello & Smith, 2014; Smith, 
2017). Hence, the observations reported in the present work of increased 
differentiation and compromised self-renewal and pluripotency of P19 cells after 
the loss of HMGN1 or HMGN2 are not relevant for the early development of an 
entire organism that can adjust to variations in cell number in the case of the 
precocious differentiation of a few cells.  
In contrast to the early embryo, the size and morphology of neural tissues relies 
on the precise spatio-temporal regulation of cellular fates and on the molecular 
switches between the expansion, neurogenic, and gliogenic phases (Hirabayashi 
& Gotoh, 2005; Miller & Gauthier, 2007). Interestingly, a previous study 
suggested that HMGN proteins promote astrocyte differentiation of NSCs at the 
onset of the astrogenic phase, but not in the neurogenic, during brain 
development (Nagao et al, 2014). Overexpression of HMGN1, HMGN2, and HMGN3 
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at the gliogenesis onset resulted in increased number of astrocytes at the 
expenses of neurons in the cerebral cortex of one-week mice, however, when 
the overexpression of the proteins occurred in the neurogenic phase, no effects 
were observed (Nagao et al, 2014). Conversely, knockdown of HMGN1, HMGN2, 
and HMGN3 at bird, markedly reduced the number of GFAP-positive astrocytes in 
the cortex of one-week old mice, while increasing the number of upper layer 
neurons (Nagao et al, 2014). These results suggest that HMGNs stabilise the 
neurogenic to gliogenic transition of NSCs, highlighting the relevance of the 
maintenance of the cell identity by HMGNs in vivo.  
In addition, the present work shows that HMGNs maintain NSC identity, as Hmgn-
knockout NSCs display higher mRNA levels of pro-neural factors and spontaneous 
neuronal differentiation. This could translate into precocious neurogenesis 
during nervous system development and could explain the reduction of NSCs at 
the SVZ of two-week old Hmgn1-knockout mice (Deng et al, 2013). It would be 
interesting to extend this finding to the neurogenic niches, SVZ and dentate 
gyrus of the hippocampus, of Hmgn2-knockout and double-knockout mice. 
Subsequently, to evaluate whether the lower number of NSCs leads to impaired 
adult neurogenesis when stimulated with exercise or learning and memory tasks. 
Finally, to investigate whether these neurogenic niches remain with lower NSCs 
numbers during all adulthood, or whether the pool is completely extinguished or 
re-established at certain age. These experiments are of special interest, since 
adult NSCs contribute to brain homeostasis, and adult neurogenesis confers 
repair and regeneration capacity, among other plasticity functions (Winner et al, 
2011). 
HMGNs are ubiquitous proteins with high degree of evolutionary conservation 
from their appearance in vertebrates. It is surprising that their loss does not 
result in stronger phenotypes. The present and previous studies have identified 
that the loss of HMGNs particularly influences processes where chromatin 
remodelling is required, ensuring proper cellular responses to stimuli. This is the 
case of cellular differentiation and reprogramming (He et al, 2018), B-cell 
activation by lipopolysaccharide (Zhang et al, 2016), glucose metabolism after 
feeding (Ueda et al, 2009), and DNA repair after damage (Birger et al, 2003). 
Therefore, it is possible to speculate that stress conditions reveal stronger 
Chapter 7  172 
 
phenotypes in mice. Likewise, aging could trigger robust alterations. The Hmgn1 
and Hmgn2 double-knockout mouse was recently generated (Deng et al, 2015) 
and there is not available information of aging processes in these or single-
knockout animals. Observation and analysis of aging Hmgn-knockout mice would 
have a high value, particularly considering the growing body of evidence that 
associates aging with tissue-specific stem cell function (Goodell & Rando, 2015), 
cell types in which HMGNs are highly expressed and have important roles in their 
stability.
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Appendix 1 
 
Supplementary Figure Derivation of monoclonal lines from parental cells 
P19 parental cells were plated at limited dilution in 96-well plates and six monoclonal lines were 
expanded from single cells (M1-M6). Relative expression of the pluripotency transcription factor 
Nanog and the pro-neural transcription factors Neurog1 and Ascl1 was determined by qRT-PCR. 
The graph represents the fold change in comparison with parental cells and error bars symbolise 
the SD of a PCR triplicate. One out of six clones shows lower Nanog expression. The transcription 
rates of Nanog and pro-neural transcription factor are inversely correlated. Data provided by A. 
Sindi (unpublished). 
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Abstract 
Background: Chromatin plasticity is thought to be fundamental to the pluripotency of 
embryonic stem cells.  Here, we investigate whether HMGN proteins play a role in 
maintaining the epigenetic landscape in stem cells. HMGN family members modulate 
chromatin structure and influence epigenetic modifications. They are highly expressed 
during early development and in the neural stem/progenitor cells of the developing and 
adult brain.  
Results: We show that functional knockout of Hmgn1 or Hmgn2 in pluripotent embryonal 
carcinoma cells leads to increased levels of spontaneous neuronal differentiation. This is 
accompanied by the loss of pluripotency markers and increases in expression of the pro-
neural transcription factors Neurog1 and Ascl1. Neural stem cells derived from these 
Hmgn-knockout lines also show increased levels of spontaneous neuronal differentiation 
and Neurog1 expression. The loss of HMGN2 is associated with the disruption of active 
chromatin states at specific classes of gene. The levels of H3K4me3, H3K9ac, H3K27ac 
and H3K122ac are considerably reduced at the pluripotency genes Nanog and Pou5f1, 
which impacts transcription. At endodermal/mesodermal lineage-specific genes, the loss 
of HMGN2 leads to a switch from a bivalent state to a repressive chromatin configuration. 
However, at the neuronal lineage genes Neurog1 and Ascl1, no epigenetic changes are 
observed and their bivalent states are retained. 
Conclusions: We conclude that HMGN proteins play important roles in maintaining 
chromatin plasticity in stem cells, and are essential for maintaining stem cell identity and 
pluripotency.  
Keywords: HMGN, chromatin, epigenetics, stem cells, embryonal carcinoma 
cells, differentiation, neuronal 
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